#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Alterations of Resting State Functional Network Connectivity in the Brain of Nicotine and Alcohol Users
#Text=Alcohol and nicotine intake result in neurological alterations at the circuit level.
1-1	0-11	Alterations	_
1-2	12-14	of	_
1-3	15-22	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-4	23-28	State	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-5	29-39	Functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-6	40-47	Network	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-7	48-60	Connectivity	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-8	61-63	in	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-9	64-67	the	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-10	68-73	Brain	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-11	74-76	of	_
1-12	77-85	Nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
1-13	86-89	and	_
1-14	90-97	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-15	98-103	Users	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[2]
1-16	104-111	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-17	112-115	and	_
1-18	116-124	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
1-19	125-131	intake	_
1-20	132-138	result	_
1-21	139-141	in	_
1-22	142-154	neurological	_
1-23	155-166	alterations	_
1-24	167-169	at	_
1-25	170-173	the	_
1-26	174-181	circuit	_
1-27	182-187	level	_
1-28	187-188	.	_

#Text=Resting state functional connectivity has shown great potential in identifying these alterations.
2-1	189-196	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]
2-2	197-202	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[3]
2-3	203-213	functional	_
2-4	214-226	connectivity	_
2-5	227-230	has	_
2-6	231-236	shown	_
2-7	237-242	great	_
2-8	243-252	potential	_
2-9	253-255	in	_
2-10	256-267	identifying	_
2-11	268-273	these	_
2-12	274-285	alterations	_
2-13	285-286	.	_

#Text=However, current studies focus on specific seeds and leave out many brain regions where effects might exist.
3-1	287-294	However	_
3-2	294-295	,	_
3-3	296-303	current	_
3-4	304-311	studies	_
3-5	312-317	focus	_
3-6	318-320	on	_
3-7	321-329	specific	_
3-8	330-335	seeds	_
3-9	336-339	and	_
3-10	340-345	leave	_
3-11	346-349	out	_
3-12	350-354	many	_
3-13	355-360	brain	_
3-14	361-368	regions	_
3-15	369-374	where	_
3-16	375-382	effects	_
3-17	383-388	might	_
3-18	389-394	exist	_
3-19	394-395	.	_

#Text=The present study uses a data driven technique for brain segmentation covering the whole brain.
4-1	396-399	The	_
4-2	400-407	present	_
4-3	408-413	study	_
4-4	414-418	uses	_
4-5	419-420	a	_
4-6	421-425	data	_
4-7	426-432	driven	_
4-8	433-442	technique	_
4-9	443-446	for	_
4-10	447-452	brain	_
4-11	453-465	segmentation	_
4-12	466-474	covering	_
4-13	475-478	the	_
4-14	479-484	whole	_
4-15	485-490	brain	_
4-16	490-491	.	_

#Text=Functional magnetic-resonance-imaging (fMRI) data were collected from 188 subjects: 51 non-substance consumption controls (CTR), 36 smoking-and-drinking subjects (SAD), 28 drinkers (DRN), and 73 smokers (SMK).
5-1	492-502	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-2	503-529	magnetic-resonance-imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-3	530-531	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-4	531-535	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-5	535-536	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[4]
5-6	537-541	data	_
5-7	542-546	were	_
5-8	547-556	collected	_
5-9	557-561	from	_
5-10	562-565	188	_
5-11	566-574	subjects	_
5-12	574-575	:	_
5-13	576-578	51	_
5-14	579-592	non-substance	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
5-15	593-604	consumption	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
5-16	605-613	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]
5-17	614-615	(	_
5-18	615-618	CTR	_
5-19	618-619	)	_
5-20	619-620	,	_
5-21	621-623	36	_
5-22	624-644	smoking-and-drinking	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[7]
5-23	645-653	subjects	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[7]
5-24	654-655	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[7]
5-25	655-658	SAD	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[7]
5-26	658-659	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[6]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[7]
5-27	659-660	,	_
5-28	661-663	28	_
5-29	664-672	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
5-30	673-674	(	_
5-31	674-677	DRN	_
5-32	677-678	)	_
5-33	678-679	,	_
5-34	680-683	and	_
5-35	684-686	73	_
5-36	687-694	smokers	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
5-37	695-696	(	_
5-38	696-699	SMK	_
5-39	699-700	)	_
5-40	700-701	.	_

#Text=Data were processed using group independent component analysis to derive resting state networks (RSN).
6-1	702-706	Data	_
6-2	707-711	were	_
6-3	712-721	processed	_
6-4	722-727	using	_
6-5	728-733	group	_
6-6	734-745	independent	_
6-7	746-755	component	_
6-8	756-764	analysis	_
6-9	765-767	to	_
6-10	768-774	derive	_
6-11	775-782	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]
6-12	783-788	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]
6-13	789-797	networks	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[8]
6-14	798-799	(	_
6-15	799-802	RSN	_
6-16	802-803	)	_
6-17	803-804	.	_

#Text=The resting state functional network connectivity (rsFNC) was then calculated through correlation between time courses.
7-1	805-808	The	_
7-2	809-816	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[9]
7-3	817-822	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[9]
7-4	823-833	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[9]
7-5	834-841	network	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[9]
7-6	842-854	connectivity	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[9]
7-7	855-856	(	_
7-8	856-861	rsFNC	_
7-9	861-862	)	_
7-10	863-866	was	_
7-11	867-871	then	_
7-12	872-882	calculated	_
7-13	883-890	through	_
7-14	891-902	correlation	_
7-15	903-910	between	_
7-16	911-915	time	_
7-17	916-923	courses	_
7-18	923-924	.	_

#Text=One-way ANOVA tests were used to detect rsFNC differences among the four groups.
8-1	925-932	One-way	_
8-2	933-938	ANOVA	_
8-3	939-944	tests	_
8-4	945-949	were	_
8-5	950-954	used	_
8-6	955-957	to	_
8-7	958-964	detect	_
8-8	965-970	rsFNC	_
8-9	971-982	differences	_
8-10	983-988	among	_
8-11	989-992	the	_
8-12	993-997	four	_
8-13	998-1004	groups	_
8-14	1004-1005	.	_

#Text=A total of 50 ANOVA tests were significant after multi-comparison correction.
9-1	1006-1007	A	_
9-2	1008-1013	total	_
9-3	1014-1016	of	_
9-4	1017-1019	50	_
9-5	1020-1025	ANOVA	_
9-6	1026-1031	tests	_
9-7	1032-1036	were	_
9-8	1037-1048	significant	_
9-9	1049-1054	after	_
9-10	1055-1071	multi-comparison	_
9-11	1072-1082	correction	_
9-12	1082-1083	.	_

#Text=Results delineate a general pattern of hypo-connectivity in the substance consumers.
10-1	1084-1091	Results	_
10-2	1092-1101	delineate	_
10-3	1102-1103	a	_
10-4	1104-1111	general	_
10-5	1112-1119	pattern	_
10-6	1120-1122	of	_
10-7	1123-1140	hypo-connectivity	_
10-8	1141-1143	in	_
10-9	1144-1147	the	_
10-10	1148-1157	substance	_
10-11	1158-1167	consumers	_
10-12	1167-1168	.	_

#Text=Precuneus, postcentral gyrus, insula and visual cortex were the main brain areas with rsFNC reduction suggesting reduced interoceptive awareness in drinkers.
11-1	1169-1178	Precuneus	_
11-2	1178-1179	,	_
11-3	1180-1191	postcentral	_
11-4	1192-1197	gyrus	_
11-5	1197-1198	,	_
11-6	1199-1205	insula	_
11-7	1206-1209	and	_
11-8	1210-1216	visual	_
11-9	1217-1223	cortex	_
11-10	1224-1228	were	_
11-11	1229-1232	the	_
11-12	1233-1237	main	_
11-13	1238-1243	brain	_
11-14	1244-1249	areas	_
11-15	1250-1254	with	_
11-16	1255-1260	rsFNC	_
11-17	1261-1270	reduction	_
11-18	1271-1281	suggesting	_
11-19	1282-1289	reduced	_
11-20	1290-1303	interoceptive	_
11-21	1304-1313	awareness	_
11-22	1314-1316	in	_
11-23	1317-1325	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
11-24	1325-1326	.	_

#Text=In addition, connectivity reduction between postcentral and one RSN covering right fusiform and lingual gyri showed significant association with severity of hazardous drinking.
12-1	1327-1329	In	_
12-2	1330-1338	addition	_
12-3	1338-1339	,	_
12-4	1340-1352	connectivity	_
12-5	1353-1362	reduction	_
12-6	1363-1370	between	_
12-7	1371-1382	postcentral	_
12-8	1383-1386	and	_
12-9	1387-1390	one	_
12-10	1391-1394	RSN	_
12-11	1395-1403	covering	_
12-12	1404-1409	right	_
12-13	1410-1418	fusiform	_
12-14	1419-1422	and	_
12-15	1423-1430	lingual	_
12-16	1431-1435	gyri	_
12-17	1436-1442	showed	_
12-18	1443-1454	significant	_
12-19	1455-1466	association	_
12-20	1467-1471	with	_
12-21	1472-1480	severity	_
12-22	1481-1483	of	_
12-23	1484-1493	hazardous	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[10]
12-24	1494-1502	drinking	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[10]
12-25	1502-1503	.	_

#Text=In smokers, connectivity changes agreed with the idea of a shift towards endogenous information processing, represented by the DMN.
13-1	1504-1506	In	_
13-2	1507-1514	smokers	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
13-3	1514-1515	,	_
13-4	1516-1528	connectivity	_
13-5	1529-1536	changes	_
13-6	1537-1543	agreed	_
13-7	1544-1548	with	_
13-8	1549-1552	the	_
13-9	1553-1557	idea	_
13-10	1558-1560	of	_
13-11	1561-1562	a	_
13-12	1563-1568	shift	_
13-13	1569-1576	towards	_
13-14	1577-1587	endogenous	_
13-15	1588-1599	information	_
13-16	1600-1610	processing	_
13-17	1610-1611	,	_
13-18	1612-1623	represented	_
13-19	1624-1626	by	_
13-20	1627-1630	the	_
13-21	1631-1634	DMN	_
13-22	1634-1635	.	_

#Text=Hypo-connectivity between thalamus and putamen was observed in smokers.
14-1	1636-1653	Hypo-connectivity	_
14-2	1654-1661	between	_
14-3	1662-1670	thalamus	_
14-4	1671-1674	and	_
14-5	1675-1682	putamen	_
14-6	1683-1686	was	_
14-7	1687-1695	observed	_
14-8	1696-1698	in	_
14-9	1699-1706	smokers	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
14-10	1706-1707	.	_

#Text=In contrast, the angular gyrus showed hyper-connectivity with the precuneus linked to smoking and significantly correlated with nicotine dependence severity.
15-1	1708-1710	In	_
15-2	1711-1719	contrast	_
15-3	1719-1720	,	_
15-4	1721-1724	the	_
15-5	1725-1732	angular	_
15-6	1733-1738	gyrus	_
15-7	1739-1745	showed	_
15-8	1746-1764	hyper-connectivity	_
15-9	1765-1769	with	_
15-10	1770-1773	the	_
15-11	1774-1783	precuneus	_
15-12	1784-1790	linked	_
15-13	1791-1793	to	_
15-14	1794-1801	smoking	_
15-15	1802-1805	and	_
15-16	1806-1819	significantly	_
15-17	1820-1830	correlated	_
15-18	1831-1835	with	_
15-19	1836-1844	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[11]
15-20	1845-1855	dependence	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[11]
15-21	1856-1864	severity	_
15-22	1864-1865	.	_

#Text=In spite of the presence of common effects, our results suggest that particular effects of alcohol and nicotine can be separated and identified.
16-1	1866-1868	In	_
16-2	1869-1874	spite	_
16-3	1875-1877	of	_
16-4	1878-1881	the	_
16-5	1882-1890	presence	_
16-6	1891-1893	of	_
16-7	1894-1900	common	_
16-8	1901-1908	effects	_
16-9	1908-1909	,	_
16-10	1910-1913	our	_
16-11	1914-1921	results	_
16-12	1922-1929	suggest	_
16-13	1930-1934	that	_
16-14	1935-1945	particular	_
16-15	1946-1953	effects	_
16-16	1954-1956	of	_
16-17	1957-1964	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
16-18	1965-1968	and	_
16-19	1969-1977	nicotine	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
16-20	1978-1981	can	_
16-21	1982-1984	be	_
16-22	1985-1994	separated	_
16-23	1995-1998	and	_
16-24	1999-2009	identified	_
16-25	2009-2010	.	_

#Text=Results also suggest that concurrent use of both substances affects brain connectivity in a complex manner, requiring careful consideration of interaction effects.
17-1	2011-2018	Results	_
17-2	2019-2023	also	_
17-3	2024-2031	suggest	_
17-4	2032-2036	that	_
17-5	2037-2047	concurrent	_
17-6	2048-2051	use	_
17-7	2052-2054	of	_
17-8	2055-2059	both	_
17-9	2060-2070	substances	_
17-10	2071-2078	affects	_
17-11	2079-2084	brain	_
17-12	2085-2097	connectivity	_
17-13	2098-2100	in	_
17-14	2101-2102	a	_
17-15	2103-2110	complex	_
17-16	2111-2117	manner	_
17-17	2117-2118	,	_
17-18	2119-2128	requiring	_
17-19	2129-2136	careful	_
17-20	2137-2150	consideration	_
17-21	2151-2153	of	_
17-22	2154-2165	interaction	_
17-23	2166-2173	effects	_
17-24	2173-2174	.	_

#Text=Graphical abstract
#Text=1 Introduction
#Text=Consumption of alcohol and nicotine results in neurological alterations that may promote continued use of both drugs.
18-1	2175-2184	Graphical	_
18-2	2185-2193	abstract	_
18-3	2194-2195	1	_
18-4	2196-2208	Introduction	_
18-5	2209-2220	Consumption	_
18-6	2221-2223	of	_
18-7	2224-2231	alcohol	_
18-8	2232-2235	and	_
18-9	2236-2244	nicotine	_
18-10	2245-2252	results	_
18-11	2253-2255	in	_
18-12	2256-2268	neurological	_
18-13	2269-2280	alterations	_
18-14	2281-2285	that	_
18-15	2286-2289	may	_
18-16	2290-2297	promote	_
18-17	2298-2307	continued	_
18-18	2308-2311	use	_
18-19	2312-2314	of	_
18-20	2315-2319	both	_
18-21	2320-2325	drugs	_
18-22	2325-2326	.	_

#Text=These alterations are grounded in circuit level changes that can be evaluated through functional connectivity (FC) among specific brain regions.
19-1	2327-2332	These	_
19-2	2333-2344	alterations	_
19-3	2345-2348	are	_
19-4	2349-2357	grounded	_
19-5	2358-2360	in	_
19-6	2361-2368	circuit	_
19-7	2369-2374	level	_
19-8	2375-2382	changes	_
19-9	2383-2387	that	_
19-10	2388-2391	can	_
19-11	2392-2394	be	_
19-12	2395-2404	evaluated	_
19-13	2405-2412	through	_
19-14	2413-2423	functional	_
19-15	2424-2436	connectivity	_
19-16	2437-2438	(	_
19-17	2438-2440	FC	_
19-18	2440-2441	)	_
19-19	2442-2447	among	_
19-20	2448-2456	specific	_
19-21	2457-2462	brain	_
19-22	2463-2470	regions	_
19-23	2470-2471	.	_

#Text=FC studies have found relationships between the intake of alcohol and cognitive, motor and coordination dysregulations.
20-1	2472-2474	FC	_
20-2	2475-2482	studies	_
20-3	2483-2487	have	_
20-4	2488-2493	found	_
20-5	2494-2507	relationships	_
20-6	2508-2515	between	_
20-7	2516-2519	the	_
20-8	2520-2526	intake	_
20-9	2527-2529	of	_
20-10	2530-2537	alcohol	_
20-11	2538-2541	and	_
20-12	2542-2551	cognitive	_
20-13	2551-2552	,	_
20-14	2553-2558	motor	_
20-15	2559-2562	and	_
20-16	2563-2575	coordination	_
20-17	2576-2590	dysregulations	_
20-18	2590-2591	.	_

#Text=Other studies suggest a link between brain FC and motor, attention and memory enhancement due to nicotine administration.
21-1	2592-2597	Other	_
21-2	2598-2605	studies	_
21-3	2606-2613	suggest	_
21-4	2614-2615	a	_
21-5	2616-2620	link	_
21-6	2621-2628	between	_
21-7	2629-2634	brain	_
21-8	2635-2637	FC	_
21-9	2638-2641	and	_
21-10	2642-2647	motor	_
21-11	2647-2648	,	_
21-12	2649-2658	attention	_
21-13	2659-2662	and	_
21-14	2663-2669	memory	_
21-15	2670-2681	enhancement	_
21-16	2682-2685	due	_
21-17	2686-2688	to	_
21-18	2689-2697	nicotine	_
21-19	2698-2712	administration	_
21-20	2712-2713	.	_

#Text=In light of these advances, patterns of brain connectivity in alcohol and nicotine users have begun to be investigated as possible diagnostic biomarkers.
22-1	2714-2716	In	_
22-2	2717-2722	light	_
22-3	2723-2725	of	_
22-4	2726-2731	these	_
22-5	2732-2740	advances	_
22-6	2740-2741	,	_
22-7	2742-2750	patterns	_
22-8	2751-2753	of	_
22-9	2754-2759	brain	_
22-10	2760-2772	connectivity	_
22-11	2773-2775	in	_
22-12	2776-2783	alcohol	_
22-13	2784-2787	and	_
22-14	2788-2796	nicotine	_
22-15	2797-2802	users	_
22-16	2803-2807	have	_
22-17	2808-2813	begun	_
22-18	2814-2816	to	_
22-19	2817-2819	be	_
22-20	2820-2832	investigated	_
22-21	2833-2835	as	_
22-22	2836-2844	possible	_
22-23	2845-2855	diagnostic	_
22-24	2856-2866	biomarkers	_
22-25	2866-2867	.	_

#Text=Understanding how these drugs induce changes in the FC of the brain might be critical for the development of addiction treatment and the improvement of clinical outcomes.
23-1	2868-2881	Understanding	_
23-2	2882-2885	how	_
23-3	2886-2891	these	_
23-4	2892-2897	drugs	_
23-5	2898-2904	induce	_
23-6	2905-2912	changes	_
23-7	2913-2915	in	_
23-8	2916-2919	the	_
23-9	2920-2922	FC	_
23-10	2923-2925	of	_
23-11	2926-2929	the	_
23-12	2930-2935	brain	_
23-13	2936-2941	might	_
23-14	2942-2944	be	_
23-15	2945-2953	critical	_
23-16	2954-2957	for	_
23-17	2958-2961	the	_
23-18	2962-2973	development	_
23-19	2974-2976	of	_
23-20	2977-2986	addiction	_
23-21	2987-2996	treatment	_
23-22	2997-3000	and	_
23-23	3001-3004	the	_
23-24	3005-3016	improvement	_
23-25	3017-3019	of	_
23-26	3020-3028	clinical	_
23-27	3029-3037	outcomes	_
23-28	3037-3038	.	_

#Text=Alcohol consumption causes gradual neurocognitive deficits ranging from mild deficits in social drinkers to profound memory and abstract processing impairments in chronic alcoholics.
24-1	3039-3046	Alcohol	_
24-2	3047-3058	consumption	_
24-3	3059-3065	causes	_
24-4	3066-3073	gradual	_
24-5	3074-3088	neurocognitive	_
24-6	3089-3097	deficits	_
24-7	3098-3105	ranging	_
24-8	3106-3110	from	_
24-9	3111-3115	mild	_
24-10	3116-3124	deficits	_
24-11	3125-3127	in	_
24-12	3128-3134	social	_
24-13	3135-3143	drinkers	_
24-14	3144-3146	to	_
24-15	3147-3155	profound	_
24-16	3156-3162	memory	_
24-17	3163-3166	and	_
24-18	3167-3175	abstract	_
24-19	3176-3186	processing	_
24-20	3187-3198	impairments	_
24-21	3199-3201	in	_
24-22	3202-3209	chronic	_
24-23	3210-3220	alcoholics	_
24-24	3220-3221	.	_

#Text=Alcohol studies based on functional magnetic resonance imaging (fMRI) have found altered functional relationships and corresponding compensatory mechanisms among different parts of the brain linked to these deficits.
25-1	3222-3229	Alcohol	_
25-2	3230-3237	studies	_
25-3	3238-3243	based	_
25-4	3244-3246	on	_
25-5	3247-3257	functional	_
25-6	3258-3266	magnetic	_
25-7	3267-3276	resonance	_
25-8	3277-3284	imaging	_
25-9	3285-3286	(	_
25-10	3286-3290	fMRI	_
25-11	3290-3291	)	_
25-12	3292-3296	have	_
25-13	3297-3302	found	_
25-14	3303-3310	altered	_
25-15	3311-3321	functional	_
25-16	3322-3335	relationships	_
25-17	3336-3339	and	_
25-18	3340-3353	corresponding	_
25-19	3354-3366	compensatory	_
25-20	3367-3377	mechanisms	_
25-21	3378-3383	among	_
25-22	3384-3393	different	_
25-23	3394-3399	parts	_
25-24	3400-3402	of	_
25-25	3403-3406	the	_
25-26	3407-3412	brain	_
25-27	3413-3419	linked	_
25-28	3420-3422	to	_
25-29	3423-3428	these	_
25-30	3429-3437	deficits	_
25-31	3437-3438	.	_

#Text=For example, a finger tapping task demonstrated that alcohol dependent patients recruited areas of the parietal lobe, inferior frontal, middle temporal, pre- and post-central gyri to compensate for a dysfunctional fronto-cerebellar network used by normal controls.
26-1	3439-3442	For	_
26-2	3443-3450	example	_
26-3	3450-3451	,	_
26-4	3452-3453	a	_
26-5	3454-3460	finger	_
26-6	3461-3468	tapping	_
26-7	3469-3473	task	_
26-8	3474-3486	demonstrated	_
26-9	3487-3491	that	_
26-10	3492-3499	alcohol	_
26-11	3500-3509	dependent	_
26-12	3510-3518	patients	_
26-13	3519-3528	recruited	_
26-14	3529-3534	areas	_
26-15	3535-3537	of	_
26-16	3538-3541	the	_
26-17	3542-3550	parietal	_
26-18	3551-3555	lobe	_
26-19	3555-3556	,	_
26-20	3557-3565	inferior	_
26-21	3566-3573	frontal	_
26-22	3573-3574	,	_
26-23	3575-3581	middle	_
26-24	3582-3590	temporal	_
26-25	3590-3591	,	_
26-26	3592-3595	pre	_
26-27	3595-3596	-	_
26-28	3597-3600	and	_
26-29	3601-3613	post-central	_
26-30	3614-3618	gyri	_
26-31	3619-3621	to	_
26-32	3622-3632	compensate	_
26-33	3633-3636	for	_
26-34	3637-3638	a	_
26-35	3639-3652	dysfunctional	_
26-36	3653-3670	fronto-cerebellar	_
26-37	3671-3678	network	_
26-38	3679-3683	used	_
26-39	3684-3686	by	_
26-40	3687-3693	normal	_
26-41	3694-3702	controls	_
26-42	3702-3703	.	_

#Text=Connectivity between the cerebellum and the default mode network (DMN) is reduced in alcoholics during resting state, but increased during a spatial working memory task to compensate and achieve same performance than controls.
27-1	3704-3716	Connectivity	_
27-2	3717-3724	between	_
27-3	3725-3728	the	_
27-4	3729-3739	cerebellum	_
27-5	3740-3743	and	_
27-6	3744-3747	the	_
27-7	3748-3755	default	_
27-8	3756-3760	mode	_
27-9	3761-3768	network	_
27-10	3769-3770	(	_
27-11	3770-3773	DMN	_
27-12	3773-3774	)	_
27-13	3775-3777	is	_
27-14	3778-3785	reduced	_
27-15	3786-3788	in	_
27-16	3789-3799	alcoholics	_
27-17	3800-3806	during	_
27-18	3807-3814	resting	_
27-19	3815-3820	state	_
27-20	3820-3821	,	_
27-21	3822-3825	but	_
27-22	3826-3835	increased	_
27-23	3836-3842	during	_
27-24	3843-3844	a	_
27-25	3845-3852	spatial	_
27-26	3853-3860	working	_
27-27	3861-3867	memory	_
27-28	3868-3872	task	_
27-29	3873-3875	to	_
27-30	3876-3886	compensate	_
27-31	3887-3890	and	_
27-32	3891-3898	achieve	_
27-33	3899-3903	same	_
27-34	3904-3915	performance	_
27-35	3916-3920	than	_
27-36	3921-3929	controls	_
27-37	3929-3930	.	_

#Text=Attenuated insula activation, observed during an emotional processing task, may be linked to reduced interoceptive awareness.
28-1	3931-3941	Attenuated	_
28-2	3942-3948	insula	_
28-3	3949-3959	activation	_
28-4	3959-3960	,	_
28-5	3961-3969	observed	_
28-6	3970-3976	during	_
28-7	3977-3979	an	_
28-8	3980-3989	emotional	_
28-9	3990-4000	processing	_
28-10	4001-4005	task	_
28-11	4005-4006	,	_
28-12	4007-4010	may	_
28-13	4011-4013	be	_
28-14	4014-4020	linked	_
28-15	4021-4023	to	_
28-16	4024-4031	reduced	_
28-17	4032-4045	interoceptive	_
28-18	4046-4055	awareness	_
28-19	4055-4056	.	_

#Text=Even after long-term alcohol abstinence, it has been found that resting state FC differs compared to controls.
29-1	4057-4061	Even	_
29-2	4062-4067	after	_
29-3	4068-4077	long-term	_
29-4	4078-4085	alcohol	_
29-5	4086-4096	abstinence	_
29-6	4096-4097	,	_
29-7	4098-4100	it	_
29-8	4101-4104	has	_
29-9	4105-4109	been	_
29-10	4110-4115	found	_
29-11	4116-4120	that	_
29-12	4121-4128	resting	_
29-13	4129-4134	state	_
29-14	4135-4137	FC	_
29-15	4138-4145	differs	_
29-16	4146-4154	compared	_
29-17	4155-4157	to	_
29-18	4158-4166	controls	_
29-19	4166-4167	.	_

#Text=Decreased resting state connectivity within reward, visual and executive control brain regions successfully predicts relapse in abstinent alcoholics, further evidence of the importance of examining FC.
30-1	4168-4177	Decreased	_
30-2	4178-4185	resting	_
30-3	4186-4191	state	_
30-4	4192-4204	connectivity	_
30-5	4205-4211	within	_
30-6	4212-4218	reward	_
30-7	4218-4219	,	_
30-8	4220-4226	visual	_
30-9	4227-4230	and	_
30-10	4231-4240	executive	_
30-11	4241-4248	control	_
30-12	4249-4254	brain	_
30-13	4255-4262	regions	_
30-14	4263-4275	successfully	_
30-15	4276-4284	predicts	_
30-16	4285-4292	relapse	_
30-17	4293-4295	in	_
30-18	4296-4305	abstinent	_
30-19	4306-4316	alcoholics	_
30-20	4316-4317	,	_
30-21	4318-4325	further	_
30-22	4326-4334	evidence	_
30-23	4335-4337	of	_
30-24	4338-4341	the	_
30-25	4342-4352	importance	_
30-26	4353-4355	of	_
30-27	4356-4365	examining	_
30-28	4366-4368	FC	_
30-29	4368-4369	.	_

#Text=A decrease of FC in executive control, sensorimotor, visual and subcortical was found in alcoholics when compared to controls.
31-1	4370-4371	A	_
31-2	4372-4380	decrease	_
31-3	4381-4383	of	_
31-4	4384-4386	FC	_
31-5	4387-4389	in	_
31-6	4390-4399	executive	_
31-7	4400-4407	control	_
31-8	4407-4408	,	_
31-9	4409-4421	sensorimotor	_
31-10	4421-4422	,	_
31-11	4423-4429	visual	_
31-12	4430-4433	and	_
31-13	4434-4445	subcortical	_
31-14	4446-4449	was	_
31-15	4450-4455	found	_
31-16	4456-4458	in	_
31-17	4459-4469	alcoholics	_
31-18	4470-4474	when	_
31-19	4475-4483	compared	_
31-20	4484-4486	to	_
31-21	4487-4495	controls	_
31-22	4495-4496	.	_

#Text=Results from all these studies lead to the proposal of a “disconnection syndrome” which can be involved in the deficient behavioral control related to alcohol use disorder.
32-1	4497-4504	Results	_
32-2	4505-4509	from	_
32-3	4510-4513	all	_
32-4	4514-4519	these	_
32-5	4520-4527	studies	_
32-6	4528-4532	lead	_
32-7	4533-4535	to	_
32-8	4536-4539	the	_
32-9	4540-4548	proposal	_
32-10	4549-4551	of	_
32-11	4552-4553	a	_
32-12	4554-4555	“	_
32-13	4555-4568	disconnection	_
32-14	4569-4577	syndrome	_
32-15	4577-4578	”	_
32-16	4579-4584	which	_
32-17	4585-4588	can	_
32-18	4589-4591	be	_
32-19	4592-4600	involved	_
32-20	4601-4603	in	_
32-21	4604-4607	the	_
32-22	4608-4617	deficient	_
32-23	4618-4628	behavioral	_
32-24	4629-4636	control	_
32-25	4637-4644	related	_
32-26	4645-4647	to	_
32-27	4648-4655	alcohol	_
32-28	4656-4659	use	_
32-29	4660-4668	disorder	_
32-30	4668-4669	.	_

#Text=Although the authors suggest that some effects could have been influenced by smoking, evidence for the existence of this disconnection pattern involving DMN, salience, subcortical and executive control networks was presented in where a whole brain analysis was performed using seed-based methods.
33-1	4670-4678	Although	_
33-2	4679-4682	the	_
33-3	4683-4690	authors	_
33-4	4691-4698	suggest	_
33-5	4699-4703	that	_
33-6	4704-4708	some	_
33-7	4709-4716	effects	_
33-8	4717-4722	could	_
33-9	4723-4727	have	_
33-10	4728-4732	been	_
33-11	4733-4743	influenced	_
33-12	4744-4746	by	_
33-13	4747-4754	smoking	_
33-14	4754-4755	,	_
33-15	4756-4764	evidence	_
33-16	4765-4768	for	_
33-17	4769-4772	the	_
33-18	4773-4782	existence	_
33-19	4783-4785	of	_
33-20	4786-4790	this	_
33-21	4791-4804	disconnection	_
33-22	4805-4812	pattern	_
33-23	4813-4822	involving	_
33-24	4823-4826	DMN	_
33-25	4826-4827	,	_
33-26	4828-4836	salience	_
33-27	4836-4837	,	_
33-28	4838-4849	subcortical	_
33-29	4850-4853	and	_
33-30	4854-4863	executive	_
33-31	4864-4871	control	_
33-32	4872-4880	networks	_
33-33	4881-4884	was	_
33-34	4885-4894	presented	_
33-35	4895-4897	in	_
33-36	4898-4903	where	_
33-37	4904-4905	a	_
33-38	4906-4911	whole	_
33-39	4912-4917	brain	_
33-40	4918-4926	analysis	_
33-41	4927-4930	was	_
33-42	4931-4940	performed	_
33-43	4941-4946	using	_
33-44	4947-4957	seed-based	_
33-45	4958-4965	methods	_
33-46	4965-4966	.	_

#Text=Given the common use of alcohol and nicotine, further studies are necessary to characterize FC changes due to alcohol use not influenced by nicotine.
34-1	4967-4972	Given	_
34-2	4973-4976	the	_
34-3	4977-4983	common	_
34-4	4984-4987	use	_
34-5	4988-4990	of	_
34-6	4991-4998	alcohol	_
34-7	4999-5002	and	_
34-8	5003-5011	nicotine	_
34-9	5011-5012	,	_
34-10	5013-5020	further	_
34-11	5021-5028	studies	_
34-12	5029-5032	are	_
34-13	5033-5042	necessary	_
34-14	5043-5045	to	_
34-15	5046-5058	characterize	_
34-16	5059-5061	FC	_
34-17	5062-5069	changes	_
34-18	5070-5073	due	_
34-19	5074-5076	to	_
34-20	5077-5084	alcohol	_
34-21	5085-5088	use	_
34-22	5089-5092	not	_
34-23	5093-5103	influenced	_
34-24	5104-5106	by	_
34-25	5107-5115	nicotine	_
34-26	5115-5116	.	_

#Text=Nicotine is an addictive substance that is known to enhance cognitive function during acute administration whereas acute withdrawal results in cognitive impairment.
35-1	5117-5125	Nicotine	_
35-2	5126-5128	is	_
35-3	5129-5131	an	_
35-4	5132-5141	addictive	_
35-5	5142-5151	substance	_
35-6	5152-5156	that	_
35-7	5157-5159	is	_
35-8	5160-5165	known	_
35-9	5166-5168	to	_
35-10	5169-5176	enhance	_
35-11	5177-5186	cognitive	_
35-12	5187-5195	function	_
35-13	5196-5202	during	_
35-14	5203-5208	acute	_
35-15	5209-5223	administration	_
35-16	5224-5231	whereas	_
35-17	5232-5237	acute	_
35-18	5238-5248	withdrawal	_
35-19	5249-5256	results	_
35-20	5257-5259	in	_
35-21	5260-5269	cognitive	_
35-22	5270-5280	impairment	_
35-23	5280-5281	.	_

#Text=Cole et al. found that cognitive withdrawal improvement, measured using an rapid visual information-processing task, observed after nicotine replacement is associated with increased anti-correlation between default mode and executive control networks.
36-1	5282-5286	Cole	_
36-2	5287-5289	et	_
36-3	5290-5292	al	_
36-4	5292-5293	.	_
36-5	5294-5299	found	_
36-6	5300-5304	that	_
36-7	5305-5314	cognitive	_
36-8	5315-5325	withdrawal	_
36-9	5326-5337	improvement	_
36-10	5337-5338	,	_
36-11	5339-5347	measured	_
36-12	5348-5353	using	_
36-13	5354-5356	an	_
36-14	5357-5362	rapid	_
36-15	5363-5369	visual	_
36-16	5370-5392	information-processing	_
36-17	5393-5397	task	_
36-18	5397-5398	,	_
36-19	5399-5407	observed	_
36-20	5408-5413	after	_
36-21	5414-5422	nicotine	_
36-22	5423-5434	replacement	_
36-23	5435-5437	is	_
36-24	5438-5448	associated	_
36-25	5449-5453	with	_
36-26	5454-5463	increased	_
36-27	5464-5480	anti-correlation	_
36-28	5481-5488	between	_
36-29	5489-5496	default	_
36-30	5497-5501	mode	_
36-31	5502-5505	and	_
36-32	5506-5515	executive	_
36-33	5516-5523	control	_
36-34	5524-5532	networks	_
36-35	5532-5533	.	_

#Text=While cognitive improvement could be linked to increased connectivity effects within executive control and fronto-parietal networks, reduced connectivity has also been found within networks involving the posterior cingulate and precuneus.
37-1	5534-5539	While	_
37-2	5540-5549	cognitive	_
37-3	5550-5561	improvement	_
37-4	5562-5567	could	_
37-5	5568-5570	be	_
37-6	5571-5577	linked	_
37-7	5578-5580	to	_
37-8	5581-5590	increased	_
37-9	5591-5603	connectivity	_
37-10	5604-5611	effects	_
37-11	5612-5618	within	_
37-12	5619-5628	executive	_
37-13	5629-5636	control	_
37-14	5637-5640	and	_
37-15	5641-5656	fronto-parietal	_
37-16	5657-5665	networks	_
37-17	5665-5666	,	_
37-18	5667-5674	reduced	_
37-19	5675-5687	connectivity	_
37-20	5688-5691	has	_
37-21	5692-5696	also	_
37-22	5697-5701	been	_
37-23	5702-5707	found	_
37-24	5708-5714	within	_
37-25	5715-5723	networks	_
37-26	5724-5733	involving	_
37-27	5734-5737	the	_
37-28	5738-5747	posterior	_
37-29	5748-5757	cingulate	_
37-30	5758-5761	and	_
37-31	5762-5771	precuneus	_
37-32	5771-5772	.	_

#Text=In the same study, Pariyadath et al. found that both increased and decreased connectivity helps in predicting smoking status using a support-vector-machine classifier.
38-1	5773-5775	In	_
38-2	5776-5779	the	_
38-3	5780-5784	same	_
38-4	5785-5790	study	_
38-5	5790-5791	,	_
38-6	5792-5802	Pariyadath	_
38-7	5803-5805	et	_
38-8	5806-5808	al	_
38-9	5808-5809	.	_
38-10	5810-5815	found	_
38-11	5816-5820	that	_
38-12	5821-5825	both	_
38-13	5826-5835	increased	_
38-14	5836-5839	and	_
38-15	5840-5849	decreased	_
38-16	5850-5862	connectivity	_
38-17	5863-5868	helps	_
38-18	5869-5871	in	_
38-19	5872-5882	predicting	_
38-20	5883-5890	smoking	_
38-21	5891-5897	status	_
38-22	5898-5903	using	_
38-23	5904-5905	a	_
38-24	5906-5928	support-vector-machine	_
38-25	5929-5939	classifier	_
38-26	5939-5940	.	_

#Text=Decreased DMN and enhanced extra-striate activity during a resting state experiment with administered nicotine have been theorized to be linked with an activity shift from internal to external information processing networks.
39-1	5941-5950	Decreased	_
39-2	5951-5954	DMN	_
39-3	5955-5958	and	_
39-4	5959-5967	enhanced	_
39-5	5968-5981	extra-striate	_
39-6	5982-5990	activity	_
39-7	5991-5997	during	_
39-8	5998-5999	a	_
39-9	6000-6007	resting	_
39-10	6008-6013	state	_
39-11	6014-6024	experiment	_
39-12	6025-6029	with	_
39-13	6030-6042	administered	_
39-14	6043-6051	nicotine	_
39-15	6052-6056	have	_
39-16	6057-6061	been	_
39-17	6062-6071	theorized	_
39-18	6072-6074	to	_
39-19	6075-6077	be	_
39-20	6078-6084	linked	_
39-21	6085-6089	with	_
39-22	6090-6092	an	_
39-23	6093-6101	activity	_
39-24	6102-6107	shift	_
39-25	6108-6112	from	_
39-26	6113-6121	internal	_
39-27	6122-6124	to	_
39-28	6125-6133	external	_
39-29	6134-6145	information	_
39-30	6146-6156	processing	_
39-31	6157-6165	networks	_
39-32	6165-6166	.	_

#Text=In contrast, a model of nicotine effects during abstinence based on resting state FC results suggests a shift in network dynamics towards endogenous information processing represented by the DMN where the insula plays an important salience role.
40-1	6167-6169	In	_
40-2	6170-6178	contrast	_
40-3	6178-6179	,	_
40-4	6180-6181	a	_
40-5	6182-6187	model	_
40-6	6188-6190	of	_
40-7	6191-6199	nicotine	_
40-8	6200-6207	effects	_
40-9	6208-6214	during	_
40-10	6215-6225	abstinence	_
40-11	6226-6231	based	_
40-12	6232-6234	on	_
40-13	6235-6242	resting	_
40-14	6243-6248	state	_
40-15	6249-6251	FC	_
40-16	6252-6259	results	_
40-17	6260-6268	suggests	_
40-18	6269-6270	a	_
40-19	6271-6276	shift	_
40-20	6277-6279	in	_
40-21	6280-6287	network	_
40-22	6288-6296	dynamics	_
40-23	6297-6304	towards	_
40-24	6305-6315	endogenous	_
40-25	6316-6327	information	_
40-26	6328-6338	processing	_
40-27	6339-6350	represented	_
40-28	6351-6353	by	_
40-29	6354-6357	the	_
40-30	6358-6361	DMN	_
40-31	6362-6367	where	_
40-32	6368-6371	the	_
40-33	6372-6378	insula	_
40-34	6379-6384	plays	_
40-35	6385-6387	an	_
40-36	6388-6397	important	_
40-37	6398-6406	salience	_
40-38	6407-6411	role	_
40-39	6411-6412	.	_

#Text=The evidence points to abnormal interactions due to nicotine addiction between brain networks of exogenous (executive control) and endogenous (DMN) attention regulated by a third salience network anchored in the insula.
41-1	6413-6416	The	_
41-2	6417-6425	evidence	_
41-3	6426-6432	points	_
41-4	6433-6435	to	_
41-5	6436-6444	abnormal	_
41-6	6445-6457	interactions	_
41-7	6458-6461	due	_
41-8	6462-6464	to	_
41-9	6465-6473	nicotine	_
41-10	6474-6483	addiction	_
41-11	6484-6491	between	_
41-12	6492-6497	brain	_
41-13	6498-6506	networks	_
41-14	6507-6509	of	_
41-15	6510-6519	exogenous	_
41-16	6520-6521	(	_
41-17	6521-6530	executive	_
41-18	6531-6538	control	_
41-19	6538-6539	)	_
41-20	6540-6543	and	_
41-21	6544-6554	endogenous	_
41-22	6555-6556	(	_
41-23	6556-6559	DMN	_
41-24	6559-6560	)	_
41-25	6561-6570	attention	_
41-26	6571-6580	regulated	_
41-27	6581-6583	by	_
41-28	6584-6585	a	_
41-29	6586-6591	third	_
41-30	6592-6600	salience	_
41-31	6601-6608	network	_
41-32	6609-6617	anchored	_
41-33	6618-6620	in	_
41-34	6621-6624	the	_
41-35	6625-6631	insula	_
41-36	6631-6632	.	_

#Text=These results suggest distinctive patterns of FC change related to the use of alcohol and nicotine.
42-1	6633-6638	These	_
42-2	6639-6646	results	_
42-3	6647-6654	suggest	_
42-4	6655-6666	distinctive	_
42-5	6667-6675	patterns	_
42-6	6676-6678	of	_
42-7	6679-6681	FC	_
42-8	6682-6688	change	_
42-9	6689-6696	related	_
42-10	6697-6699	to	_
42-11	6700-6703	the	_
42-12	6704-6707	use	_
42-13	6708-6710	of	_
42-14	6711-6718	alcohol	_
42-15	6719-6722	and	_
42-16	6723-6731	nicotine	_
42-17	6731-6732	.	_

#Text=One limitation of these important results is the use of predetermined regions of interest or seeds.
43-1	6733-6736	One	_
43-2	6737-6747	limitation	_
43-3	6748-6750	of	_
43-4	6751-6756	these	_
43-5	6757-6766	important	_
43-6	6767-6774	results	_
43-7	6775-6777	is	_
43-8	6778-6781	the	_
43-9	6782-6785	use	_
43-10	6786-6788	of	_
43-11	6789-6802	predetermined	_
43-12	6803-6810	regions	_
43-13	6811-6813	of	_
43-14	6814-6822	interest	_
43-15	6823-6825	or	_
43-16	6826-6831	seeds	_
43-17	6831-6832	.	_

#Text=As well described by Li, et al., seed-based methodology implies that detected effects in FC are sensitive to the selected seed and the knowledge used to determine the seed.
44-1	6833-6835	As	_
44-2	6836-6840	well	_
44-3	6841-6850	described	_
44-4	6851-6853	by	_
44-5	6854-6856	Li	_
44-6	6856-6857	,	_
44-7	6858-6860	et	_
44-8	6861-6863	al	_
44-9	6863-6864	.	_
44-10	6864-6865	,	_
44-11	6866-6876	seed-based	_
44-12	6877-6888	methodology	_
44-13	6889-6896	implies	_
44-14	6897-6901	that	_
44-15	6902-6910	detected	_
44-16	6911-6918	effects	_
44-17	6919-6921	in	_
44-18	6922-6924	FC	_
44-19	6925-6928	are	_
44-20	6929-6938	sensitive	_
44-21	6939-6941	to	_
44-22	6942-6945	the	_
44-23	6946-6954	selected	_
44-24	6955-6959	seed	_
44-25	6960-6963	and	_
44-26	6964-6967	the	_
44-27	6968-6977	knowledge	_
44-28	6978-6982	used	_
44-29	6983-6985	to	_
44-30	6986-6995	determine	_
44-31	6996-6999	the	_
44-32	7000-7004	seed	_
44-33	7004-7005	.	_

#Text=Thus, it is also important to complement previous work with approaches that are less dependent on a specific seed assumption.
45-1	7006-7010	Thus	_
45-2	7010-7011	,	_
45-3	7012-7014	it	_
45-4	7015-7017	is	_
45-5	7018-7022	also	_
45-6	7023-7032	important	_
45-7	7033-7035	to	_
45-8	7036-7046	complement	_
45-9	7047-7055	previous	_
45-10	7056-7060	work	_
45-11	7061-7065	with	_
45-12	7066-7076	approaches	_
45-13	7077-7081	that	_
45-14	7082-7085	are	_
45-15	7086-7090	less	_
45-16	7091-7100	dependent	_
45-17	7101-7103	on	_
45-18	7104-7105	a	_
45-19	7106-7114	specific	_
45-20	7115-7119	seed	_
45-21	7120-7130	assumption	_
45-22	7130-7131	.	_

#Text=In this work we utilize group independent component analysis (gICA) to obtain a data driven parcellation of the brain into spatial-temporal components.
46-1	7132-7134	In	_
46-2	7135-7139	this	_
46-3	7140-7144	work	_
46-4	7145-7147	we	_
46-5	7148-7155	utilize	_
46-6	7156-7161	group	_
46-7	7162-7173	independent	_
46-8	7174-7183	component	_
46-9	7184-7192	analysis	_
46-10	7193-7194	(	_
46-11	7194-7198	gICA	_
46-12	7198-7199	)	_
46-13	7200-7202	to	_
46-14	7203-7209	obtain	_
46-15	7210-7211	a	_
46-16	7212-7216	data	_
46-17	7217-7223	driven	_
46-18	7224-7236	parcellation	_
46-19	7237-7239	of	_
46-20	7240-7243	the	_
46-21	7244-7249	brain	_
46-22	7250-7254	into	_
46-23	7255-7271	spatial-temporal	_
46-24	7272-7282	components	_
46-25	7282-7283	.	_

#Text=Brain regions are segregated into maximally spatially independent components or networks in a fully data-driven manner.
47-1	7284-7289	Brain	_
47-2	7290-7297	regions	_
47-3	7298-7301	are	_
47-4	7302-7312	segregated	_
47-5	7313-7317	into	_
47-6	7318-7327	maximally	_
47-7	7328-7337	spatially	_
47-8	7338-7349	independent	_
47-9	7350-7360	components	_
47-10	7361-7363	or	_
47-11	7364-7372	networks	_
47-12	7373-7375	in	_
47-13	7376-7377	a	_
47-14	7378-7383	fully	_
47-15	7384-7395	data-driven	_
47-16	7396-7402	manner	_
47-17	7402-7403	.	_

#Text=Using resting state fMRI data as input, the gICA algorithm provides a set of resting state networks (RSN), each composed of coherently interacting brain areas, each of which is a reflection of ‘within network’ connectivity.
48-1	7404-7409	Using	_
48-2	7410-7417	resting	_
48-3	7418-7423	state	_
48-4	7424-7428	fMRI	_
48-5	7429-7433	data	_
48-6	7434-7436	as	_
48-7	7437-7442	input	_
48-8	7442-7443	,	_
48-9	7444-7447	the	_
48-10	7448-7452	gICA	_
48-11	7453-7462	algorithm	_
48-12	7463-7471	provides	_
48-13	7472-7473	a	_
48-14	7474-7477	set	_
48-15	7478-7480	of	_
48-16	7481-7488	resting	_
48-17	7489-7494	state	_
48-18	7495-7503	networks	_
48-19	7504-7505	(	_
48-20	7505-7508	RSN	_
48-21	7508-7509	)	_
48-22	7509-7510	,	_
48-23	7511-7515	each	_
48-24	7516-7524	composed	_
48-25	7525-7527	of	_
48-26	7528-7538	coherently	_
48-27	7539-7550	interacting	_
48-28	7551-7556	brain	_
48-29	7557-7562	areas	_
48-30	7562-7563	,	_
48-31	7564-7568	each	_
48-32	7569-7571	of	_
48-33	7572-7577	which	_
48-34	7578-7580	is	_
48-35	7581-7582	a	_
48-36	7583-7593	reflection	_
48-37	7594-7596	of	_
48-38	7597-7598	‘	_
48-39	7598-7604	within	_
48-40	7605-7612	network	_
48-41	7612-7613	’	_
48-42	7614-7626	connectivity	_
48-43	7626-7627	.	_

#Text=The temporal correlation between RSN time courses constitutes a measure of “among network” connectivity, called functional network connectivity.
49-1	7628-7631	The	_
49-2	7632-7640	temporal	_
49-3	7641-7652	correlation	_
49-4	7653-7660	between	_
49-5	7661-7664	RSN	_
49-6	7665-7669	time	_
49-7	7670-7677	courses	_
49-8	7678-7689	constitutes	_
49-9	7690-7691	a	_
49-10	7692-7699	measure	_
49-11	7700-7702	of	_
49-12	7703-7704	“	_
49-13	7704-7709	among	_
49-14	7710-7717	network	_
49-15	7717-7718	”	_
49-16	7719-7731	connectivity	_
49-17	7731-7732	,	_
49-18	7733-7739	called	_
49-19	7740-7750	functional	_
49-20	7751-7758	network	_
49-21	7759-7771	connectivity	_
49-22	7771-7772	.	_

#Text=Another common limitation found in some FC studies is the lack of a clear separation between alcohol and nicotine consumption.
50-1	7773-7780	Another	_
50-2	7781-7787	common	_
50-3	7788-7798	limitation	_
50-4	7799-7804	found	_
50-5	7805-7807	in	_
50-6	7808-7812	some	_
50-7	7813-7815	FC	_
50-8	7816-7823	studies	_
50-9	7824-7826	is	_
50-10	7827-7830	the	_
50-11	7831-7835	lack	_
50-12	7836-7838	of	_
50-13	7839-7840	a	_
50-14	7841-7846	clear	_
50-15	7847-7857	separation	_
50-16	7858-7865	between	_
50-17	7866-7873	alcohol	_
50-18	7874-7877	and	_
50-19	7878-7886	nicotine	_
50-20	7887-7898	consumption	_
50-21	7898-7899	.	_

#Text=Although it is known that the effects of alcohol and nicotine are moderately to strongly related, combined and separate influences of nicotine and alcohol use in resting state FC have not been thoroughly studied.
51-1	7900-7908	Although	_
51-2	7909-7911	it	_
51-3	7912-7914	is	_
51-4	7915-7920	known	_
51-5	7921-7925	that	_
51-6	7926-7929	the	_
51-7	7930-7937	effects	_
51-8	7938-7940	of	_
51-9	7941-7948	alcohol	_
51-10	7949-7952	and	_
51-11	7953-7961	nicotine	_
51-12	7962-7965	are	_
51-13	7966-7976	moderately	_
51-14	7977-7979	to	_
51-15	7980-7988	strongly	_
51-16	7989-7996	related	_
51-17	7996-7997	,	_
51-18	7998-8006	combined	_
51-19	8007-8010	and	_
51-20	8011-8019	separate	_
51-21	8020-8030	influences	_
51-22	8031-8033	of	_
51-23	8034-8042	nicotine	_
51-24	8043-8046	and	_
51-25	8047-8054	alcohol	_
51-26	8055-8058	use	_
51-27	8059-8061	in	_
51-28	8062-8069	resting	_
51-29	8070-8075	state	_
51-30	8076-8078	FC	_
51-31	8079-8083	have	_
51-32	8084-8087	not	_
51-33	8088-8092	been	_
51-34	8093-8103	thoroughly	_
51-35	8104-8111	studied	_
51-36	8111-8112	.	_

#Text=In this work, we have carefully selected subjects that smoke nicotine and drink alcohol in a separate or combined manner.
52-1	8113-8115	In	_
52-2	8116-8120	this	_
52-3	8121-8125	work	_
52-4	8125-8126	,	_
52-5	8127-8129	we	_
52-6	8130-8134	have	_
52-7	8135-8144	carefully	_
52-8	8145-8153	selected	_
52-9	8154-8162	subjects	_
52-10	8163-8167	that	_
52-11	8168-8173	smoke	_
52-12	8174-8182	nicotine	_
52-13	8183-8186	and	_
52-14	8187-8192	drink	_
52-15	8193-8200	alcohol	_
52-16	8201-8203	in	_
52-17	8204-8205	a	_
52-18	8206-8214	separate	_
52-19	8215-8217	or	_
52-20	8218-8226	combined	_
52-21	8227-8233	manner	_
52-22	8233-8234	.	_

#Text=We hypothesize that different patterns of FC exist depending on drinking, smoking or combined drinking and smoking.
53-1	8235-8237	We	_
53-2	8238-8249	hypothesize	_
53-3	8250-8254	that	_
53-4	8255-8264	different	_
53-5	8265-8273	patterns	_
53-6	8274-8276	of	_
53-7	8277-8279	FC	_
53-8	8280-8285	exist	_
53-9	8286-8295	depending	_
53-10	8296-8298	on	_
53-11	8299-8307	drinking	_
53-12	8307-8308	,	_
53-13	8309-8316	smoking	_
53-14	8317-8319	or	_
53-15	8320-8328	combined	_
53-16	8329-8337	drinking	_
53-17	8338-8341	and	_
53-18	8342-8349	smoking	_
53-19	8349-8350	.	_

#Text=Based on previous research we expect to see decreased connectivity associated with reward, executive control, default mode and visual brain areas in alcohol users.
54-1	8351-8356	Based	_
54-2	8357-8359	on	_
54-3	8360-8368	previous	_
54-4	8369-8377	research	_
54-5	8378-8380	we	_
54-6	8381-8387	expect	_
54-7	8388-8390	to	_
54-8	8391-8394	see	_
54-9	8395-8404	decreased	_
54-10	8405-8417	connectivity	_
54-11	8418-8428	associated	_
54-12	8429-8433	with	_
54-13	8434-8440	reward	_
54-14	8440-8441	,	_
54-15	8442-8451	executive	_
54-16	8452-8459	control	_
54-17	8459-8460	,	_
54-18	8461-8468	default	_
54-19	8469-8473	mode	_
54-20	8474-8477	and	_
54-21	8478-8484	visual	_
54-22	8485-8490	brain	_
54-23	8491-8496	areas	_
54-24	8497-8499	in	_
54-25	8500-8507	alcohol	_
54-26	8508-8513	users	_
54-27	8513-8514	.	_

#Text=With respect to nicotine use, both increases and decreases in connectivity effects are anticipated for cingulated cortex, precuneus, and executive function areas.
55-1	8515-8519	With	_
55-2	8520-8527	respect	_
55-3	8528-8530	to	_
55-4	8531-8539	nicotine	_
55-5	8540-8543	use	_
55-6	8543-8544	,	_
55-7	8545-8549	both	_
55-8	8550-8559	increases	_
55-9	8560-8563	and	_
55-10	8564-8573	decreases	_
55-11	8574-8576	in	_
55-12	8577-8589	connectivity	_
55-13	8590-8597	effects	_
55-14	8598-8601	are	_
55-15	8602-8613	anticipated	_
55-16	8614-8617	for	_
55-17	8618-8628	cingulated	_
55-18	8629-8635	cortex	_
55-19	8635-8636	,	_
55-20	8637-8646	precuneus	_
55-21	8646-8647	,	_
55-22	8648-8651	and	_
55-23	8652-8661	executive	_
55-24	8662-8670	function	_
55-25	8671-8676	areas	_
55-26	8676-8677	.	_

#Text=Common neural pathways for drug dependence exist, but alcohol and nicotine have different mechanisms of action.
56-1	8678-8684	Common	_
56-2	8685-8691	neural	_
56-3	8692-8700	pathways	_
56-4	8701-8704	for	_
56-5	8705-8709	drug	_
56-6	8710-8720	dependence	_
56-7	8721-8726	exist	_
56-8	8726-8727	,	_
56-9	8728-8731	but	_
56-10	8732-8739	alcohol	_
56-11	8740-8743	and	_
56-12	8744-8752	nicotine	_
56-13	8753-8757	have	_
56-14	8758-8767	different	_
56-15	8768-8778	mechanisms	_
56-16	8779-8781	of	_
56-17	8782-8788	action	_
56-18	8788-8789	.	_

#Text=While nicotine seems to be able to directly activate dopamine neurons in the ventral tegmental area, alcohol may indirectly produce a similar effect by inhibiting GABAergic receptors.
57-1	8790-8795	While	_
57-2	8796-8804	nicotine	_
57-3	8805-8810	seems	_
57-4	8811-8813	to	_
57-5	8814-8816	be	_
57-6	8817-8821	able	_
57-7	8822-8824	to	_
57-8	8825-8833	directly	_
57-9	8834-8842	activate	_
57-10	8843-8851	dopamine	_
57-11	8852-8859	neurons	_
57-12	8860-8862	in	_
57-13	8863-8866	the	_
57-14	8867-8874	ventral	_
57-15	8875-8884	tegmental	_
57-16	8885-8889	area	_
57-17	8889-8890	,	_
57-18	8891-8898	alcohol	_
57-19	8899-8902	may	_
57-20	8903-8913	indirectly	_
57-21	8914-8921	produce	_
57-22	8922-8923	a	_
57-23	8924-8931	similar	_
57-24	8932-8938	effect	_
57-25	8939-8941	by	_
57-26	8942-8952	inhibiting	_
57-27	8953-8962	GABAergic	_
57-28	8963-8972	receptors	_
57-29	8972-8973	.	_

#Text=In this sense, we expect to observe both common and different brain connectivity effects in smoking and drinking subjects depending on their similar effects in the reward system, but exerted through different pathways.
58-1	8974-8976	In	_
58-2	8977-8981	this	_
58-3	8982-8987	sense	_
58-4	8987-8988	,	_
58-5	8989-8991	we	_
58-6	8992-8998	expect	_
58-7	8999-9001	to	_
58-8	9002-9009	observe	_
58-9	9010-9014	both	_
58-10	9015-9021	common	_
58-11	9022-9025	and	_
58-12	9026-9035	different	_
58-13	9036-9041	brain	_
58-14	9042-9054	connectivity	_
58-15	9055-9062	effects	_
58-16	9063-9065	in	_
58-17	9066-9073	smoking	_
58-18	9074-9077	and	_
58-19	9078-9086	drinking	_
58-20	9087-9095	subjects	_
58-21	9096-9105	depending	_
58-22	9106-9108	on	_
58-23	9109-9114	their	_
58-24	9115-9122	similar	_
58-25	9123-9130	effects	_
58-26	9131-9133	in	_
58-27	9134-9137	the	_
58-28	9138-9144	reward	_
58-29	9145-9151	system	_
58-30	9151-9152	,	_
58-31	9153-9156	but	_
58-32	9157-9164	exerted	_
58-33	9165-9172	through	_
58-34	9173-9182	different	_
58-35	9183-9191	pathways	_
58-36	9191-9192	.	_

#Text=The motivation for our data-driven approach is to confirm the patterns of dysfunction linked to alcohol (general disconnection) and nicotine (network dysfunction) derived from seed based analyses.
59-1	9193-9196	The	_
59-2	9197-9207	motivation	_
59-3	9208-9211	for	_
59-4	9212-9215	our	_
59-5	9216-9227	data-driven	_
59-6	9228-9236	approach	_
59-7	9237-9239	is	_
59-8	9240-9242	to	_
59-9	9243-9250	confirm	_
59-10	9251-9254	the	_
59-11	9255-9263	patterns	_
59-12	9264-9266	of	_
59-13	9267-9278	dysfunction	_
59-14	9279-9285	linked	_
59-15	9286-9288	to	_
59-16	9289-9296	alcohol	_
59-17	9297-9298	(	_
59-18	9298-9305	general	_
59-19	9306-9319	disconnection	_
59-20	9319-9320	)	_
59-21	9321-9324	and	_
59-22	9325-9333	nicotine	_
59-23	9334-9335	(	_
59-24	9335-9342	network	_
59-25	9343-9354	dysfunction	_
59-26	9354-9355	)	_
59-27	9356-9363	derived	_
59-28	9364-9368	from	_
59-29	9369-9373	seed	_
59-30	9374-9379	based	_
59-31	9380-9388	analyses	_
59-32	9388-9389	.	_

#Text=Instead, we expect to observe these patterns of intrinsic connectivity using a whole brain analysis.
60-1	9390-9397	Instead	_
60-2	9397-9398	,	_
60-3	9399-9401	we	_
60-4	9402-9408	expect	_
60-5	9409-9411	to	_
60-6	9412-9419	observe	_
60-7	9420-9425	these	_
60-8	9426-9434	patterns	_
60-9	9435-9437	of	_
60-10	9438-9447	intrinsic	_
60-11	9448-9460	connectivity	_
60-12	9461-9466	using	_
60-13	9467-9468	a	_
60-14	9469-9474	whole	_
60-15	9475-9480	brain	_
60-16	9481-9489	analysis	_
60-17	9489-9490	.	_

#Text=We also expect to identify aspects of network dysfunction not previously found in the literature that can help refining future studies of substance use.
61-1	9491-9493	We	_
61-2	9494-9498	also	_
61-3	9499-9505	expect	_
61-4	9506-9508	to	_
61-5	9509-9517	identify	_
61-6	9518-9525	aspects	_
61-7	9526-9528	of	_
61-8	9529-9536	network	_
61-9	9537-9548	dysfunction	_
61-10	9549-9552	not	_
61-11	9553-9563	previously	_
61-12	9564-9569	found	_
61-13	9570-9572	in	_
61-14	9573-9576	the	_
61-15	9577-9587	literature	_
61-16	9588-9592	that	_
61-17	9593-9596	can	_
61-18	9597-9601	help	_
61-19	9602-9610	refining	_
61-20	9611-9617	future	_
61-21	9618-9625	studies	_
61-22	9626-9628	of	_
61-23	9629-9638	substance	_
61-24	9639-9642	use	_
61-25	9642-9643	.	_

#Text=Another goal is to find the main effects that discriminate between substances as well as effects that characterize their interaction.
62-1	9644-9651	Another	_
62-2	9652-9656	goal	_
62-3	9657-9659	is	_
62-4	9660-9662	to	_
62-5	9663-9667	find	_
62-6	9668-9671	the	_
62-7	9672-9676	main	_
62-8	9677-9684	effects	_
62-9	9685-9689	that	_
62-10	9690-9702	discriminate	_
62-11	9703-9710	between	_
62-12	9711-9721	substances	_
62-13	9722-9724	as	_
62-14	9725-9729	well	_
62-15	9730-9732	as	_
62-16	9733-9740	effects	_
62-17	9741-9745	that	_
62-18	9746-9758	characterize	_
62-19	9759-9764	their	_
62-20	9765-9776	interaction	_
62-21	9776-9777	.	_

#Text=We chose to use the gICA approach because it is especially useful for capturing both specific and unique aspects of the connectivity.
#Text=2 Materials and Methods
#Text=2.1 Subjects
#Text=Data were collected from 188 subjects: 71 females and 117 males between the ages of 18 and 54 (33.3 ± 9.3) years.
63-1	9778-9780	We	_
63-2	9781-9786	chose	_
63-3	9787-9789	to	_
63-4	9790-9793	use	_
63-5	9794-9797	the	_
63-6	9798-9802	gICA	_
63-7	9803-9811	approach	_
63-8	9812-9819	because	_
63-9	9820-9822	it	_
63-10	9823-9825	is	_
63-11	9826-9836	especially	_
63-12	9837-9843	useful	_
63-13	9844-9847	for	_
63-14	9848-9857	capturing	_
63-15	9858-9862	both	_
63-16	9863-9871	specific	_
63-17	9872-9875	and	_
63-18	9876-9882	unique	_
63-19	9883-9890	aspects	_
63-20	9891-9893	of	_
63-21	9894-9897	the	_
63-22	9898-9910	connectivity	_
63-23	9910-9911	.	_
63-24	9912-9913	2	_
63-25	9914-9923	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[12]
63-26	9924-9927	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[12]
63-27	9928-9935	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[12]
63-28	9936-9939	2.1	_
63-29	9940-9948	Subjects	_
63-30	9949-9953	Data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-31	9954-9958	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-32	9959-9968	collected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-33	9969-9973	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-34	9974-9977	188	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-35	9978-9986	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-36	9986-9987	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-37	9988-9990	71	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-38	9991-9998	females	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-39	9999-10002	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-40	10003-10006	117	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-41	10007-10012	males	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-42	10013-10020	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-43	10021-10024	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-44	10025-10029	ages	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-45	10030-10032	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-46	10033-10035	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-47	10036-10039	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-48	10040-10042	54	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-49	10043-10044	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-50	10044-10048	33.3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-51	10049-10050	±	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-52	10051-10054	9.3	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-53	10054-10055	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-54	10056-10061	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
63-55	10061-10062	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]

#Text=Subjects were excluded if there was injury to the brain, brain-related medical problems, bipolar or psychotic disorders.
64-1	10063-10071	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-2	10072-10076	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-3	10077-10085	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-4	10086-10088	if	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-5	10089-10094	there	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-6	10095-10098	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-7	10099-10105	injury	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-8	10106-10108	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-9	10109-10112	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-10	10113-10118	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-11	10118-10119	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-12	10120-10133	brain-related	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-13	10134-10141	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-14	10142-10150	problems	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-15	10150-10151	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-16	10152-10159	bipolar	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-17	10160-10162	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-18	10163-10172	psychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-19	10173-10182	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]
64-20	10182-10183	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]

#Text=In addition, the exclusion criterion includes use of illicit drugs confirmed or rejected by urinalysis.
65-1	10184-10186	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-2	10187-10195	addition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-3	10195-10196	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-4	10197-10200	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-5	10201-10210	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-6	10211-10220	criterion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-7	10221-10229	includes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-8	10230-10233	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-9	10234-10236	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-10	10237-10244	illicit	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-11	10245-10250	drugs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-12	10251-10260	confirmed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-13	10261-10263	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-14	10264-10272	rejected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-15	10273-10275	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-16	10276-10286	urinalysis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]
65-17	10286-10287	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]

#Text=Four groups were defined according to different levels of substance dependence: control (CTR), drinker (DRN), smoker (SMK), and smoking and drinking (SAD).
66-1	10288-10292	Four	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-2	10293-10299	groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-3	10300-10304	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-4	10305-10312	defined	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-5	10313-10322	according	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-6	10323-10325	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-7	10326-10335	different	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-8	10336-10342	levels	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-9	10343-10345	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-10	10346-10355	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-11	10356-10366	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-12	10366-10367	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-13	10368-10375	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[17]
66-14	10376-10377	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-15	10377-10380	CTR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-16	10380-10381	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-17	10381-10382	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-18	10383-10390	drinker	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[18]
66-19	10391-10392	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-20	10392-10395	DRN	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-21	10395-10396	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-22	10396-10397	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-23	10398-10404	smoker	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[19]
66-24	10405-10406	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-25	10406-10409	SMK	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-26	10409-10410	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-27	10410-10411	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-28	10412-10415	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-29	10416-10423	smoking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-30	10424-10427	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-31	10428-10436	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-32	10437-10438	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-33	10438-10441	SAD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-34	10441-10442	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]
66-35	10442-10443	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]

#Text=The DRN group is composed of 28 subjects that scored 8 or greater on the Alcohol Use Disorder Identification Test (AUDIT).
67-1	10444-10447	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-2	10448-10451	DRN	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[21]
67-3	10452-10457	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-4	10458-10460	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-5	10461-10469	composed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-6	10470-10472	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-7	10473-10475	28	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-8	10476-10484	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-9	10485-10489	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-10	10490-10496	scored	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-11	10497-10498	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-12	10499-10501	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-13	10502-10509	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-14	10510-10512	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-15	10513-10516	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
67-16	10517-10524	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-17	10525-10528	Use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-18	10529-10537	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-19	10538-10552	Identification	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-20	10553-10557	Test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-21	10558-10559	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-22	10559-10564	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-23	10564-10565	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[22]
67-24	10565-10566	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]

#Text=The maximum Fagerstrom Test for Nicotine Dependence (FTND) score for the DRN group is 4.
68-1	10567-10570	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-2	10571-10578	maximum	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-3	10579-10589	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-4	10590-10594	Test	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-5	10595-10598	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-6	10599-10607	Nicotine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-7	10608-10618	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-8	10619-10620	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-9	10620-10624	FTND	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-10	10624-10625	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[23]
68-11	10626-10631	score	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-12	10632-10635	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-13	10636-10639	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-14	10640-10643	DRN	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[24]
68-15	10644-10649	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-16	10650-10652	is	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-17	10653-10654	4	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
68-18	10654-10655	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]

#Text=The SMK group includes 73 smokers with a FTND score greater than 7.
69-1	10656-10659	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-2	10660-10663	SMK	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[26]
69-3	10664-10669	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-4	10670-10678	includes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-5	10679-10681	73	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-6	10682-10689	smokers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[27]
69-7	10690-10694	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-8	10695-10696	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-9	10697-10701	FTND	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[28]
69-10	10702-10707	score	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-11	10708-10715	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-12	10716-10720	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-13	10721-10722	7	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]
69-14	10722-10723	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[25]

#Text=The SAD group consists of 36 subjects that scored greater than 8 on the AUDIT and greater than 7 on the FTND.
70-1	10724-10727	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-2	10728-10731	SAD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-3	10732-10737	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-4	10738-10746	consists	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-5	10747-10749	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-6	10750-10752	36	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-7	10753-10761	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-8	10762-10766	that	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-9	10767-10773	scored	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-10	10774-10781	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-11	10782-10786	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-12	10787-10788	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-13	10789-10791	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-14	10792-10795	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-15	10796-10801	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest[30]
70-16	10802-10805	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-17	10806-10813	greater	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-18	10814-10818	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-19	10819-10820	7	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-20	10821-10823	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-21	10824-10827	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]
70-22	10828-10832	FTND	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[31]
70-23	10832-10833	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[29]

#Text=There is no significant difference in AUDIT score between SAD and DRN groups and there is no significant difference of FTND score between SAD and SMK groups.
71-1	10834-10839	There	_
71-2	10840-10842	is	_
71-3	10843-10845	no	_
71-4	10846-10857	significant	_
71-5	10858-10868	difference	_
71-6	10869-10871	in	_
71-7	10872-10877	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
71-8	10878-10883	score	_
71-9	10884-10891	between	_
71-10	10892-10895	SAD	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[32]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[33]
71-11	10896-10899	and	_
71-12	10900-10903	DRN	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
71-13	10904-10910	groups	_
71-14	10911-10914	and	_
71-15	10915-10920	there	_
71-16	10921-10923	is	_
71-17	10924-10926	no	_
71-18	10927-10938	significant	_
71-19	10939-10949	difference	_
71-20	10950-10952	of	_
71-21	10953-10957	FTND	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
71-22	10958-10963	score	_
71-23	10964-10971	between	_
71-24	10972-10975	SAD	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse[34]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[35]
71-25	10976-10979	and	_
71-26	10980-10983	SMK	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
71-27	10984-10990	groups	_
71-28	10990-10991	.	_

#Text=Detailed information about the four groups can be found in Table 1.
72-1	10992-11000	Detailed	_
72-2	11001-11012	information	_
72-3	11013-11018	about	_
72-4	11019-11022	the	_
72-5	11023-11027	four	_
72-6	11028-11034	groups	_
72-7	11035-11038	can	_
72-8	11039-11041	be	_
72-9	11042-11047	found	_
72-10	11048-11050	in	_
72-11	11051-11056	Table	_
72-12	11057-11058	1	_
72-13	11058-11059	.	_

#Text=The threshold used to select subjects for the DRN have been used before to detect hazardous drinking and corresponds to the minimum criteria for at-risk drinking.
73-1	11060-11063	The	_
73-2	11064-11073	threshold	_
73-3	11074-11078	used	_
73-4	11079-11081	to	_
73-5	11082-11088	select	_
73-6	11089-11097	subjects	_
73-7	11098-11101	for	_
73-8	11102-11105	the	_
73-9	11106-11109	DRN	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
73-10	11110-11114	have	_
73-11	11115-11119	been	_
73-12	11120-11124	used	_
73-13	11125-11131	before	_
73-14	11132-11134	to	_
73-15	11135-11141	detect	_
73-16	11142-11151	hazardous	_
73-17	11152-11160	drinking	_
73-18	11161-11164	and	_
73-19	11165-11176	corresponds	_
73-20	11177-11179	to	_
73-21	11180-11183	the	_
73-22	11184-11191	minimum	_
73-23	11192-11200	criteria	_
73-24	11201-11204	for	_
73-25	11205-11212	at-risk	_
73-26	11213-11221	drinking	_
73-27	11221-11222	.	_

#Text=The SMK group was selected with a more conservative threshold than previously utilized for training of machine learning algorithms.
74-1	11223-11226	The	_
74-2	11227-11230	SMK	http://maven.renci.org/NeuroBridge/neurobridge#NicotineAbuse
74-3	11231-11236	group	_
74-4	11237-11240	was	_
74-5	11241-11249	selected	_
74-6	11250-11254	with	_
74-7	11255-11256	a	_
74-8	11257-11261	more	_
74-9	11262-11274	conservative	_
74-10	11275-11284	threshold	_
74-11	11285-11289	than	_
74-12	11290-11300	previously	_
74-13	11301-11309	utilized	_
74-14	11310-11313	for	_
74-15	11314-11322	training	_
74-16	11323-11325	of	_
74-17	11326-11333	machine	_
74-18	11334-11342	learning	_
74-19	11343-11353	algorithms	_
74-20	11353-11354	.	_

#Text=Other relevant data collected included the Beck Depression Inventory (BDI), the Impulsive Sensation Seeking Scale (ImpSS) and income as socio-economic status variable.
75-1	11355-11360	Other	_
75-2	11361-11369	relevant	_
75-3	11370-11374	data	_
75-4	11375-11384	collected	_
75-5	11385-11393	included	_
75-6	11394-11397	the	_
75-7	11398-11402	Beck	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[36]
75-8	11403-11413	Depression	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[36]
75-9	11414-11423	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[36]
75-10	11424-11425	(	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[36]
75-11	11425-11428	BDI	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[36]
75-12	11428-11429	)	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[36]
75-13	11429-11430	,	_
75-14	11431-11434	the	_
75-15	11435-11444	Impulsive	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-16	11445-11454	Sensation	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-17	11455-11462	Seeking	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-18	11463-11468	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-19	11469-11470	(	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-20	11470-11475	ImpSS	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-21	11475-11476	)	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale[37]
75-22	11477-11480	and	_
75-23	11481-11487	income	_
75-24	11488-11490	as	_
75-25	11491-11505	socio-economic	_
75-26	11506-11512	status	_
75-27	11513-11521	variable	_
75-28	11521-11522	.	_

#Text=Income was categorized in 7 levels: 1-$0-$9,999/year, 2-$10,000-$19,999/year, 3-$20,000-$29,999/year, 4-$30,000-$39,999/year, 5-$40,000-$49,999/year, 6-$50,000-$59,999/year, and 7-Over $60,000/year.
76-1	11523-11529	Income	_
76-2	11530-11533	was	_
76-3	11534-11545	categorized	_
76-4	11546-11548	in	_
76-5	11549-11550	7	_
76-6	11551-11557	levels	_
76-7	11557-11558	:	_
76-8	11559-11560	1	_
76-9	11560-11561	-	_
76-10	11561-11563	$0	_
76-11	11563-11564	-	_
76-12	11564-11570	$9,999	_
76-13	11570-11571	/	_
76-14	11571-11575	year	_
76-15	11575-11576	,	_
76-16	11577-11578	2	_
76-17	11578-11579	-	_
76-18	11579-11586	$10,000	_
76-19	11586-11587	-	_
76-20	11587-11594	$19,999	_
76-21	11594-11595	/	_
76-22	11595-11599	year	_
76-23	11599-11600	,	_
76-24	11601-11602	3	_
76-25	11602-11603	-	_
76-26	11603-11610	$20,000	_
76-27	11610-11611	-	_
76-28	11611-11618	$29,999	_
76-29	11618-11619	/	_
76-30	11619-11623	year	_
76-31	11623-11624	,	_
76-32	11625-11626	4	_
76-33	11626-11627	-	_
76-34	11627-11634	$30,000	_
76-35	11634-11635	-	_
76-36	11635-11642	$39,999	_
76-37	11642-11643	/	_
76-38	11643-11647	year	_
76-39	11647-11648	,	_
76-40	11649-11650	5	_
76-41	11650-11651	-	_
76-42	11651-11658	$40,000	_
76-43	11658-11659	-	_
76-44	11659-11666	$49,999	_
76-45	11666-11667	/	_
76-46	11667-11671	year	_
76-47	11671-11672	,	_
76-48	11673-11674	6	_
76-49	11674-11675	-	_
76-50	11675-11682	$50,000	_
76-51	11682-11683	-	_
76-52	11683-11690	$59,999	_
76-53	11690-11691	/	_
76-54	11691-11695	year	_
76-55	11695-11696	,	_
76-56	11697-11700	and	_
76-57	11701-11702	7	_
76-58	11702-11703	-	_
76-59	11703-11707	Over	_
76-60	11708-11715	$60,000	_
76-61	11715-11716	/	_
76-62	11716-11720	year	_
76-63	11720-11721	.	_

#Text=The CTR group included 51 healthy individuals with no history of substance abuse/dependence assessed using the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P).
77-1	11722-11725	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-2	11726-11729	CTR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[39]
77-3	11730-11735	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-4	11736-11744	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-5	11745-11747	51	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-6	11748-11755	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-7	11756-11767	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-8	11768-11772	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-9	11773-11775	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-10	11776-11783	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-11	11784-11786	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-12	11787-11796	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-13	11797-11802	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-14	11802-11803	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-15	11803-11813	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[40]
77-16	11814-11822	assessed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-17	11823-11828	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-18	11829-11832	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-19	11833-11843	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-20	11844-11852	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-21	11853-11862	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-22	11863-11866	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-23	11867-11876	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-24	11877-11881	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-25	11882-11883	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-26	11884-11893	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[41]
77-27	11893-11894	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-28	11895-11903	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-29	11904-11911	Version	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-30	11911-11912	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-31	11913-11920	Patient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-32	11921-11928	Edition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-33	11929-11930	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-34	11930-11936	SCID-I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-35	11936-11937	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-36	11937-11938	P	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-37	11938-11939	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]
77-38	11939-11940	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[38]

#Text=Control subjects with current abuse or dependence of alcohol were excluded.
78-1	11941-11948	Control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[43]
78-2	11949-11957	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[43]
78-3	11958-11962	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-4	11963-11970	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-5	11971-11976	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-6	11977-11979	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-7	11980-11990	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-8	11991-11993	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-9	11994-12001	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-10	12002-12006	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-11	12007-12015	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]
78-12	12015-12016	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[42]

#Text=All control subjects reported themselves as non-smokers and scored zero for the FTND.
79-1	12017-12020	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-2	12021-12028	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[45]
79-3	12029-12037	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[45]
79-4	12038-12046	reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-5	12047-12057	themselves	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-6	12058-12060	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-7	12061-12072	non-smokers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-8	12073-12076	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-9	12077-12083	scored	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-10	12084-12088	zero	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-11	12089-12092	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-12	12093-12096	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
79-13	12097-12101	FTND	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]|http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence[46]
79-14	12101-12102	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]

#Text=None of the control subjects reported use of marijuana.
80-1	12103-12107	None	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-2	12108-12110	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-3	12111-12114	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-4	12115-12122	control	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-5	12123-12131	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-6	12132-12140	reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-7	12141-12144	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-8	12145-12147	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-9	12148-12157	marijuana	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]
80-10	12157-12158	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[44]

#Text=AUDIT, BDI, ImpSS and income measures were not collected for this group.
#Text=2.2 MRI Data
#Text=Resting state functional MRI data were collected on a 3T Siemens TIM Trio (Erlangen, Germany) scanner.
81-1	12159-12164	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
81-2	12164-12165	,	_
81-3	12166-12169	BDI	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale
81-4	12169-12170	,	_
81-5	12171-12176	ImpSS	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsiveSensationSeekingScale
81-6	12177-12180	and	_
81-7	12181-12187	income	_
81-8	12188-12196	measures	_
81-9	12197-12201	were	_
81-10	12202-12205	not	_
81-11	12206-12215	collected	_
81-12	12216-12219	for	_
81-13	12220-12224	this	_
81-14	12225-12230	group	_
81-15	12230-12231	.	_
81-16	12232-12235	2.2	_
81-17	12236-12239	MRI	_
81-18	12240-12244	Data	_
81-19	12245-12252	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[47]
81-20	12253-12258	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[47]
81-21	12259-12269	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[47]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[48]
81-22	12270-12273	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[47]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[48]
81-23	12274-12278	data	_
81-24	12279-12283	were	_
81-25	12284-12293	collected	_
81-26	12294-12296	on	_
81-27	12297-12298	a	_
81-28	12299-12301	3T	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-29	12302-12309	Siemens	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-30	12310-12313	TIM	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-31	12314-12318	Trio	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-32	12319-12320	(	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-33	12320-12328	Erlangen	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-34	12328-12329	,	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-35	12330-12337	Germany	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-36	12337-12338	)	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-37	12339-12346	scanner	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]
81-38	12346-12347	.	http://www.case.edu/ProvCaRe/provcare#MagneticResonanceImagingInstrument[49]

#Text=Participants kept their eyes open during the 5-minute resting scan.
82-1	12348-12360	Participants	_
82-2	12361-12365	kept	_
82-3	12366-12371	their	_
82-4	12372-12376	eyes	_
82-5	12377-12381	open	_
82-6	12382-12388	during	_
82-7	12389-12392	the	_
82-8	12393-12394	5	_
82-9	12394-12395	-	_
82-10	12395-12401	minute	_
82-11	12402-12409	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[50]
82-12	12410-12414	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[50]
82-13	12414-12415	.	_

#Text=Echo-planar EPI sequence images (TR = 2,000 ms, TE = 29 ms, flip angle = 75°) were acquired with an 8-channel head coil.
83-1	12416-12427	Echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[51]
83-2	12428-12431	EPI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[51]
83-3	12432-12440	sequence	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[51]
83-4	12441-12447	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol[51]
83-5	12448-12449	(	_
83-6	12449-12451	TR	_
83-7	12452-12453	=	_
83-8	12454-12459	2,000	_
83-9	12460-12462	ms	_
83-10	12462-12463	,	_
83-11	12464-12466	TE	_
83-12	12467-12468	=	_
83-13	12469-12471	29	_
83-14	12472-12474	ms	_
83-15	12474-12475	,	_
83-16	12476-12480	flip	_
83-17	12481-12486	angle	_
83-18	12487-12488	=	_
83-19	12489-12491	75	_
83-20	12491-12492	°	_
83-21	12492-12493	)	_
83-22	12494-12498	were	_
83-23	12499-12507	acquired	_
83-24	12508-12512	with	_
83-25	12513-12515	an	_
83-26	12516-12517	8	_
83-27	12517-12518	-	_
83-28	12518-12525	channel	_
83-29	12526-12530	head	_
83-30	12531-12535	coil	_
83-31	12535-12536	.	_

#Text=Each volume consisted of 33 axial slices (64 × 64 matrix, 3.75 × 3.75 mm2, 3.5 mm thickness, 1 mm gap).
84-1	12537-12541	Each	_
84-2	12542-12548	volume	_
84-3	12549-12558	consisted	_
84-4	12559-12561	of	_
84-5	12562-12564	33	_
84-6	12565-12570	axial	_
84-7	12571-12577	slices	_
84-8	12578-12579	(	_
84-9	12579-12581	64	_
84-10	12582-12583	×	_
84-11	12584-12586	64	_
84-12	12587-12593	matrix	_
84-13	12593-12594	,	_
84-14	12595-12599	3.75	_
84-15	12600-12601	×	_
84-16	12602-12606	3.75	_
84-17	12607-12610	mm2	_
84-18	12610-12611	,	_
84-19	12612-12615	3.5	_
84-20	12616-12618	mm	_
84-21	12619-12628	thickness	_
84-22	12628-12629	,	_
84-23	12630-12631	1	_
84-24	12632-12634	mm	_
84-25	12635-12638	gap	_
84-26	12638-12639	)	_
84-27	12639-12640	.	_

#Text=Resting state fMRI data were preprocessed using the statistical parametric mapping software (SPM; http://www.fil.ion.ucl.ac.uk/spm) including slice-timing correction, realignment, co-registration and spatial normalization.
85-1	12641-12648	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[52]
85-2	12649-12654	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[52]
85-3	12655-12659	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[52]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[53]
85-4	12660-12664	data	_
85-5	12665-12669	were	_
85-6	12670-12682	preprocessed	_
85-7	12683-12688	using	_
85-8	12689-12692	the	_
85-9	12693-12704	statistical	_
85-10	12705-12715	parametric	_
85-11	12716-12723	mapping	_
85-12	12724-12732	software	_
85-13	12733-12734	(	_
85-14	12734-12737	SPM	_
85-15	12737-12738	;	_
85-16	12739-12743	http	_
85-17	12743-12744	:	_
85-18	12744-12745	/	_
85-19	12745-12746	/	_
85-20	12746-12767	www.fil.ion.ucl.ac.uk	_
85-21	12767-12768	/	_
85-22	12768-12771	spm	_
85-23	12771-12772	)	_
85-24	12773-12782	including	_
85-25	12783-12795	slice-timing	_
85-26	12796-12806	correction	_
85-27	12806-12807	,	_
85-28	12808-12819	realignment	_
85-29	12819-12820	,	_
85-30	12821-12836	co-registration	_
85-31	12837-12840	and	_
85-32	12841-12848	spatial	_
85-33	12849-12862	normalization	_
85-34	12862-12863	.	_

#Text=Images were transformed to the Montreal Neurological Institute (MNI) standard space.
86-1	12864-12870	Images	_
86-2	12871-12875	were	_
86-3	12876-12887	transformed	_
86-4	12888-12890	to	_
86-5	12891-12894	the	_
86-6	12895-12903	Montreal	_
86-7	12904-12916	Neurological	_
86-8	12917-12926	Institute	_
86-9	12927-12928	(	_
86-10	12928-12931	MNI	_
86-11	12931-12932	)	_
86-12	12933-12941	standard	_
86-13	12942-12947	space	_
86-14	12947-12948	.	_

#Text=The first five scans were discarded to allow for T1 equilibration.
87-1	12949-12952	The	_
87-2	12953-12958	first	_
87-3	12959-12963	five	_
87-4	12964-12969	scans	_
87-5	12970-12974	were	_
87-6	12975-12984	discarded	_
87-7	12985-12987	to	_
87-8	12988-12993	allow	_
87-9	12994-12997	for	_
87-10	12998-13000	T1	_
87-11	13001-13014	equilibration	_
87-12	13014-13015	.	_

#Text=The DVARS method was used to find spike regressors where the root mean square (RMS) head movement exceeded 3 standard deviations.
88-1	13016-13019	The	_
88-2	13020-13025	DVARS	_
88-3	13026-13032	method	_
88-4	13033-13036	was	_
88-5	13037-13041	used	_
88-6	13042-13044	to	_
88-7	13045-13049	find	_
88-8	13050-13055	spike	_
88-9	13056-13066	regressors	_
88-10	13067-13072	where	_
88-11	13073-13076	the	_
88-12	13077-13081	root	_
88-13	13082-13086	mean	_
88-14	13087-13093	square	_
88-15	13094-13095	(	_
88-16	13095-13098	RMS	_
88-17	13098-13099	)	_
88-18	13100-13104	head	_
88-19	13105-13113	movement	_
88-20	13114-13122	exceeded	_
88-21	13123-13124	3	_
88-22	13125-13133	standard	_
88-23	13134-13144	deviations	_
88-24	13144-13145	.	_

#Text=Time courses, with a size of 145 time steps, were orthogonalized with respect to i) linear, quadratic and cubic trends; ii) the 6 realignment parameters and iii) realignment parameters derivatives.
89-1	13146-13150	Time	_
89-2	13151-13158	courses	_
89-3	13158-13159	,	_
89-4	13160-13164	with	_
89-5	13165-13166	a	_
89-6	13167-13171	size	_
89-7	13172-13174	of	_
89-8	13175-13178	145	_
89-9	13179-13183	time	_
89-10	13184-13189	steps	_
89-11	13189-13190	,	_
89-12	13191-13195	were	_
89-13	13196-13210	orthogonalized	_
89-14	13211-13215	with	_
89-15	13216-13223	respect	_
89-16	13224-13226	to	_
89-17	13227-13228	i	_
89-18	13228-13229	)	_
89-19	13230-13236	linear	_
89-20	13236-13237	,	_
89-21	13238-13247	quadratic	_
89-22	13248-13251	and	_
89-23	13252-13257	cubic	_
89-24	13258-13264	trends	_
89-25	13264-13265	;	_
89-26	13266-13268	ii	_
89-27	13268-13269	)	_
89-28	13270-13273	the	_
89-29	13274-13275	6	_
89-30	13276-13287	realignment	_
89-31	13288-13298	parameters	_
89-32	13299-13302	and	_
89-33	13303-13306	iii	_
89-34	13306-13307	)	_
89-35	13308-13319	realignment	_
89-36	13320-13330	parameters	_
89-37	13331-13342	derivatives	_
89-38	13342-13343	.	_

#Text=The decision to pre-process these nuisances at this point is based on recent recommendations in the field.
90-1	13344-13347	The	_
90-2	13348-13356	decision	_
90-3	13357-13359	to	_
90-4	13360-13371	pre-process	_
90-5	13372-13377	these	_
90-6	13378-13387	nuisances	_
90-7	13388-13390	at	_
90-8	13391-13395	this	_
90-9	13396-13401	point	_
90-10	13402-13404	is	_
90-11	13405-13410	based	_
90-12	13411-13413	on	_
90-13	13414-13420	recent	_
90-14	13421-13436	recommendations	_
90-15	13437-13439	in	_
90-16	13440-13443	the	_
90-17	13444-13449	field	_
90-18	13449-13450	.	_

#Text=The fMRI data were smoothed using a FWHM Gaussian kernel of size 6 mm.
91-1	13451-13454	The	_
91-2	13455-13459	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
91-3	13460-13464	data	_
91-4	13465-13469	were	_
91-5	13470-13478	smoothed	_
91-6	13479-13484	using	_
91-7	13485-13486	a	_
91-8	13487-13491	FWHM	_
91-9	13492-13500	Gaussian	_
91-10	13501-13507	kernel	_
91-11	13508-13510	of	_
91-12	13511-13515	size	_
91-13	13516-13517	6	_
91-14	13518-13520	mm	_
91-15	13520-13521	.	_

#Text=The data were then analyzed with Infomax based gICA with 120 and 100 components for the first and second decomposition levels respectively.
92-1	13522-13525	The	_
92-2	13526-13530	data	_
92-3	13531-13535	were	_
92-4	13536-13540	then	_
92-5	13541-13549	analyzed	_
92-6	13550-13554	with	_
92-7	13555-13562	Infomax	_
92-8	13563-13568	based	_
92-9	13569-13573	gICA	_
92-10	13574-13578	with	_
92-11	13579-13582	120	_
92-12	13583-13586	and	_
92-13	13587-13590	100	_
92-14	13591-13601	components	_
92-15	13602-13605	for	_
92-16	13606-13609	the	_
92-17	13610-13615	first	_
92-18	13616-13619	and	_
92-19	13620-13626	second	_
92-20	13627-13640	decomposition	_
92-21	13641-13647	levels	_
92-22	13648-13660	respectively	_
92-23	13660-13661	.	_

#Text=The number of components was determined using ICASSO such that its R-index is close to the minimum and the quality index for any given component is above 0.7.
93-1	13662-13665	The	_
93-2	13666-13672	number	_
93-3	13673-13675	of	_
93-4	13676-13686	components	_
93-5	13687-13690	was	_
93-6	13691-13701	determined	_
93-7	13702-13707	using	_
93-8	13708-13714	ICASSO	_
93-9	13715-13719	such	_
93-10	13720-13724	that	_
93-11	13725-13728	its	_
93-12	13729-13736	R-index	_
93-13	13737-13739	is	_
93-14	13740-13745	close	_
93-15	13746-13748	to	_
93-16	13749-13752	the	_
93-17	13753-13760	minimum	_
93-18	13761-13764	and	_
93-19	13765-13768	the	_
93-20	13769-13776	quality	_
93-21	13777-13782	index	_
93-22	13783-13786	for	_
93-23	13787-13790	any	_
93-24	13791-13796	given	_
93-25	13797-13806	component	_
93-26	13807-13809	is	_
93-27	13810-13815	above	_
93-28	13816-13819	0.7	_
93-29	13819-13820	.	_

#Text=A total of 39 components out of the 100 estimated components were selected based on frequency content and visual inspection in order to include components that were low noise and free of major artifacts.
94-1	13821-13822	A	_
94-2	13823-13828	total	_
94-3	13829-13831	of	_
94-4	13832-13834	39	_
94-5	13835-13845	components	_
94-6	13846-13849	out	_
94-7	13850-13852	of	_
94-8	13853-13856	the	_
94-9	13857-13860	100	_
94-10	13861-13870	estimated	_
94-11	13871-13881	components	_
94-12	13882-13886	were	_
94-13	13887-13895	selected	_
94-14	13896-13901	based	_
94-15	13902-13904	on	_
94-16	13905-13914	frequency	_
94-17	13915-13922	content	_
94-18	13923-13926	and	_
94-19	13927-13933	visual	_
94-20	13934-13944	inspection	_
94-21	13945-13947	in	_
94-22	13948-13953	order	_
94-23	13954-13956	to	_
94-24	13957-13964	include	_
94-25	13965-13975	components	_
94-26	13976-13980	that	_
94-27	13981-13985	were	_
94-28	13986-13989	low	_
94-29	13990-13995	noise	_
94-30	13996-13999	and	_
94-31	14000-14004	free	_
94-32	14005-14007	of	_
94-33	14008-14013	major	_
94-34	14014-14023	artifacts	_
94-35	14023-14024	.	_

#Text=These 39 components were considered the RSNs of interest.
95-1	14025-14030	These	_
95-2	14031-14033	39	_
95-3	14034-14044	components	_
95-4	14045-14049	were	_
95-5	14050-14060	considered	_
95-6	14061-14064	the	_
95-7	14065-14069	RSNs	_
95-8	14070-14072	of	_
95-9	14073-14081	interest	_
95-10	14081-14082	.	_

#Text=Spatial maps of the 39 components were z-transformed in order to identify the main brain areas included in each RSN.
96-1	14083-14090	Spatial	_
96-2	14091-14095	maps	_
96-3	14096-14098	of	_
96-4	14099-14102	the	_
96-5	14103-14105	39	_
96-6	14106-14116	components	_
96-7	14117-14121	were	_
96-8	14122-14135	z-transformed	_
96-9	14136-14138	in	_
96-10	14139-14144	order	_
96-11	14145-14147	to	_
96-12	14148-14156	identify	_
96-13	14157-14160	the	_
96-14	14161-14165	main	_
96-15	14166-14171	brain	_
96-16	14172-14177	areas	_
96-17	14178-14186	included	_
96-18	14187-14189	in	_
96-19	14190-14194	each	_
96-20	14195-14198	RSN	_
96-21	14198-14199	.	_

#Text=Time courses were then filtered using a band-pass filter 0.01 to 0.15 Hz.
97-1	14200-14204	Time	_
97-2	14205-14212	courses	_
97-3	14213-14217	were	_
97-4	14218-14222	then	_
97-5	14223-14231	filtered	_
97-6	14232-14237	using	_
97-7	14238-14239	a	_
97-8	14240-14249	band-pass	_
97-9	14250-14256	filter	_
97-10	14257-14261	0.01	_
97-11	14262-14264	to	_
97-12	14265-14269	0.15	_
97-13	14270-14272	Hz	_
97-14	14272-14273	.	_

#Text=Finally, resting state functional network connectivity (rsFNC) matrices were calculated for each subject based on the correlation coefficients between the time courses of all possible pairs formed with the 39 chosen components.
98-1	14274-14281	Finally	_
98-2	14281-14282	,	_
98-3	14283-14290	resting	_
98-4	14291-14296	state	_
98-5	14297-14307	functional	_
98-6	14308-14315	network	_
98-7	14316-14328	connectivity	_
98-8	14329-14330	(	_
98-9	14330-14335	rsFNC	_
98-10	14335-14336	)	_
98-11	14337-14345	matrices	_
98-12	14346-14350	were	_
98-13	14351-14361	calculated	_
98-14	14362-14365	for	_
98-15	14366-14370	each	_
98-16	14371-14378	subject	_
98-17	14379-14384	based	_
98-18	14385-14387	on	_
98-19	14388-14391	the	_
98-20	14392-14403	correlation	_
98-21	14404-14416	coefficients	_
98-22	14417-14424	between	_
98-23	14425-14428	the	_
98-24	14429-14433	time	_
98-25	14434-14441	courses	_
98-26	14442-14444	of	_
98-27	14445-14448	all	_
98-28	14449-14457	possible	_
98-29	14458-14463	pairs	_
98-30	14464-14470	formed	_
98-31	14471-14475	with	_
98-32	14476-14479	the	_
98-33	14480-14482	39	_
98-34	14483-14489	chosen	_
98-35	14490-14500	components	_
98-36	14500-14501	.	_

#Text=Spike time courses were censored from the calculation of correlation coefficients.
#Text=2.3 Functional Connectivity Analysis
#Text=The Fisher transformation was applied to all rsFNC values prior to statistical testing.
99-1	14502-14507	Spike	_
99-2	14508-14512	time	_
99-3	14513-14520	courses	_
99-4	14521-14525	were	_
99-5	14526-14534	censored	_
99-6	14535-14539	from	_
99-7	14540-14543	the	_
99-8	14544-14555	calculation	_
99-9	14556-14558	of	_
99-10	14559-14570	correlation	_
99-11	14571-14583	coefficients	_
99-12	14583-14584	.	_
99-13	14585-14588	2.3	_
99-14	14589-14599	Functional	_
99-15	14600-14612	Connectivity	_
99-16	14613-14621	Analysis	_
99-17	14622-14625	The	_
99-18	14626-14632	Fisher	_
99-19	14633-14647	transformation	_
99-20	14648-14651	was	_
99-21	14652-14659	applied	_
99-22	14660-14662	to	_
99-23	14663-14666	all	_
99-24	14667-14672	rsFNC	_
99-25	14673-14679	values	_
99-26	14680-14685	prior	_
99-27	14686-14688	to	_
99-28	14689-14700	statistical	_
99-29	14701-14708	testing	_
99-30	14708-14709	.	_

#Text=Age and sex differences were regressed out for each rsFNC along the subject dimension.
100-1	14710-14713	Age	_
100-2	14714-14717	and	_
100-3	14718-14721	sex	_
100-4	14722-14733	differences	_
100-5	14734-14738	were	_
100-6	14739-14748	regressed	_
100-7	14749-14752	out	_
100-8	14753-14756	for	_
100-9	14757-14761	each	_
100-10	14762-14767	rsFNC	_
100-11	14768-14773	along	_
100-12	14774-14777	the	_
100-13	14778-14785	subject	_
100-14	14786-14795	dimension	_
100-15	14795-14796	.	_

#Text=The rsFNC matrices were then organized into the four groups: CTR, DRN, SMK and SAD.
101-1	14797-14800	The	_
101-2	14801-14806	rsFNC	_
101-3	14807-14815	matrices	_
101-4	14816-14820	were	_
101-5	14821-14825	then	_
101-6	14826-14835	organized	_
101-7	14836-14840	into	_
101-8	14841-14844	the	_
101-9	14845-14849	four	_
101-10	14850-14856	groups	_
101-11	14856-14857	:	_
101-12	14858-14861	CTR	_
101-13	14861-14862	,	_
101-14	14863-14866	DRN	_
101-15	14866-14867	,	_
101-16	14868-14871	SMK	_
101-17	14872-14875	and	_
101-18	14876-14879	SAD	_
101-19	14879-14880	.	_

#Text=Group differences were evaluated for each rsFNC pair using one-way ANOVA.
102-1	14881-14886	Group	_
102-2	14887-14898	differences	_
102-3	14899-14903	were	_
102-4	14904-14913	evaluated	_
102-5	14914-14917	for	_
102-6	14918-14922	each	_
102-7	14923-14928	rsFNC	_
102-8	14929-14933	pair	_
102-9	14934-14939	using	_
102-10	14940-14947	one-way	_
102-11	14948-14953	ANOVA	_
102-12	14953-14954	.	_

#Text=Statistical significance for each ANOVA was assessed at the p < 0.05 level and corrected using false discovery rate (FDR) multiple comparison correction.
103-1	14955-14966	Statistical	_
103-2	14967-14979	significance	_
103-3	14980-14983	for	_
103-4	14984-14988	each	_
103-5	14989-14994	ANOVA	_
103-6	14995-14998	was	_
103-7	14999-15007	assessed	_
103-8	15008-15010	at	_
103-9	15011-15014	the	_
103-10	15015-15016	p	_
103-11	15017-15018	<	_
103-12	15019-15023	0.05	_
103-13	15024-15029	level	_
103-14	15030-15033	and	_
103-15	15034-15043	corrected	_
103-16	15044-15049	using	_
103-17	15050-15055	false	_
103-18	15056-15065	discovery	_
103-19	15066-15070	rate	_
103-20	15071-15072	(	_
103-21	15072-15075	FDR	_
103-22	15075-15076	)	_
103-23	15077-15085	multiple	_
103-24	15086-15096	comparison	_
103-25	15097-15107	correction	_
103-26	15107-15108	.	_

#Text=Post hoc analyses based on the Fisher's least significant difference procedure were applied to those ANOVA results surviving FDR correction.
104-1	15109-15113	Post	_
104-2	15114-15117	hoc	_
104-3	15118-15126	analyses	_
104-4	15127-15132	based	_
104-5	15133-15135	on	_
104-6	15136-15139	the	_
104-7	15140-15148	Fisher's	_
104-8	15149-15154	least	_
104-9	15155-15166	significant	_
104-10	15167-15177	difference	_
104-11	15178-15187	procedure	_
104-12	15188-15192	were	_
104-13	15193-15200	applied	_
104-14	15201-15203	to	_
104-15	15204-15209	those	_
104-16	15210-15215	ANOVA	_
104-17	15216-15223	results	_
104-18	15224-15233	surviving	_
104-19	15234-15237	FDR	_
104-20	15238-15248	correction	_
104-21	15248-15249	.	_

#Text=The rsFNCs with significant group differences, tested using one-way ANOVA, were further analyzed for significant relationship with AUDIT and FTND variables.
105-1	15250-15253	The	_
105-2	15254-15260	rsFNCs	_
105-3	15261-15265	with	_
105-4	15266-15277	significant	_
105-5	15278-15283	group	_
105-6	15284-15295	differences	_
105-7	15295-15296	,	_
105-8	15297-15303	tested	_
105-9	15304-15309	using	_
105-10	15310-15317	one-way	_
105-11	15318-15323	ANOVA	_
105-12	15323-15324	,	_
105-13	15325-15329	were	_
105-14	15330-15337	further	_
105-15	15338-15346	analyzed	_
105-16	15347-15350	for	_
105-17	15351-15362	significant	_
105-18	15363-15375	relationship	_
105-19	15376-15380	with	_
105-20	15381-15386	AUDIT	_
105-21	15387-15390	and	_
105-22	15391-15395	FTND	_
105-23	15396-15405	variables	_
105-24	15405-15406	.	_

#Text=A regression model was implemented separately for different sample groups, where the original Fisher transformed rsFNC data was utilized as the dependent variable for each of the regression models, and confounding factors sex, age, BDI, ImpSS and income were included as independent variables.
106-1	15407-15408	A	_
106-2	15409-15419	regression	_
106-3	15420-15425	model	_
106-4	15426-15429	was	_
106-5	15430-15441	implemented	_
106-6	15442-15452	separately	_
106-7	15453-15456	for	_
106-8	15457-15466	different	_
106-9	15467-15473	sample	_
106-10	15474-15480	groups	_
106-11	15480-15481	,	_
106-12	15482-15487	where	_
106-13	15488-15491	the	_
106-14	15492-15500	original	_
106-15	15501-15507	Fisher	_
106-16	15508-15519	transformed	_
106-17	15520-15525	rsFNC	_
106-18	15526-15530	data	_
106-19	15531-15534	was	_
106-20	15535-15543	utilized	_
106-21	15544-15546	as	_
106-22	15547-15550	the	_
106-23	15551-15560	dependent	_
106-24	15561-15569	variable	_
106-25	15570-15573	for	_
106-26	15574-15578	each	_
106-27	15579-15581	of	_
106-28	15582-15585	the	_
106-29	15586-15596	regression	_
106-30	15597-15603	models	_
106-31	15603-15604	,	_
106-32	15605-15608	and	_
106-33	15609-15620	confounding	_
106-34	15621-15628	factors	_
106-35	15629-15632	sex	_
106-36	15632-15633	,	_
106-37	15634-15637	age	_
106-38	15637-15638	,	_
106-39	15639-15642	BDI	_
106-40	15642-15643	,	_
106-41	15644-15649	ImpSS	_
106-42	15650-15653	and	_
106-43	15654-15660	income	_
106-44	15661-15665	were	_
106-45	15666-15674	included	_
106-46	15675-15677	as	_
106-47	15678-15689	independent	_
106-48	15690-15699	variables	_
106-49	15699-15700	.	_

#Text=FTND as an additional independent variable was included for subjects in the SMK group.
107-1	15701-15705	FTND	_
107-2	15706-15708	as	_
107-3	15709-15711	an	_
107-4	15712-15722	additional	_
107-5	15723-15734	independent	_
107-6	15735-15743	variable	_
107-7	15744-15747	was	_
107-8	15748-15756	included	_
107-9	15757-15760	for	_
107-10	15761-15769	subjects	_
107-11	15770-15772	in	_
107-12	15773-15776	the	_
107-13	15777-15780	SMK	_
107-14	15781-15786	group	_
107-15	15786-15787	.	_

#Text=AUDIT was similarly tested for the DRN group.
108-1	15788-15793	AUDIT	_
108-2	15794-15797	was	_
108-3	15798-15807	similarly	_
108-4	15808-15814	tested	_
108-5	15815-15818	for	_
108-6	15819-15822	the	_
108-7	15823-15826	DRN	_
108-8	15827-15832	group	_
108-9	15832-15833	.	_

#Text=In the case of the SAD group, the interaction between AUDIT and FTND was added.
#Text=3 Results
#Text=Figure 1 shows spatial maps for the set of 39 selected RSNs and Table 2 displays their peak activation coordinates.
109-1	15834-15836	In	_
109-2	15837-15840	the	_
109-3	15841-15845	case	_
109-4	15846-15848	of	_
109-5	15849-15852	the	_
109-6	15853-15856	SAD	_
109-7	15857-15862	group	_
109-8	15862-15863	,	_
109-9	15864-15867	the	_
109-10	15868-15879	interaction	_
109-11	15880-15887	between	_
109-12	15888-15893	AUDIT	_
109-13	15894-15897	and	_
109-14	15898-15902	FTND	_
109-15	15903-15906	was	_
109-16	15907-15912	added	_
109-17	15912-15913	.	_
109-18	15914-15915	3	_
109-19	15916-15923	Results	_
109-20	15924-15930	Figure	_
109-21	15931-15932	1	_
109-22	15933-15938	shows	_
109-23	15939-15946	spatial	_
109-24	15947-15951	maps	_
109-25	15952-15955	for	_
109-26	15956-15959	the	_
109-27	15960-15963	set	_
109-28	15964-15966	of	_
109-29	15967-15969	39	_
109-30	15970-15978	selected	_
109-31	15979-15983	RSNs	_
109-32	15984-15987	and	_
109-33	15988-15993	Table	_
109-34	15994-15995	2	_
109-35	15996-16004	displays	_
109-36	16005-16010	their	_
109-37	16011-16015	peak	_
109-38	16016-16026	activation	_
109-39	16027-16038	coordinates	_
109-40	16038-16039	.	_

#Text=The RSN groups reflect RSN functions and anatomies following the strategy presented in previous rsFNC studies.
110-1	16040-16043	The	_
110-2	16044-16047	RSN	_
110-3	16048-16054	groups	_
110-4	16055-16062	reflect	_
110-5	16063-16066	RSN	_
110-6	16067-16076	functions	_
110-7	16077-16080	and	_
110-8	16081-16090	anatomies	_
110-9	16091-16100	following	_
110-10	16101-16104	the	_
110-11	16105-16113	strategy	_
110-12	16114-16123	presented	_
110-13	16124-16126	in	_
110-14	16127-16135	previous	_
110-15	16136-16141	rsFNC	_
110-16	16142-16149	studies	_
110-17	16149-16150	.	_

#Text=Considered RSN groups are subcortical (SBC), cerebellum (CER), auditory (AUD), sensorimotor (SEN), visual (VIS), salience (SAL), default mode network (DMN), executive control network (ECN) and precuneus (PRE).
111-1	16151-16161	Considered	_
111-2	16162-16165	RSN	_
111-3	16166-16172	groups	_
111-4	16173-16176	are	_
111-5	16177-16188	subcortical	_
111-6	16189-16190	(	_
111-7	16190-16193	SBC	_
111-8	16193-16194	)	_
111-9	16194-16195	,	_
111-10	16196-16206	cerebellum	_
111-11	16207-16208	(	_
111-12	16208-16211	CER	_
111-13	16211-16212	)	_
111-14	16212-16213	,	_
111-15	16214-16222	auditory	_
111-16	16223-16224	(	_
111-17	16224-16227	AUD	_
111-18	16227-16228	)	_
111-19	16228-16229	,	_
111-20	16230-16242	sensorimotor	_
111-21	16243-16244	(	_
111-22	16244-16247	SEN	_
111-23	16247-16248	)	_
111-24	16248-16249	,	_
111-25	16250-16256	visual	_
111-26	16257-16258	(	_
111-27	16258-16261	VIS	_
111-28	16261-16262	)	_
111-29	16262-16263	,	_
111-30	16264-16272	salience	_
111-31	16273-16274	(	_
111-32	16274-16277	SAL	_
111-33	16277-16278	)	_
111-34	16278-16279	,	_
111-35	16280-16287	default	_
111-36	16288-16292	mode	_
111-37	16293-16300	network	_
111-38	16301-16302	(	_
111-39	16302-16305	DMN	_
111-40	16305-16306	)	_
111-41	16306-16307	,	_
111-42	16308-16317	executive	_
111-43	16318-16325	control	_
111-44	16326-16333	network	_
111-45	16334-16335	(	_
111-46	16335-16338	ECN	_
111-47	16338-16339	)	_
111-48	16340-16343	and	_
111-49	16344-16353	precuneus	_
111-50	16354-16355	(	_
111-51	16355-16358	PRE	_
111-52	16358-16359	)	_
111-53	16359-16360	.	_

#Text=Spatial overlap with functional brain areas were confirmed by visual comparison with the 90 spatial maps defined by Shirer and by running peak activation coordinates through the meta-analysis software publicly available at http://www.neurosynth.org/.
112-1	16361-16368	Spatial	_
112-2	16369-16376	overlap	_
112-3	16377-16381	with	_
112-4	16382-16392	functional	_
112-5	16393-16398	brain	_
112-6	16399-16404	areas	_
112-7	16405-16409	were	_
112-8	16410-16419	confirmed	_
112-9	16420-16422	by	_
112-10	16423-16429	visual	_
112-11	16430-16440	comparison	_
112-12	16441-16445	with	_
112-13	16446-16449	the	_
112-14	16450-16452	90	_
112-15	16453-16460	spatial	_
112-16	16461-16465	maps	_
112-17	16466-16473	defined	_
112-18	16474-16476	by	_
112-19	16477-16483	Shirer	_
112-20	16484-16487	and	_
112-21	16488-16490	by	_
112-22	16491-16498	running	_
112-23	16499-16503	peak	_
112-24	16504-16514	activation	_
112-25	16515-16526	coordinates	_
112-26	16527-16534	through	_
112-27	16535-16538	the	_
112-28	16539-16552	meta-analysis	_
112-29	16553-16561	software	_
112-30	16562-16570	publicly	_
112-31	16571-16580	available	_
112-32	16581-16583	at	_
112-33	16584-16588	http	_
112-34	16588-16589	:	_
112-35	16589-16590	/	_
112-36	16590-16591	/	_
112-37	16591-16609	www.neurosynth.org	_
112-38	16609-16610	/	_
112-39	16610-16611	.	_

#Text=RSNs with peak activations in thalamus and putamen constitute the SBC group.
113-1	16612-16616	RSNs	_
113-2	16617-16621	with	_
113-3	16622-16626	peak	_
113-4	16627-16638	activations	_
113-5	16639-16641	in	_
113-6	16642-16650	thalamus	_
113-7	16651-16654	and	_
113-8	16655-16662	putamen	_
113-9	16663-16673	constitute	_
113-10	16674-16677	the	_
113-11	16678-16681	SBC	_
113-12	16682-16687	group	_
113-13	16687-16688	.	_

#Text=The CER group comprises RSNs with activations on left and right lobule VIIa.
114-1	16689-16692	The	_
114-2	16693-16696	CER	_
114-3	16697-16702	group	_
114-4	16703-16712	comprises	_
114-5	16713-16717	RSNs	_
114-6	16718-16722	with	_
114-7	16723-16734	activations	_
114-8	16735-16737	on	_
114-9	16738-16742	left	_
114-10	16743-16746	and	_
114-11	16747-16752	right	_
114-12	16753-16759	lobule	_
114-13	16760-16764	VIIa	_
114-14	16764-16765	.	_

#Text=The auditory RSN is located at the Heschl’s gyrus.
115-1	16766-16769	The	_
115-2	16770-16778	auditory	_
115-3	16779-16782	RSN	_
115-4	16783-16785	is	_
115-5	16786-16793	located	_
115-6	16794-16796	at	_
115-7	16797-16800	the	_
115-8	16801-16807	Heschl	_
115-9	16807-16808	’	_
115-10	16808-16809	s	_
115-11	16810-16815	gyrus	_
115-12	16815-16816	.	_

#Text=The SEN group covers part of the supplementary motor area (SMA) and large portions of the postcentral gyrus.
116-1	16817-16820	The	_
116-2	16821-16824	SEN	_
116-3	16825-16830	group	_
116-4	16831-16837	covers	_
116-5	16838-16842	part	_
116-6	16843-16845	of	_
116-7	16846-16849	the	_
116-8	16850-16863	supplementary	_
116-9	16864-16869	motor	_
116-10	16870-16874	area	_
116-11	16875-16876	(	_
116-12	16876-16879	SMA	_
116-13	16879-16880	)	_
116-14	16881-16884	and	_
116-15	16885-16890	large	_
116-16	16891-16899	portions	_
116-17	16900-16902	of	_
116-18	16903-16906	the	_
116-19	16907-16918	postcentral	_
116-20	16919-16924	gyrus	_
116-21	16924-16925	.	_

#Text=Fusiform, lingual, superior, middle and inferior occipital gyri are included in the VIS group.
117-1	16926-16934	Fusiform	_
117-2	16934-16935	,	_
117-3	16936-16943	lingual	_
117-4	16943-16944	,	_
117-5	16945-16953	superior	_
117-6	16953-16954	,	_
117-7	16955-16961	middle	_
117-8	16962-16965	and	_
117-9	16966-16974	inferior	_
117-10	16975-16984	occipital	_
117-11	16985-16989	gyri	_
117-12	16990-16993	are	_
117-13	16994-17002	included	_
117-14	17003-17005	in	_
117-15	17006-17009	the	_
117-16	17010-17013	VIS	_
117-17	17014-17019	group	_
117-18	17019-17020	.	_

#Text=One VIS RSN labeled Lingual/Vermis is a complex network that embraces the lingual gyrus as well as the cerebellar vermis.
118-1	17021-17024	One	_
118-2	17025-17028	VIS	_
118-3	17029-17032	RSN	_
118-4	17033-17040	labeled	_
118-5	17041-17048	Lingual	_
118-6	17048-17049	/	_
118-7	17049-17055	Vermis	_
118-8	17056-17058	is	_
118-9	17059-17060	a	_
118-10	17061-17068	complex	_
118-11	17069-17076	network	_
118-12	17077-17081	that	_
118-13	17082-17090	embraces	_
118-14	17091-17094	the	_
118-15	17095-17102	lingual	_
118-16	17103-17108	gyrus	_
118-17	17109-17111	as	_
118-18	17112-17116	well	_
118-19	17117-17119	as	_
118-20	17120-17123	the	_
118-21	17124-17134	cerebellar	_
118-22	17135-17141	vermis	_
118-23	17141-17142	.	_

#Text=Areas on the left and right insula, superior temporal and supramarginal gyri are included in the SAL group.
119-1	17143-17148	Areas	_
119-2	17149-17151	on	_
119-3	17152-17155	the	_
119-4	17156-17160	left	_
119-5	17161-17164	and	_
119-6	17165-17170	right	_
119-7	17171-17177	insula	_
119-8	17177-17178	,	_
119-9	17179-17187	superior	_
119-10	17188-17196	temporal	_
119-11	17197-17200	and	_
119-12	17201-17214	supramarginal	_
119-13	17215-17219	gyri	_
119-14	17220-17223	are	_
119-15	17224-17232	included	_
119-16	17233-17235	in	_
119-17	17236-17239	the	_
119-18	17240-17243	SAL	_
119-19	17244-17249	group	_
119-20	17249-17250	.	_

#Text=The DMN group is comprised of anterior cingulate cortex (ACC), angular gyrus and posterior cingulate cortex (PCC) with some precuneus overlap.
120-1	17251-17254	The	_
120-2	17255-17258	DMN	_
120-3	17259-17264	group	_
120-4	17265-17267	is	_
120-5	17268-17277	comprised	_
120-6	17278-17280	of	_
120-7	17281-17289	anterior	_
120-8	17290-17299	cingulate	_
120-9	17300-17306	cortex	_
120-10	17307-17308	(	_
120-11	17308-17311	ACC	_
120-12	17311-17312	)	_
120-13	17312-17313	,	_
120-14	17314-17321	angular	_
120-15	17322-17327	gyrus	_
120-16	17328-17331	and	_
120-17	17332-17341	posterior	_
120-18	17342-17351	cingulate	_
120-19	17352-17358	cortex	_
120-20	17359-17360	(	_
120-21	17360-17363	PCC	_
120-22	17363-17364	)	_
120-23	17365-17369	with	_
120-24	17370-17374	some	_
120-25	17375-17384	precuneus	_
120-26	17385-17392	overlap	_
120-27	17392-17393	.	_

#Text=The ECN group is composed of fronto-parietal regions including inferior parietal lobule (IPL), inferior frontal gyrus (IFG) and middle frontal gyrus (MFG).
121-1	17394-17397	The	_
121-2	17398-17401	ECN	_
121-3	17402-17407	group	_
121-4	17408-17410	is	_
121-5	17411-17419	composed	_
121-6	17420-17422	of	_
121-7	17423-17438	fronto-parietal	_
121-8	17439-17446	regions	_
121-9	17447-17456	including	_
121-10	17457-17465	inferior	_
121-11	17466-17474	parietal	_
121-12	17475-17481	lobule	_
121-13	17482-17483	(	_
121-14	17483-17486	IPL	_
121-15	17486-17487	)	_
121-16	17487-17488	,	_
121-17	17489-17497	inferior	_
121-18	17498-17505	frontal	_
121-19	17506-17511	gyrus	_
121-20	17512-17513	(	_
121-21	17513-17516	IFG	_
121-22	17516-17517	)	_
121-23	17518-17521	and	_
121-24	17522-17528	middle	_
121-25	17529-17536	frontal	_
121-26	17537-17542	gyrus	_
121-27	17543-17544	(	_
121-28	17544-17547	MFG	_
121-29	17547-17548	)	_
121-30	17548-17549	.	_

#Text=RSNs in the PRE group cover regions of the precuneus including overlap with the cuneus.
122-1	17550-17554	RSNs	_
122-2	17555-17557	in	_
122-3	17558-17561	the	_
122-4	17562-17565	PRE	_
122-5	17566-17571	group	_
122-6	17572-17577	cover	_
122-7	17578-17585	regions	_
122-8	17586-17588	of	_
122-9	17589-17592	the	_
122-10	17593-17602	precuneus	_
122-11	17603-17612	including	_
122-12	17613-17620	overlap	_
122-13	17621-17625	with	_
122-14	17626-17629	the	_
122-15	17630-17636	cuneus	_
122-16	17636-17637	.	_

#Text=Figure 2 displays the mean rsFNC matrices for CTR, SMK, DRN, and SAD groups.
123-1	17638-17644	Figure	_
123-2	17645-17646	2	_
123-3	17647-17655	displays	_
123-4	17656-17659	the	_
123-5	17660-17664	mean	_
123-6	17665-17670	rsFNC	_
123-7	17671-17679	matrices	_
123-8	17680-17683	for	_
123-9	17684-17687	CTR	_
123-10	17687-17688	,	_
123-11	17689-17692	SMK	_
123-12	17692-17693	,	_
123-13	17694-17697	DRN	_
123-14	17697-17698	,	_
123-15	17699-17702	and	_
123-16	17703-17706	SAD	_
123-17	17707-17713	groups	_
123-18	17713-17714	.	_

#Text=Compared to the CTR matrix, DRN and SAD matrices show a clear pattern of decreased rsFNC between VIS-SEN, VIS-SAL, and SEN-PRE RSN groups.
124-1	17715-17723	Compared	_
124-2	17724-17726	to	_
124-3	17727-17730	the	_
124-4	17731-17734	CTR	_
124-5	17735-17741	matrix	_
124-6	17741-17742	,	_
124-7	17743-17746	DRN	_
124-8	17747-17750	and	_
124-9	17751-17754	SAD	_
124-10	17755-17763	matrices	_
124-11	17764-17768	show	_
124-12	17769-17770	a	_
124-13	17771-17776	clear	_
124-14	17777-17784	pattern	_
124-15	17785-17787	of	_
124-16	17788-17797	decreased	_
124-17	17798-17803	rsFNC	_
124-18	17804-17811	between	_
124-19	17812-17819	VIS-SEN	_
124-20	17819-17820	,	_
124-21	17821-17828	VIS-SAL	_
124-22	17828-17829	,	_
124-23	17830-17833	and	_
124-24	17834-17841	SEN-PRE	_
124-25	17842-17845	RSN	_
124-26	17846-17852	groups	_
124-27	17852-17853	.	_

#Text=The differences between rsFNC matrices of CTR and SMK groups are few and difficult to spot.
125-1	17854-17857	The	_
125-2	17858-17869	differences	_
125-3	17870-17877	between	_
125-4	17878-17883	rsFNC	_
125-5	17884-17892	matrices	_
125-6	17893-17895	of	_
125-7	17896-17899	CTR	_
125-8	17900-17903	and	_
125-9	17904-17907	SMK	_
125-10	17908-17914	groups	_
125-11	17915-17918	are	_
125-12	17919-17922	few	_
125-13	17923-17926	and	_
125-14	17927-17936	difficult	_
125-15	17937-17939	to	_
125-16	17940-17944	spot	_
125-17	17944-17945	.	_

#Text=The most notable difference is an anti-correlation increase between PCC and Precentral-3b RSNs in the SMK group.
126-1	17946-17949	The	_
126-2	17950-17954	most	_
126-3	17955-17962	notable	_
126-4	17963-17973	difference	_
126-5	17974-17976	is	_
126-6	17977-17979	an	_
126-7	17980-17996	anti-correlation	_
126-8	17997-18005	increase	_
126-9	18006-18013	between	_
126-10	18014-18017	PCC	_
126-11	18018-18021	and	_
126-12	18022-18032	Precentral	_
126-13	18032-18033	-	_
126-14	18033-18035	3b	_
126-15	18036-18040	RSNs	_
126-16	18041-18043	in	_
126-17	18044-18047	the	_
126-18	18048-18051	SMK	_
126-19	18052-18057	group	_
126-20	18057-18058	.	_

#Text=The ANOVA test revealed 50 rsFNCs with significant group differences after FDR correction (p < 0.05).
127-1	18059-18062	The	_
127-2	18063-18068	ANOVA	_
127-3	18069-18073	test	_
127-4	18074-18082	revealed	_
127-5	18083-18085	50	_
127-6	18086-18092	rsFNCs	_
127-7	18093-18097	with	_
127-8	18098-18109	significant	_
127-9	18110-18115	group	_
127-10	18116-18127	differences	_
127-11	18128-18133	after	_
127-12	18134-18137	FDR	_
127-13	18138-18148	correction	_
127-14	18149-18150	(	_
127-15	18150-18151	p	_
127-16	18152-18153	<	_
127-17	18154-18158	0.05	_
127-18	18158-18159	)	_
127-19	18159-18160	.	_

#Text=Supplementary Figure 1 shows ANOVA tables for the aforementioned results.
128-1	18161-18174	Supplementary	_
128-2	18175-18181	Figure	_
128-3	18182-18183	1	_
128-4	18184-18189	shows	_
128-5	18190-18195	ANOVA	_
128-6	18196-18202	tables	_
128-7	18203-18206	for	_
128-8	18207-18210	the	_
128-9	18211-18225	aforementioned	_
128-10	18226-18233	results	_
128-11	18233-18234	.	_

#Text=The histogram presented in Figure 3 summarizes the relevant information contained in the post-hoc outcomes for a cleaner presentation of the observed effects.
129-1	18235-18238	The	_
129-2	18239-18248	histogram	_
129-3	18249-18258	presented	_
129-4	18259-18261	in	_
129-5	18262-18268	Figure	_
129-6	18269-18270	3	_
129-7	18271-18281	summarizes	_
129-8	18282-18285	the	_
129-9	18286-18294	relevant	_
129-10	18295-18306	information	_
129-11	18307-18316	contained	_
129-12	18317-18319	in	_
129-13	18320-18323	the	_
129-14	18324-18332	post-hoc	_
129-15	18333-18341	outcomes	_
129-16	18342-18345	for	_
129-17	18346-18347	a	_
129-18	18348-18355	cleaner	_
129-19	18356-18368	presentation	_
129-20	18369-18371	of	_
129-21	18372-18375	the	_
129-22	18376-18384	observed	_
129-23	18385-18392	effects	_
129-24	18392-18393	.	_

#Text=The significant rsFNC differences were catalogued as driven by smoking and drinking, drinking, or smoking. rsFNC differences where the SMK group was different from the CTR group were considered as driven by smoking. rsFNC differences were considered as driven by drinking when the DRN group was different from the CTR group.
130-1	18394-18397	The	_
130-2	18398-18409	significant	_
130-3	18410-18415	rsFNC	_
130-4	18416-18427	differences	_
130-5	18428-18432	were	_
130-6	18433-18443	catalogued	_
130-7	18444-18446	as	_
130-8	18447-18453	driven	_
130-9	18454-18456	by	_
130-10	18457-18464	smoking	_
130-11	18465-18468	and	_
130-12	18469-18477	drinking	_
130-13	18477-18478	,	_
130-14	18479-18487	drinking	_
130-15	18487-18488	,	_
130-16	18489-18491	or	_
130-17	18492-18499	smoking	_
130-18	18499-18500	.	_
130-19	18501-18506	rsFNC	_
130-20	18507-18518	differences	_
130-21	18519-18524	where	_
130-22	18525-18528	the	_
130-23	18529-18532	SMK	_
130-24	18533-18538	group	_
130-25	18539-18542	was	_
130-26	18543-18552	different	_
130-27	18553-18557	from	_
130-28	18558-18561	the	_
130-29	18562-18565	CTR	_
130-30	18566-18571	group	_
130-31	18572-18576	were	_
130-32	18577-18587	considered	_
130-33	18588-18590	as	_
130-34	18591-18597	driven	_
130-35	18598-18600	by	_
130-36	18601-18608	smoking	_
130-37	18608-18609	.	_
130-38	18610-18615	rsFNC	_
130-39	18616-18627	differences	_
130-40	18628-18632	were	_
130-41	18633-18643	considered	_
130-42	18644-18646	as	_
130-43	18647-18653	driven	_
130-44	18654-18656	by	_
130-45	18657-18665	drinking	_
130-46	18666-18670	when	_
130-47	18671-18674	the	_
130-48	18675-18678	DRN	_
130-49	18679-18684	group	_
130-50	18685-18688	was	_
130-51	18689-18698	different	_
130-52	18699-18703	from	_
130-53	18704-18707	the	_
130-54	18708-18711	CTR	_
130-55	18712-18717	group	_
130-56	18717-18718	.	_

#Text=If the SAD group was different from the CTR group, or both SMK and DRN groups were different from the CTR group, the rsFNC difference was designated as driven by smoking and drinking.
131-1	18719-18721	If	_
131-2	18722-18725	the	_
131-3	18726-18729	SAD	_
131-4	18730-18735	group	_
131-5	18736-18739	was	_
131-6	18740-18749	different	_
131-7	18750-18754	from	_
131-8	18755-18758	the	_
131-9	18759-18762	CTR	_
131-10	18763-18768	group	_
131-11	18768-18769	,	_
131-12	18770-18772	or	_
131-13	18773-18777	both	_
131-14	18778-18781	SMK	_
131-15	18782-18785	and	_
131-16	18786-18789	DRN	_
131-17	18790-18796	groups	_
131-18	18797-18801	were	_
131-19	18802-18811	different	_
131-20	18812-18816	from	_
131-21	18817-18820	the	_
131-22	18821-18824	CTR	_
131-23	18825-18830	group	_
131-24	18830-18831	,	_
131-25	18832-18835	the	_
131-26	18836-18841	rsFNC	_
131-27	18842-18852	difference	_
131-28	18853-18856	was	_
131-29	18857-18867	designated	_
131-30	18868-18870	as	_
131-31	18871-18877	driven	_
131-32	18878-18880	by	_
131-33	18881-18888	smoking	_
131-34	18889-18892	and	_
131-35	18893-18901	drinking	_
131-36	18901-18902	.	_

#Text=The rsFNC between Postcentral-3b and PCC was a special case because the SMK group showed increased anti-correlation, the DRN group decreased anti-correlation, but the SAD group exhibited no difference when compared to the CTR group.
132-1	18903-18906	The	_
132-2	18907-18912	rsFNC	_
132-3	18913-18920	between	_
132-4	18921-18932	Postcentral	_
132-5	18932-18933	-	_
132-6	18933-18935	3b	_
132-7	18936-18939	and	_
132-8	18940-18943	PCC	_
132-9	18944-18947	was	_
132-10	18948-18949	a	_
132-11	18950-18957	special	_
132-12	18958-18962	case	_
132-13	18963-18970	because	_
132-14	18971-18974	the	_
132-15	18975-18978	SMK	_
132-16	18979-18984	group	_
132-17	18985-18991	showed	_
132-18	18992-19001	increased	_
132-19	19002-19018	anti-correlation	_
132-20	19018-19019	,	_
132-21	19020-19023	the	_
132-22	19024-19027	DRN	_
132-23	19028-19033	group	_
132-24	19034-19043	decreased	_
132-25	19044-19060	anti-correlation	_
132-26	19060-19061	,	_
132-27	19062-19065	but	_
132-28	19066-19069	the	_
132-29	19070-19073	SAD	_
132-30	19074-19079	group	_
132-31	19080-19089	exhibited	_
132-32	19090-19092	no	_
132-33	19093-19103	difference	_
132-34	19104-19108	when	_
132-35	19109-19117	compared	_
132-36	19118-19120	to	_
132-37	19121-19124	the	_
132-38	19125-19128	CTR	_
132-39	19129-19134	group	_
132-40	19134-19135	.	_

#Text=We labeled this case as protective in a separate group with one rsFNC.
133-1	19136-19138	We	_
133-2	19139-19146	labeled	_
133-3	19147-19151	this	_
133-4	19152-19156	case	_
133-5	19157-19159	as	_
133-6	19160-19170	protective	_
133-7	19171-19173	in	_
133-8	19174-19175	a	_
133-9	19176-19184	separate	_
133-10	19185-19190	group	_
133-11	19191-19195	with	_
133-12	19196-19199	one	_
133-13	19200-19205	rsFNC	_
133-14	19205-19206	.	_

#Text=Where possible, results in the histogram of Figure 3 were organized around rsFNCs with repeated RSNs.
134-1	19207-19212	Where	_
134-2	19213-19221	possible	_
134-3	19221-19222	,	_
134-4	19223-19230	results	_
134-5	19231-19233	in	_
134-6	19234-19237	the	_
134-7	19238-19247	histogram	_
134-8	19248-19250	of	_
134-9	19251-19257	Figure	_
134-10	19258-19259	3	_
134-11	19260-19264	were	_
134-12	19265-19274	organized	_
134-13	19275-19281	around	_
134-14	19282-19288	rsFNCs	_
134-15	19289-19293	with	_
134-16	19294-19302	repeated	_
134-17	19303-19307	RSNs	_
134-18	19307-19308	.	_

#Text=This organization allowed us to identify RSN patterns of interest and perform an organized interpretation of the results.
135-1	19309-19313	This	_
135-2	19314-19326	organization	_
135-3	19327-19334	allowed	_
135-4	19335-19337	us	_
135-5	19338-19340	to	_
135-6	19341-19349	identify	_
135-7	19350-19353	RSN	_
135-8	19354-19362	patterns	_
135-9	19363-19365	of	_
135-10	19366-19374	interest	_
135-11	19375-19378	and	_
135-12	19379-19386	perform	_
135-13	19387-19389	an	_
135-14	19390-19399	organized	_
135-15	19400-19414	interpretation	_
135-16	19415-19417	of	_
135-17	19418-19421	the	_
135-18	19422-19429	results	_
135-19	19429-19430	.	_

#Text=Figure 4 displays the spatial location of RSNs appearing in Figure 3 with their rsFNCs represented by edges.
136-1	19431-19437	Figure	_
136-2	19438-19439	4	_
136-3	19440-19448	displays	_
136-4	19449-19452	the	_
136-5	19453-19460	spatial	_
136-6	19461-19469	location	_
136-7	19470-19472	of	_
136-8	19473-19477	RSNs	_
136-9	19478-19487	appearing	_
136-10	19488-19490	in	_
136-11	19491-19497	Figure	_
136-12	19498-19499	3	_
136-13	19500-19504	with	_
136-14	19505-19510	their	_
136-15	19511-19517	rsFNCs	_
136-16	19518-19529	represented	_
136-17	19530-19532	by	_
136-18	19533-19538	edges	_
136-19	19538-19539	.	_

#Text=In the ANOVAs driven by smoking and drinking, the left middle occipital gyrus (L MOG) RSN exhibit hypo-connectivity with many other SEN, VIS and SAL RSNs.
137-1	19540-19542	In	_
137-2	19543-19546	the	_
137-3	19547-19553	ANOVAs	_
137-4	19554-19560	driven	_
137-5	19561-19563	by	_
137-6	19564-19571	smoking	_
137-7	19572-19575	and	_
137-8	19576-19584	drinking	_
137-9	19584-19585	,	_
137-10	19586-19589	the	_
137-11	19590-19594	left	_
137-12	19595-19601	middle	_
137-13	19602-19611	occipital	_
137-14	19612-19617	gyrus	_
137-15	19618-19619	(	_
137-16	19619-19620	L	_
137-17	19621-19624	MOG	_
137-18	19624-19625	)	_
137-19	19626-19629	RSN	_
137-20	19630-19637	exhibit	_
137-21	19638-19655	hypo-connectivity	_
137-22	19656-19660	with	_
137-23	19661-19665	many	_
137-24	19666-19671	other	_
137-25	19672-19675	SEN	_
137-26	19675-19676	,	_
137-27	19677-19680	VIS	_
137-28	19681-19684	and	_
137-29	19685-19688	SAL	_
137-30	19689-19693	RSNs	_
137-31	19693-19694	.	_

#Text=In the right side, right inferior occipital gyrus (R IOG) and right superior occipital gyrus (R SOG) shows similar hypo-connectivity pattern with SEN, VIS and PRE RSNs.
138-1	19695-19697	In	_
138-2	19698-19701	the	_
138-3	19702-19707	right	_
138-4	19708-19712	side	_
138-5	19712-19713	,	_
138-6	19714-19719	right	_
138-7	19720-19728	inferior	_
138-8	19729-19738	occipital	_
138-9	19739-19744	gyrus	_
138-10	19745-19746	(	_
138-11	19746-19747	R	_
138-12	19748-19751	IOG	_
138-13	19751-19752	)	_
138-14	19753-19756	and	_
138-15	19757-19762	right	_
138-16	19763-19771	superior	_
138-17	19772-19781	occipital	_
138-18	19782-19787	gyrus	_
138-19	19788-19789	(	_
138-20	19789-19790	R	_
138-21	19791-19794	SOG	_
138-22	19794-19795	)	_
138-23	19796-19801	shows	_
138-24	19802-19809	similar	_
138-25	19810-19827	hypo-connectivity	_
138-26	19828-19835	pattern	_
138-27	19836-19840	with	_
138-28	19841-19844	SEN	_
138-29	19844-19845	,	_
138-30	19846-19849	VIS	_
138-31	19850-19853	and	_
138-32	19854-19857	PRE	_
138-33	19858-19862	RSNs	_
138-34	19862-19863	.	_

#Text=In relation to the ECN, one hypoconnectivity was found between left inferior parietal lobule (L IPL) and a VIS RSN in the left inferior occipital gyrus (L IOG).
139-1	19864-19866	In	_
139-2	19867-19875	relation	_
139-3	19876-19878	to	_
139-4	19879-19882	the	_
139-5	19883-19886	ECN	_
139-6	19886-19887	,	_
139-7	19888-19891	one	_
139-8	19892-19908	hypoconnectivity	_
139-9	19909-19912	was	_
139-10	19913-19918	found	_
139-11	19919-19926	between	_
139-12	19927-19931	left	_
139-13	19932-19940	inferior	_
139-14	19941-19949	parietal	_
139-15	19950-19956	lobule	_
139-16	19957-19958	(	_
139-17	19958-19959	L	_
139-18	19960-19963	IPL	_
139-19	19963-19964	)	_
139-20	19965-19968	and	_
139-21	19969-19970	a	_
139-22	19971-19974	VIS	_
139-23	19975-19978	RSN	_
139-24	19979-19981	in	_
139-25	19982-19985	the	_
139-26	19986-19990	left	_
139-27	19991-19999	inferior	_
139-28	20000-20009	occipital	_
139-29	20010-20015	gyrus	_
139-30	20016-20017	(	_
139-31	20017-20018	L	_
139-32	20019-20022	IOG	_
139-33	20022-20023	)	_
139-34	20023-20024	.	_

#Text=Other connectivity reductions compared to controls involve the Lingual/Vermis and other RSNs of the VIS and PRE groups.
140-1	20025-20030	Other	_
140-2	20031-20043	connectivity	_
140-3	20044-20054	reductions	_
140-4	20055-20063	compared	_
140-5	20064-20066	to	_
140-6	20067-20075	controls	_
140-7	20076-20083	involve	_
140-8	20084-20087	the	_
140-9	20088-20095	Lingual	_
140-10	20095-20096	/	_
140-11	20096-20102	Vermis	_
140-12	20103-20106	and	_
140-13	20107-20112	other	_
140-14	20113-20117	RSNs	_
140-15	20118-20120	of	_
140-16	20121-20124	the	_
140-17	20125-20128	VIS	_
140-18	20129-20132	and	_
140-19	20133-20136	PRE	_
140-20	20137-20143	groups	_
140-21	20143-20144	.	_

#Text=No hyper-connectivity was observed among the ANOVA results driven by smoking and drinking.
141-1	20145-20147	No	_
141-2	20148-20166	hyper-connectivity	_
141-3	20167-20170	was	_
141-4	20171-20179	observed	_
141-5	20180-20185	among	_
141-6	20186-20189	the	_
141-7	20190-20195	ANOVA	_
141-8	20196-20203	results	_
141-9	20204-20210	driven	_
141-10	20211-20213	by	_
141-11	20214-20221	smoking	_
141-12	20222-20225	and	_
141-13	20226-20234	drinking	_
141-14	20234-20235	.	_

#Text=The rsFNC differences driven by drinking followed a similar pattern as those in the smoking and drinking category.
142-1	20236-20239	The	_
142-2	20240-20245	rsFNC	_
142-3	20246-20257	differences	_
142-4	20258-20264	driven	_
142-5	20265-20267	by	_
142-6	20268-20276	drinking	_
142-7	20277-20285	followed	_
142-8	20286-20287	a	_
142-9	20288-20295	similar	_
142-10	20296-20303	pattern	_
142-11	20304-20306	as	_
142-12	20307-20312	those	_
142-13	20313-20315	in	_
142-14	20316-20319	the	_
142-15	20320-20327	smoking	_
142-16	20328-20331	and	_
142-17	20332-20340	drinking	_
142-18	20341-20349	category	_
142-19	20349-20350	.	_

#Text=The most prominent result is hypo-connectivity among SAL, PRE, SEN and VIS RSNs.
143-1	20351-20354	The	_
143-2	20355-20359	most	_
143-3	20360-20369	prominent	_
143-4	20370-20376	result	_
143-5	20377-20379	is	_
143-6	20380-20397	hypo-connectivity	_
143-7	20398-20403	among	_
143-8	20404-20407	SAL	_
143-9	20407-20408	,	_
143-10	20409-20412	PRE	_
143-11	20412-20413	,	_
143-12	20414-20417	SEN	_
143-13	20418-20421	and	_
143-14	20422-20425	VIS	_
143-15	20426-20430	RSNs	_
143-16	20430-20431	.	_

#Text=A distinctive exception to the spread hypo-connectivity pattern is the increased connectivity in the DRN group compared to the CTR group between the reward system, represented by the putamen, and areas of visual processing characterized by the Lingual/Vermis RSN.
144-1	20432-20433	A	_
144-2	20434-20445	distinctive	_
144-3	20446-20455	exception	_
144-4	20456-20458	to	_
144-5	20459-20462	the	_
144-6	20463-20469	spread	_
144-7	20470-20487	hypo-connectivity	_
144-8	20488-20495	pattern	_
144-9	20496-20498	is	_
144-10	20499-20502	the	_
144-11	20503-20512	increased	_
144-12	20513-20525	connectivity	_
144-13	20526-20528	in	_
144-14	20529-20532	the	_
144-15	20533-20536	DRN	_
144-16	20537-20542	group	_
144-17	20543-20551	compared	_
144-18	20552-20554	to	_
144-19	20555-20558	the	_
144-20	20559-20562	CTR	_
144-21	20563-20568	group	_
144-22	20569-20576	between	_
144-23	20577-20580	the	_
144-24	20581-20587	reward	_
144-25	20588-20594	system	_
144-26	20594-20595	,	_
144-27	20596-20607	represented	_
144-28	20608-20610	by	_
144-29	20611-20614	the	_
144-30	20615-20622	putamen	_
144-31	20622-20623	,	_
144-32	20624-20627	and	_
144-33	20628-20633	areas	_
144-34	20634-20636	of	_
144-35	20637-20643	visual	_
144-36	20644-20654	processing	_
144-37	20655-20668	characterized	_
144-38	20669-20671	by	_
144-39	20672-20675	the	_
144-40	20676-20683	Lingual	_
144-41	20683-20684	/	_
144-42	20684-20690	Vermis	_
144-43	20691-20694	RSN	_
144-44	20694-20695	.	_

#Text=Only two rsFNC results were found to be driven by smoking including a hypo-connectivity between thalamus and putamen plus a hyperconnectivity between precuneus and left angular gyrus.
145-1	20696-20700	Only	_
145-2	20701-20704	two	_
145-3	20705-20710	rsFNC	_
145-4	20711-20718	results	_
145-5	20719-20723	were	_
145-6	20724-20729	found	_
145-7	20730-20732	to	_
145-8	20733-20735	be	_
145-9	20736-20742	driven	_
145-10	20743-20745	by	_
145-11	20746-20753	smoking	_
145-12	20754-20763	including	_
145-13	20764-20765	a	_
145-14	20766-20783	hypo-connectivity	_
145-15	20784-20791	between	_
145-16	20792-20800	thalamus	_
145-17	20801-20804	and	_
145-18	20805-20812	putamen	_
145-19	20813-20817	plus	_
145-20	20818-20819	a	_
145-21	20820-20837	hyperconnectivity	_
145-22	20838-20845	between	_
145-23	20846-20855	precuneus	_
145-24	20856-20859	and	_
145-25	20860-20864	left	_
145-26	20865-20872	angular	_
145-27	20873-20878	gyrus	_
145-28	20878-20879	.	_

#Text=Significant relationship with AUDIT and FTND were found in four rsFNCs as described in Table 3.
146-1	20880-20891	Significant	_
146-2	20892-20904	relationship	_
146-3	20905-20909	with	_
146-4	20910-20915	AUDIT	_
146-5	20916-20919	and	_
146-6	20920-20924	FTND	_
146-7	20925-20929	were	_
146-8	20930-20935	found	_
146-9	20936-20938	in	_
146-10	20939-20943	four	_
146-11	20944-20950	rsFNCs	_
146-12	20951-20953	as	_
146-13	20954-20963	described	_
146-14	20964-20966	in	_
146-15	20967-20972	Table	_
146-16	20973-20974	3	_
146-17	20974-20975	.	_

#Text=No significant relationship with the other considered confounding factors was found in any of the four results displayed in Table 3.
147-1	20976-20978	No	_
147-2	20979-20990	significant	_
147-3	20991-21003	relationship	_
147-4	21004-21008	with	_
147-5	21009-21012	the	_
147-6	21013-21018	other	_
147-7	21019-21029	considered	_
147-8	21030-21041	confounding	_
147-9	21042-21049	factors	_
147-10	21050-21053	was	_
147-11	21054-21059	found	_
147-12	21060-21062	in	_
147-13	21063-21066	any	_
147-14	21067-21069	of	_
147-15	21070-21073	the	_
147-16	21074-21078	four	_
147-17	21079-21086	results	_
147-18	21087-21096	displayed	_
147-19	21097-21099	in	_
147-20	21100-21105	Table	_
147-21	21106-21107	3	_
147-22	21107-21108	.	_

#Text=In smokers, the connectivity between L Angular and Precuneus RSNs increases with the FTND measure.
148-1	21109-21111	In	_
148-2	21112-21119	smokers	_
148-3	21119-21120	,	_
148-4	21121-21124	the	_
148-5	21125-21137	connectivity	_
148-6	21138-21145	between	_
148-7	21146-21147	L	_
148-8	21148-21155	Angular	_
148-9	21156-21159	and	_
148-10	21160-21169	Precuneus	_
148-11	21170-21174	RSNs	_
148-12	21175-21184	increases	_
148-13	21185-21189	with	_
148-14	21190-21193	the	_
148-15	21194-21198	FTND	_
148-16	21199-21206	measure	_
148-17	21206-21207	.	_

#Text=No relationship with FTND was found for thalamus vs. putamen, which is the only other rsFNC with group difference between CTR and SMK groups.
149-1	21208-21210	No	_
149-2	21211-21223	relationship	_
149-3	21224-21228	with	_
149-4	21229-21233	FTND	_
149-5	21234-21237	was	_
149-6	21238-21243	found	_
149-7	21244-21247	for	_
149-8	21248-21256	thalamus	_
149-9	21257-21259	vs	_
149-10	21259-21260	.	_
149-11	21261-21268	putamen	_
149-12	21268-21269	,	_
149-13	21270-21275	which	_
149-14	21276-21278	is	_
149-15	21279-21282	the	_
149-16	21283-21287	only	_
149-17	21288-21293	other	_
149-18	21294-21299	rsFNC	_
149-19	21300-21304	with	_
149-20	21305-21310	group	_
149-21	21311-21321	difference	_
149-22	21322-21329	between	_
149-23	21330-21333	CTR	_
149-24	21334-21337	and	_
149-25	21338-21341	SMK	_
149-26	21342-21348	groups	_
149-27	21348-21349	.	_

#Text=The rsFNC between Postcentral-3b and R Fusiform Gyrus/Lingual RSNs decreased as the AUDIT score increases for the DRN samples.
150-1	21350-21353	The	_
150-2	21354-21359	rsFNC	_
150-3	21360-21367	between	_
150-4	21368-21379	Postcentral	_
150-5	21379-21380	-	_
150-6	21380-21382	3b	_
150-7	21383-21386	and	_
150-8	21387-21388	R	_
150-9	21389-21397	Fusiform	_
150-10	21398-21403	Gyrus	_
150-11	21403-21404	/	_
150-12	21404-21411	Lingual	_
150-13	21412-21416	RSNs	_
150-14	21417-21426	decreased	_
150-15	21427-21429	as	_
150-16	21430-21433	the	_
150-17	21434-21439	AUDIT	_
150-18	21440-21445	score	_
150-19	21446-21455	increases	_
150-20	21456-21459	for	_
150-21	21460-21463	the	_
150-22	21464-21467	DRN	_
150-23	21468-21475	samples	_
150-24	21475-21476	.	_

#Text=This relationship coincides with the general hypo-connectivity found in alcohol consumers between sensorimotor and visual areas.
151-1	21477-21481	This	_
151-2	21482-21494	relationship	_
151-3	21495-21504	coincides	_
151-4	21505-21509	with	_
151-5	21510-21513	the	_
151-6	21514-21521	general	_
151-7	21522-21539	hypo-connectivity	_
151-8	21540-21545	found	_
151-9	21546-21548	in	_
151-10	21549-21556	alcohol	_
151-11	21557-21566	consumers	_
151-12	21567-21574	between	_
151-13	21575-21587	sensorimotor	_
151-14	21588-21591	and	_
151-15	21592-21598	visual	_
151-16	21599-21604	areas	_
151-17	21604-21605	.	_

#Text=Two rsFNCs were related to the interaction of FTND with AUDIT.
152-1	21606-21609	Two	_
152-2	21610-21616	rsFNCs	_
152-3	21617-21621	were	_
152-4	21622-21629	related	_
152-5	21630-21632	to	_
152-6	21633-21636	the	_
152-7	21637-21648	interaction	_
152-8	21649-21651	of	_
152-9	21652-21656	FTND	_
152-10	21657-21661	with	_
152-11	21662-21667	AUDIT	_
152-12	21667-21668	.	_

#Text=The SMA-6 vs.
153-1	21669-21672	The	_
153-2	21673-21676	SMA	_
153-3	21676-21677	-	_
153-4	21677-21678	6	_
153-5	21679-21681	vs	_
153-6	21681-21682	.	_

#Text=R IOG and the L Fusiform/Lingual vs.
154-1	21683-21684	R	_
154-2	21685-21688	IOG	_
154-3	21689-21692	and	_
154-4	21693-21696	the	_
154-5	21697-21698	L	_
154-6	21699-21707	Fusiform	_
154-7	21707-21708	/	_
154-8	21708-21715	Lingual	_
154-9	21716-21718	vs	_
154-10	21718-21719	.	_

#Text=Cuneus rsFNCs decreased as the interaction term increased.
#Text=4 Discussion
#Text=The objective of this work was to use a data driven analysis technique to find different patterns of rsFNC characterizing groups of subjects who smoke, drink or both.
155-1	21720-21726	Cuneus	_
155-2	21727-21733	rsFNCs	_
155-3	21734-21743	decreased	_
155-4	21744-21746	as	_
155-5	21747-21750	the	_
155-6	21751-21762	interaction	_
155-7	21763-21767	term	_
155-8	21768-21777	increased	_
155-9	21777-21778	.	_
155-10	21779-21780	4	_
155-11	21781-21791	Discussion	_
155-12	21792-21795	The	_
155-13	21796-21805	objective	_
155-14	21806-21808	of	_
155-15	21809-21813	this	_
155-16	21814-21818	work	_
155-17	21819-21822	was	_
155-18	21823-21825	to	_
155-19	21826-21829	use	_
155-20	21830-21831	a	_
155-21	21832-21836	data	_
155-22	21837-21843	driven	_
155-23	21844-21852	analysis	_
155-24	21853-21862	technique	_
155-25	21863-21865	to	_
155-26	21866-21870	find	_
155-27	21871-21880	different	_
155-28	21881-21889	patterns	_
155-29	21890-21892	of	_
155-30	21893-21898	rsFNC	_
155-31	21899-21913	characterizing	_
155-32	21914-21920	groups	_
155-33	21921-21923	of	_
155-34	21924-21932	subjects	_
155-35	21933-21936	who	_
155-36	21937-21942	smoke	_
155-37	21942-21943	,	_
155-38	21944-21949	drink	_
155-39	21950-21952	or	_
155-40	21953-21957	both	_
155-41	21957-21958	.	_

#Text=The data driven nature of our approach reduced possible bias present in seed-based analyses.
156-1	21959-21962	The	_
156-2	21963-21967	data	_
156-3	21968-21974	driven	_
156-4	21975-21981	nature	_
156-5	21982-21984	of	_
156-6	21985-21988	our	_
156-7	21989-21997	approach	_
156-8	21998-22005	reduced	_
156-9	22006-22014	possible	_
156-10	22015-22019	bias	_
156-11	22020-22027	present	_
156-12	22028-22030	in	_
156-13	22031-22041	seed-based	_
156-14	22042-22050	analyses	_
156-15	22050-22051	.	_

#Text=Obtained results do not invalidate some of the previously reported observations using a-priori regions of interests, but instead reveal the strongest effects found in the population under study.
157-1	22052-22060	Obtained	_
157-2	22061-22068	results	_
157-3	22069-22071	do	_
157-4	22072-22075	not	_
157-5	22076-22086	invalidate	_
157-6	22087-22091	some	_
157-7	22092-22094	of	_
157-8	22095-22098	the	_
157-9	22099-22109	previously	_
157-10	22110-22118	reported	_
157-11	22119-22131	observations	_
157-12	22132-22137	using	_
157-13	22138-22146	a-priori	_
157-14	22147-22154	regions	_
157-15	22155-22157	of	_
157-16	22158-22167	interests	_
157-17	22167-22168	,	_
157-18	22169-22172	but	_
157-19	22173-22180	instead	_
157-20	22181-22187	reveal	_
157-21	22188-22191	the	_
157-22	22192-22201	strongest	_
157-23	22202-22209	effects	_
157-24	22210-22215	found	_
157-25	22216-22218	in	_
157-26	22219-22222	the	_
157-27	22223-22233	population	_
157-28	22234-22239	under	_
157-29	22240-22245	study	_
157-30	22245-22246	.	_

#Text=The observed general pattern describes a hypo-connectivity in substance dependence subjects compared to controls.
158-1	22247-22250	The	_
158-2	22251-22259	observed	_
158-3	22260-22267	general	_
158-4	22268-22275	pattern	_
158-5	22276-22285	describes	_
158-6	22286-22287	a	_
158-7	22288-22305	hypo-connectivity	_
158-8	22306-22308	in	_
158-9	22309-22318	substance	_
158-10	22319-22329	dependence	_
158-11	22330-22338	subjects	_
158-12	22339-22347	compared	_
158-13	22348-22350	to	_
158-14	22351-22359	controls	_
158-15	22359-22360	.	_

#Text=The hypo-connectivity was prominent between visual RSNs connected to sensorimotor, salience and precuneus RSNs.
159-1	22361-22364	The	_
159-2	22365-22382	hypo-connectivity	_
159-3	22383-22386	was	_
159-4	22387-22396	prominent	_
159-5	22397-22404	between	_
159-6	22405-22411	visual	_
159-7	22412-22416	RSNs	_
159-8	22417-22426	connected	_
159-9	22427-22429	to	_
159-10	22430-22442	sensorimotor	_
159-11	22442-22443	,	_
159-12	22444-22452	salience	_
159-13	22453-22456	and	_
159-14	22457-22466	precuneus	_
159-15	22467-22471	RSNs	_
159-16	22471-22472	.	_

#Text=On the contrary, hyper-connectivity observations were few, but pointing to important brain regions including the DMN, precuneus and putamen.
160-1	22473-22475	On	_
160-2	22476-22479	the	_
160-3	22480-22488	contrary	_
160-4	22488-22489	,	_
160-5	22490-22508	hyper-connectivity	_
160-6	22509-22521	observations	_
160-7	22522-22526	were	_
160-8	22527-22530	few	_
160-9	22530-22531	,	_
160-10	22532-22535	but	_
160-11	22536-22544	pointing	_
160-12	22545-22547	to	_
160-13	22548-22557	important	_
160-14	22558-22563	brain	_
160-15	22564-22571	regions	_
160-16	22572-22581	including	_
160-17	22582-22585	the	_
160-18	22586-22589	DMN	_
160-19	22589-22590	,	_
160-20	22591-22600	precuneus	_
160-21	22601-22604	and	_
160-22	22605-22612	putamen	_
160-23	22612-22613	.	_

#Text=Results suggest that nicotine and alcohol produce both similar and distinctive effects in brain connectivity indicating the possibility of disentangling rsFNC dysfunctions related to alcohol use disorder from those associated to nicotine dependence.
161-1	22614-22621	Results	_
161-2	22622-22629	suggest	_
161-3	22630-22634	that	_
161-4	22635-22643	nicotine	_
161-5	22644-22647	and	_
161-6	22648-22655	alcohol	_
161-7	22656-22663	produce	_
161-8	22664-22668	both	_
161-9	22669-22676	similar	_
161-10	22677-22680	and	_
161-11	22681-22692	distinctive	_
161-12	22693-22700	effects	_
161-13	22701-22703	in	_
161-14	22704-22709	brain	_
161-15	22710-22722	connectivity	_
161-16	22723-22733	indicating	_
161-17	22734-22737	the	_
161-18	22738-22749	possibility	_
161-19	22750-22752	of	_
161-20	22753-22766	disentangling	_
161-21	22767-22772	rsFNC	_
161-22	22773-22785	dysfunctions	_
161-23	22786-22793	related	_
161-24	22794-22796	to	_
161-25	22797-22804	alcohol	_
161-26	22805-22808	use	_
161-27	22809-22817	disorder	_
161-28	22818-22822	from	_
161-29	22823-22828	those	_
161-30	22829-22839	associated	_
161-31	22840-22842	to	_
161-32	22843-22851	nicotine	_
161-33	22852-22862	dependence	_
161-34	22862-22863	.	_

#Text=An increase in the connectivity between DMN and precuneus was found to be an important feature that identified smokers with a low probability of alcohol use disorders.
162-1	22864-22866	An	_
162-2	22867-22875	increase	_
162-3	22876-22878	in	_
162-4	22879-22882	the	_
162-5	22883-22895	connectivity	_
162-6	22896-22903	between	_
162-7	22904-22907	DMN	_
162-8	22908-22911	and	_
162-9	22912-22921	precuneus	_
162-10	22922-22925	was	_
162-11	22926-22931	found	_
162-12	22932-22934	to	_
162-13	22935-22937	be	_
162-14	22938-22940	an	_
162-15	22941-22950	important	_
162-16	22951-22958	feature	_
162-17	22959-22963	that	_
162-18	22964-22974	identified	_
162-19	22975-22982	smokers	_
162-20	22983-22987	with	_
162-21	22988-22989	a	_
162-22	22990-22993	low	_
162-23	22994-23005	probability	_
162-24	23006-23008	of	_
162-25	23009-23016	alcohol	_
162-26	23017-23020	use	_
162-27	23021-23030	disorders	_
162-28	23030-23031	.	_

#Text=This distinction may provide an important clue for future biomarkers research.
163-1	23032-23036	This	_
163-2	23037-23048	distinction	_
163-3	23049-23052	may	_
163-4	23053-23060	provide	_
163-5	23061-23063	an	_
163-6	23064-23073	important	_
163-7	23074-23078	clue	_
163-8	23079-23082	for	_
163-9	23083-23089	future	_
163-10	23090-23100	biomarkers	_
163-11	23101-23109	research	_
163-12	23109-23110	.	_

#Text=Our analysis distinguished visual and sensorimotor regions as principal areas where the rsFNC might be reduced due to alcohol or nicotine use.
164-1	23111-23114	Our	_
164-2	23115-23123	analysis	_
164-3	23124-23137	distinguished	_
164-4	23138-23144	visual	_
164-5	23145-23148	and	_
164-6	23149-23161	sensorimotor	_
164-7	23162-23169	regions	_
164-8	23170-23172	as	_
164-9	23173-23182	principal	_
164-10	23183-23188	areas	_
164-11	23189-23194	where	_
164-12	23195-23198	the	_
164-13	23199-23204	rsFNC	_
164-14	23205-23210	might	_
164-15	23211-23213	be	_
164-16	23214-23221	reduced	_
164-17	23222-23225	due	_
164-18	23226-23228	to	_
164-19	23229-23236	alcohol	_
164-20	23237-23239	or	_
164-21	23240-23248	nicotine	_
164-22	23249-23252	use	_
164-23	23252-23253	.	_

#Text=The significant hypo-connectivity of SMK, SAD and DRN subjects when compared to the CTR subjects revolved around these RSN groups.
165-1	23254-23257	The	_
165-2	23258-23269	significant	_
165-3	23270-23287	hypo-connectivity	_
165-4	23288-23290	of	_
165-5	23291-23294	SMK	_
165-6	23294-23295	,	_
165-7	23296-23299	SAD	_
165-8	23300-23303	and	_
165-9	23304-23307	DRN	_
165-10	23308-23316	subjects	_
165-11	23317-23321	when	_
165-12	23322-23330	compared	_
165-13	23331-23333	to	_
165-14	23334-23337	the	_
165-15	23338-23341	CTR	_
165-16	23342-23350	subjects	_
165-17	23351-23359	revolved	_
165-18	23360-23366	around	_
165-19	23367-23372	these	_
165-20	23373-23376	RSN	_
165-21	23377-23383	groups	_
165-22	23383-23384	.	_

#Text=Other RSN groups affected by both smoking and drinking were ECN, SAL and PRE indicating the existence of common effects across the brain.
166-1	23385-23390	Other	_
166-2	23391-23394	RSN	_
166-3	23395-23401	groups	_
166-4	23402-23410	affected	_
166-5	23411-23413	by	_
166-6	23414-23418	both	_
166-7	23419-23426	smoking	_
166-8	23427-23430	and	_
166-9	23431-23439	drinking	_
166-10	23440-23444	were	_
166-11	23445-23448	ECN	_
166-12	23448-23449	,	_
166-13	23450-23453	SAL	_
166-14	23454-23457	and	_
166-15	23458-23461	PRE	_
166-16	23462-23472	indicating	_
166-17	23473-23476	the	_
166-18	23477-23486	existence	_
166-19	23487-23489	of	_
166-20	23490-23496	common	_
166-21	23497-23504	effects	_
166-22	23505-23511	across	_
166-23	23512-23515	the	_
166-24	23516-23521	brain	_
166-25	23521-23522	.	_

#Text=These results agree with the detriment of network global efficiency previously observed in both smokers and drinkers.
167-1	23523-23528	These	_
167-2	23529-23536	results	_
167-3	23537-23542	agree	_
167-4	23543-23547	with	_
167-5	23548-23551	the	_
167-6	23552-23561	detriment	_
167-7	23562-23564	of	_
167-8	23565-23572	network	_
167-9	23573-23579	global	_
167-10	23580-23590	efficiency	_
167-11	23591-23601	previously	_
167-12	23602-23610	observed	_
167-13	23611-23613	in	_
167-14	23614-23618	both	_
167-15	23619-23626	smokers	_
167-16	23627-23630	and	_
167-17	23631-23639	drinkers	_
167-18	23639-23640	.	_

#Text=Few differences were detected when the post-hoc analysis in our data compared rsFNC differences of SAD vs.
168-1	23641-23644	Few	_
168-2	23645-23656	differences	_
168-3	23657-23661	were	_
168-4	23662-23670	detected	_
168-5	23671-23675	when	_
168-6	23676-23679	the	_
168-7	23680-23688	post-hoc	_
168-8	23689-23697	analysis	_
168-9	23698-23700	in	_
168-10	23701-23704	our	_
168-11	23705-23709	data	_
168-12	23710-23718	compared	_
168-13	23719-23724	rsFNC	_
168-14	23725-23736	differences	_
168-15	23737-23739	of	_
168-16	23740-23743	SAD	_
168-17	23744-23746	vs	_
168-18	23746-23747	.	_

#Text=DRN and SAD vs.
169-1	23748-23751	DRN	_
169-2	23752-23755	and	_
169-3	23756-23759	SAD	_
169-4	23760-23762	vs	_
169-5	23762-23763	.	_

#Text=SMK groups indicating that common effects cannot differentiate between the substances.
170-1	23764-23767	SMK	_
170-2	23768-23774	groups	_
170-3	23775-23785	indicating	_
170-4	23786-23790	that	_
170-5	23791-23797	common	_
170-6	23798-23805	effects	_
170-7	23806-23812	cannot	_
170-8	23813-23826	differentiate	_
170-9	23827-23834	between	_
170-10	23835-23838	the	_
170-11	23839-23849	substances	_
170-12	23849-23850	.	_

#Text=A different study found an opposite outcome among visual, sensorimotor, cuneus and insula areas in subjects using cocaine, marijuana and alcohol, but this hyper-connectivity was observed after abstinence periods longer than 4 days.
171-1	23851-23852	A	_
171-2	23853-23862	different	_
171-3	23863-23868	study	_
171-4	23869-23874	found	_
171-5	23875-23877	an	_
171-6	23878-23886	opposite	_
171-7	23887-23894	outcome	_
171-8	23895-23900	among	_
171-9	23901-23907	visual	_
171-10	23907-23908	,	_
171-11	23909-23921	sensorimotor	_
171-12	23921-23922	,	_
171-13	23923-23929	cuneus	_
171-14	23930-23933	and	_
171-15	23934-23940	insula	_
171-16	23941-23946	areas	_
171-17	23947-23949	in	_
171-18	23950-23958	subjects	_
171-19	23959-23964	using	_
171-20	23965-23972	cocaine	_
171-21	23972-23973	,	_
171-22	23974-23983	marijuana	_
171-23	23984-23987	and	_
171-24	23988-23995	alcohol	_
171-25	23995-23996	,	_
171-26	23997-24000	but	_
171-27	24001-24005	this	_
171-28	24006-24024	hyper-connectivity	_
171-29	24025-24028	was	_
171-30	24029-24037	observed	_
171-31	24038-24043	after	_
171-32	24044-24054	abstinence	_
171-33	24055-24062	periods	_
171-34	24063-24069	longer	_
171-35	24070-24074	than	_
171-36	24075-24076	4	_
171-37	24077-24081	days	_
171-38	24081-24082	.	_

#Text=These rsFNC dysfunctions likely specify effects that may be commonly linked to multiple substances of abuse where hyper-connectivity during withdrawal follows an initial hypo-connectivity during consumption.
172-1	24083-24088	These	_
172-2	24089-24094	rsFNC	_
172-3	24095-24107	dysfunctions	_
172-4	24108-24114	likely	_
172-5	24115-24122	specify	_
172-6	24123-24130	effects	_
172-7	24131-24135	that	_
172-8	24136-24139	may	_
172-9	24140-24142	be	_
172-10	24143-24151	commonly	_
172-11	24152-24158	linked	_
172-12	24159-24161	to	_
172-13	24162-24170	multiple	_
172-14	24171-24181	substances	_
172-15	24182-24184	of	_
172-16	24185-24190	abuse	_
172-17	24191-24196	where	_
172-18	24197-24215	hyper-connectivity	_
172-19	24216-24222	during	_
172-20	24223-24233	withdrawal	_
172-21	24234-24241	follows	_
172-22	24242-24244	an	_
172-23	24245-24252	initial	_
172-24	24253-24270	hypo-connectivity	_
172-25	24271-24277	during	_
172-26	24278-24289	consumption	_
172-27	24289-24290	.	_

#Text=Despite using DSM-IV-TR Axis I to exclude subjects with alcohol problems in controls, the absence of an AUDIT score for the CTR subjects limits our capacity to perform a more thorough interpretation of these results.
173-1	24291-24298	Despite	_
173-2	24299-24304	using	_
173-3	24305-24314	DSM-IV-TR	_
173-4	24315-24319	Axis	_
173-5	24320-24321	I	_
173-6	24322-24324	to	_
173-7	24325-24332	exclude	_
173-8	24333-24341	subjects	_
173-9	24342-24346	with	_
173-10	24347-24354	alcohol	_
173-11	24355-24363	problems	_
173-12	24364-24366	in	_
173-13	24367-24375	controls	_
173-14	24375-24376	,	_
173-15	24377-24380	the	_
173-16	24381-24388	absence	_
173-17	24389-24391	of	_
173-18	24392-24394	an	_
173-19	24395-24400	AUDIT	_
173-20	24401-24406	score	_
173-21	24407-24410	for	_
173-22	24411-24414	the	_
173-23	24415-24418	CTR	_
173-24	24419-24427	subjects	_
173-25	24428-24434	limits	_
173-26	24435-24438	our	_
173-27	24439-24447	capacity	_
173-28	24448-24450	to	_
173-29	24451-24458	perform	_
173-30	24459-24460	a	_
173-31	24461-24465	more	_
173-32	24466-24474	thorough	_
173-33	24475-24489	interpretation	_
173-34	24490-24492	of	_
173-35	24493-24498	these	_
173-36	24499-24506	results	_
173-37	24506-24507	.	_

#Text=We observed hyper-connectivity in the set driven by drinking associated with the rsFNC between lingual/cerebellar vermis and putamen.
174-1	24508-24510	We	_
174-2	24511-24519	observed	_
174-3	24520-24538	hyper-connectivity	_
174-4	24539-24541	in	_
174-5	24542-24545	the	_
174-6	24546-24549	set	_
174-7	24550-24556	driven	_
174-8	24557-24559	by	_
174-9	24560-24568	drinking	_
174-10	24569-24579	associated	_
174-11	24580-24584	with	_
174-12	24585-24588	the	_
174-13	24589-24594	rsFNC	_
174-14	24595-24602	between	_
174-15	24603-24610	lingual	_
174-16	24610-24611	/	_
174-17	24611-24621	cerebellar	_
174-18	24622-24628	vermis	_
174-19	24629-24632	and	_
174-20	24633-24640	putamen	_
174-21	24640-24641	.	_

#Text=For this pair, the rsFNC was higher for the DRN group than for any of the other three groups.
175-1	24642-24645	For	_
175-2	24646-24650	this	_
175-3	24651-24655	pair	_
175-4	24655-24656	,	_
175-5	24657-24660	the	_
175-6	24661-24666	rsFNC	_
175-7	24667-24670	was	_
175-8	24671-24677	higher	_
175-9	24678-24681	for	_
175-10	24682-24685	the	_
175-11	24686-24689	DRN	_
175-12	24690-24695	group	_
175-13	24696-24700	than	_
175-14	24701-24704	for	_
175-15	24705-24708	any	_
175-16	24709-24711	of	_
175-17	24712-24715	the	_
175-18	24716-24721	other	_
175-19	24722-24727	three	_
175-20	24728-24734	groups	_
175-21	24734-24735	.	_

#Text=This observation points to an abnormal influence over the brain reward system known to be affected by alcohol.
176-1	24736-24740	This	_
176-2	24741-24752	observation	_
176-3	24753-24759	points	_
176-4	24760-24762	to	_
176-5	24763-24765	an	_
176-6	24766-24774	abnormal	_
176-7	24775-24784	influence	_
176-8	24785-24789	over	_
176-9	24790-24793	the	_
176-10	24794-24799	brain	_
176-11	24800-24806	reward	_
176-12	24807-24813	system	_
176-13	24814-24819	known	_
176-14	24820-24822	to	_
176-15	24823-24825	be	_
176-16	24826-24834	affected	_
176-17	24835-24837	by	_
176-18	24838-24845	alcohol	_
176-19	24845-24846	.	_

#Text=In particular, the putamen is an area where an increase of dendritic spine density and an enhancement of glutamatergic transmission was linked to alcohol in primates.
177-1	24847-24849	In	_
177-2	24850-24860	particular	_
177-3	24860-24861	,	_
177-4	24862-24865	the	_
177-5	24866-24873	putamen	_
177-6	24874-24876	is	_
177-7	24877-24879	an	_
177-8	24880-24884	area	_
177-9	24885-24890	where	_
177-10	24891-24893	an	_
177-11	24894-24902	increase	_
177-12	24903-24905	of	_
177-13	24906-24915	dendritic	_
177-14	24916-24921	spine	_
177-15	24922-24929	density	_
177-16	24930-24933	and	_
177-17	24934-24936	an	_
177-18	24937-24948	enhancement	_
177-19	24949-24951	of	_
177-20	24952-24965	glutamatergic	_
177-21	24966-24978	transmission	_
177-22	24979-24982	was	_
177-23	24983-24989	linked	_
177-24	24990-24992	to	_
177-25	24993-25000	alcohol	_
177-26	25001-25003	in	_
177-27	25004-25012	primates	_
177-28	25012-25013	.	_

#Text=This neuroadaptation could in part explain an increase of connectivity related to the putamen.
178-1	25014-25018	This	_
178-2	25019-25034	neuroadaptation	_
178-3	25035-25040	could	_
178-4	25041-25043	in	_
178-5	25044-25048	part	_
178-6	25049-25056	explain	_
178-7	25057-25059	an	_
178-8	25060-25068	increase	_
178-9	25069-25071	of	_
178-10	25072-25084	connectivity	_
178-11	25085-25092	related	_
178-12	25093-25095	to	_
178-13	25096-25099	the	_
178-14	25100-25107	putamen	_
178-15	25107-25108	.	_

#Text=A different result was obtained for the insula where hypo-connectivity was observed.
179-1	25109-25110	A	_
179-2	25111-25120	different	_
179-3	25121-25127	result	_
179-4	25128-25131	was	_
179-5	25132-25140	obtained	_
179-6	25141-25144	for	_
179-7	25145-25148	the	_
179-8	25149-25155	insula	_
179-9	25156-25161	where	_
179-10	25162-25179	hypo-connectivity	_
179-11	25180-25183	was	_
179-12	25184-25192	observed	_
179-13	25192-25193	.	_

#Text=Since the insula is an area known to be involved in interoception of bodily functions, insula hypo-connectivity observed in our results is consistent with reduced interoceptive awareness previously linked to alcohol addiction.
180-1	25194-25199	Since	_
180-2	25200-25203	the	_
180-3	25204-25210	insula	_
180-4	25211-25213	is	_
180-5	25214-25216	an	_
180-6	25217-25221	area	_
180-7	25222-25227	known	_
180-8	25228-25230	to	_
180-9	25231-25233	be	_
180-10	25234-25242	involved	_
180-11	25243-25245	in	_
180-12	25246-25259	interoception	_
180-13	25260-25262	of	_
180-14	25263-25269	bodily	_
180-15	25270-25279	functions	_
180-16	25279-25280	,	_
180-17	25281-25287	insula	_
180-18	25288-25305	hypo-connectivity	_
180-19	25306-25314	observed	_
180-20	25315-25317	in	_
180-21	25318-25321	our	_
180-22	25322-25329	results	_
180-23	25330-25332	is	_
180-24	25333-25343	consistent	_
180-25	25344-25348	with	_
180-26	25349-25356	reduced	_
180-27	25357-25370	interoceptive	_
180-28	25371-25380	awareness	_
180-29	25381-25391	previously	_
180-30	25392-25398	linked	_
180-31	25399-25401	to	_
180-32	25402-25409	alcohol	_
180-33	25410-25419	addiction	_
180-34	25419-25420	.	_

#Text=Hypoconnectivity within the insula has been previously reported and hypothesized as playing a role in alcohol relapse because of a diminished awareness of substance use.
181-1	25421-25437	Hypoconnectivity	_
181-2	25438-25444	within	_
181-3	25445-25448	the	_
181-4	25449-25455	insula	_
181-5	25456-25459	has	_
181-6	25460-25464	been	_
181-7	25465-25475	previously	_
181-8	25476-25484	reported	_
181-9	25485-25488	and	_
181-10	25489-25501	hypothesized	_
181-11	25502-25504	as	_
181-12	25505-25512	playing	_
181-13	25513-25514	a	_
181-14	25515-25519	role	_
181-15	25520-25522	in	_
181-16	25523-25530	alcohol	_
181-17	25531-25538	relapse	_
181-18	25539-25546	because	_
181-19	25547-25549	of	_
181-20	25550-25551	a	_
181-21	25552-25562	diminished	_
181-22	25563-25572	awareness	_
181-23	25573-25575	of	_
181-24	25576-25585	substance	_
181-25	25586-25589	use	_
181-26	25589-25590	.	_

#Text=Another possible explanation for the observed hypo-connectivity is the known damage to white matter caused by alcohol which disrupts the anatomical connection between left insula and lingual gyrus.The insula and the putamen are regions that has been previously associated with the brain reward system and with different directions of effects including loss of connectivity and increased connectivity.
182-1	25591-25598	Another	_
182-2	25599-25607	possible	_
182-3	25608-25619	explanation	_
182-4	25620-25623	for	_
182-5	25624-25627	the	_
182-6	25628-25636	observed	_
182-7	25637-25654	hypo-connectivity	_
182-8	25655-25657	is	_
182-9	25658-25661	the	_
182-10	25662-25667	known	_
182-11	25668-25674	damage	_
182-12	25675-25677	to	_
182-13	25678-25683	white	_
182-14	25684-25690	matter	_
182-15	25691-25697	caused	_
182-16	25698-25700	by	_
182-17	25701-25708	alcohol	_
182-18	25709-25714	which	_
182-19	25715-25723	disrupts	_
182-20	25724-25727	the	_
182-21	25728-25738	anatomical	_
182-22	25739-25749	connection	_
182-23	25750-25757	between	_
182-24	25758-25762	left	_
182-25	25763-25769	insula	_
182-26	25770-25773	and	_
182-27	25774-25781	lingual	_
182-28	25782-25791	gyrus.The	_
182-29	25792-25798	insula	_
182-30	25799-25802	and	_
182-31	25803-25806	the	_
182-32	25807-25814	putamen	_
182-33	25815-25818	are	_
182-34	25819-25826	regions	_
182-35	25827-25831	that	_
182-36	25832-25835	has	_
182-37	25836-25840	been	_
182-38	25841-25851	previously	_
182-39	25852-25862	associated	_
182-40	25863-25867	with	_
182-41	25868-25871	the	_
182-42	25872-25877	brain	_
182-43	25878-25884	reward	_
182-44	25885-25891	system	_
182-45	25892-25895	and	_
182-46	25896-25900	with	_
182-47	25901-25910	different	_
182-48	25911-25921	directions	_
182-49	25922-25924	of	_
182-50	25925-25932	effects	_
182-51	25933-25942	including	_
182-52	25943-25947	loss	_
182-53	25948-25950	of	_
182-54	25951-25963	connectivity	_
182-55	25964-25967	and	_
182-56	25968-25977	increased	_
182-57	25978-25990	connectivity	_
182-58	25990-25991	.	_

#Text=However, we could not confirm a link between putamen or insula connectivity changes and the AUDIT score, which might be due to small sample size and small AUDIT range in the DRN population.
183-1	25992-25999	However	_
183-2	25999-26000	,	_
183-3	26001-26003	we	_
183-4	26004-26009	could	_
183-5	26010-26013	not	_
183-6	26014-26021	confirm	_
183-7	26022-26023	a	_
183-8	26024-26028	link	_
183-9	26029-26036	between	_
183-10	26037-26044	putamen	_
183-11	26045-26047	or	_
183-12	26048-26054	insula	_
183-13	26055-26067	connectivity	_
183-14	26068-26075	changes	_
183-15	26076-26079	and	_
183-16	26080-26083	the	_
183-17	26084-26089	AUDIT	_
183-18	26090-26095	score	_
183-19	26095-26096	,	_
183-20	26097-26102	which	_
183-21	26103-26108	might	_
183-22	26109-26111	be	_
183-23	26112-26115	due	_
183-24	26116-26118	to	_
183-25	26119-26124	small	_
183-26	26125-26131	sample	_
183-27	26132-26136	size	_
183-28	26137-26140	and	_
183-29	26141-26146	small	_
183-30	26147-26152	AUDIT	_
183-31	26153-26158	range	_
183-32	26159-26161	in	_
183-33	26162-26165	the	_
183-34	26166-26169	DRN	_
183-35	26170-26180	population	_
183-36	26180-26181	.	_

#Text=Our data suggests that connectivity of the reward system may go in different directions of effects where putamen connectivity increases due to a neuroplasticity mechanism, but insular connectivity decreases due to microstructural disruption of white matter.
184-1	26182-26185	Our	_
184-2	26186-26190	data	_
184-3	26191-26199	suggests	_
184-4	26200-26204	that	_
184-5	26205-26217	connectivity	_
184-6	26218-26220	of	_
184-7	26221-26224	the	_
184-8	26225-26231	reward	_
184-9	26232-26238	system	_
184-10	26239-26242	may	_
184-11	26243-26245	go	_
184-12	26246-26248	in	_
184-13	26249-26258	different	_
184-14	26259-26269	directions	_
184-15	26270-26272	of	_
184-16	26273-26280	effects	_
184-17	26281-26286	where	_
184-18	26287-26294	putamen	_
184-19	26295-26307	connectivity	_
184-20	26308-26317	increases	_
184-21	26318-26321	due	_
184-22	26322-26324	to	_
184-23	26325-26326	a	_
184-24	26327-26342	neuroplasticity	_
184-25	26343-26352	mechanism	_
184-26	26352-26353	,	_
184-27	26354-26357	but	_
184-28	26358-26365	insular	_
184-29	26366-26378	connectivity	_
184-30	26379-26388	decreases	_
184-31	26389-26392	due	_
184-32	26393-26395	to	_
184-33	26396-26411	microstructural	_
184-34	26412-26422	disruption	_
184-35	26423-26425	of	_
184-36	26426-26431	white	_
184-37	26432-26438	matter	_
184-38	26438-26439	.	_

#Text=Reduced connectivity among insula, precuneus, SMA, postcentral, lingual/vermis and fusiform gyri characterized the rsFNCs driven by drinking.
185-1	26440-26447	Reduced	_
185-2	26448-26460	connectivity	_
185-3	26461-26466	among	_
185-4	26467-26473	insula	_
185-5	26473-26474	,	_
185-6	26475-26484	precuneus	_
185-7	26484-26485	,	_
185-8	26486-26489	SMA	_
185-9	26489-26490	,	_
185-10	26491-26502	postcentral	_
185-11	26502-26503	,	_
185-12	26504-26511	lingual	_
185-13	26511-26512	/	_
185-14	26512-26518	vermis	_
185-15	26519-26522	and	_
185-16	26523-26531	fusiform	_
185-17	26532-26536	gyri	_
185-18	26537-26550	characterized	_
185-19	26551-26554	the	_
185-20	26555-26561	rsFNCs	_
185-21	26562-26568	driven	_
185-22	26569-26571	by	_
185-23	26572-26580	drinking	_
185-24	26580-26581	.	_

#Text=These results are consistent with previous hypoconnectivity observations in visual and sensorimotor areas.
186-1	26582-26587	These	_
186-2	26588-26595	results	_
186-3	26596-26599	are	_
186-4	26600-26610	consistent	_
186-5	26611-26615	with	_
186-6	26616-26624	previous	_
186-7	26625-26641	hypoconnectivity	_
186-8	26642-26654	observations	_
186-9	26655-26657	in	_
186-10	26658-26664	visual	_
186-11	26665-26668	and	_
186-12	26669-26681	sensorimotor	_
186-13	26682-26687	areas	_
186-14	26687-26688	.	_

#Text=Our analysis also pointed to the precuneus as an area associated with alcohol use disorders as it has been previously found.
187-1	26689-26692	Our	_
187-2	26693-26701	analysis	_
187-3	26702-26706	also	_
187-4	26707-26714	pointed	_
187-5	26715-26717	to	_
187-6	26718-26721	the	_
187-7	26722-26731	precuneus	_
187-8	26732-26734	as	_
187-9	26735-26737	an	_
187-10	26738-26742	area	_
187-11	26743-26753	associated	_
187-12	26754-26758	with	_
187-13	26759-26766	alcohol	_
187-14	26767-26770	use	_
187-15	26771-26780	disorders	_
187-16	26781-26783	as	_
187-17	26784-26786	it	_
187-18	26787-26790	has	_
187-19	26791-26795	been	_
187-20	26796-26806	previously	_
187-21	26807-26812	found	_
187-22	26812-26813	.	_

#Text=Abnormal activation in the precuneus of subjects with alcohol use disorder has been thought to be associated with craving and the processing of visual memories.
188-1	26814-26822	Abnormal	_
188-2	26823-26833	activation	_
188-3	26834-26836	in	_
188-4	26837-26840	the	_
188-5	26841-26850	precuneus	_
188-6	26851-26853	of	_
188-7	26854-26862	subjects	_
188-8	26863-26867	with	_
188-9	26868-26875	alcohol	_
188-10	26876-26879	use	_
188-11	26880-26888	disorder	_
188-12	26889-26892	has	_
188-13	26893-26897	been	_
188-14	26898-26905	thought	_
188-15	26906-26908	to	_
188-16	26909-26911	be	_
188-17	26912-26922	associated	_
188-18	26923-26927	with	_
188-19	26928-26935	craving	_
188-20	26936-26939	and	_
188-21	26940-26943	the	_
188-22	26944-26954	processing	_
188-23	26955-26957	of	_
188-24	26958-26964	visual	_
188-25	26965-26973	memories	_
188-26	26973-26974	.	_

#Text=In our results, sensorimotor, precuneus and visual dysfunctions seem ubiquitous in both smokers and drinkers after looking at the rsFNCs driven by smoking and drinking.
189-1	26975-26977	In	_
189-2	26978-26981	our	_
189-3	26982-26989	results	_
189-4	26989-26990	,	_
189-5	26991-27003	sensorimotor	_
189-6	27003-27004	,	_
189-7	27005-27014	precuneus	_
189-8	27015-27018	and	_
189-9	27019-27025	visual	_
189-10	27026-27038	dysfunctions	_
189-11	27039-27043	seem	_
189-12	27044-27054	ubiquitous	_
189-13	27055-27057	in	_
189-14	27058-27062	both	_
189-15	27063-27070	smokers	_
189-16	27071-27074	and	_
189-17	27075-27083	drinkers	_
189-18	27084-27089	after	_
189-19	27090-27097	looking	_
189-20	27098-27100	at	_
189-21	27101-27104	the	_
189-22	27105-27111	rsFNCs	_
189-23	27112-27118	driven	_
189-24	27119-27121	by	_
189-25	27122-27129	smoking	_
189-26	27130-27133	and	_
189-27	27134-27142	drinking	_
189-28	27142-27143	.	_

#Text=However, we point out that visual dysfunction associated to drinking in our data were located around fusiform and lingual gyri.
190-1	27144-27151	However	_
190-2	27151-27152	,	_
190-3	27153-27155	we	_
190-4	27156-27161	point	_
190-5	27162-27165	out	_
190-6	27166-27170	that	_
190-7	27171-27177	visual	_
190-8	27178-27189	dysfunction	_
190-9	27190-27200	associated	_
190-10	27201-27203	to	_
190-11	27204-27212	drinking	_
190-12	27213-27215	in	_
190-13	27216-27219	our	_
190-14	27220-27224	data	_
190-15	27225-27229	were	_
190-16	27230-27237	located	_
190-17	27238-27244	around	_
190-18	27245-27253	fusiform	_
190-19	27254-27257	and	_
190-20	27258-27265	lingual	_
190-21	27266-27270	gyri	_
190-22	27270-27271	.	_

#Text=In contrast, rsFNC differences driven by both smoking and drinking were more frequently located about superior, middle and inferior occipital gyri.
191-1	27272-27274	In	_
191-2	27275-27283	contrast	_
191-3	27283-27284	,	_
191-4	27285-27290	rsFNC	_
191-5	27291-27302	differences	_
191-6	27303-27309	driven	_
191-7	27310-27312	by	_
191-8	27313-27317	both	_
191-9	27318-27325	smoking	_
191-10	27326-27329	and	_
191-11	27330-27338	drinking	_
191-12	27339-27343	were	_
191-13	27344-27348	more	_
191-14	27349-27359	frequently	_
191-15	27360-27367	located	_
191-16	27368-27373	about	_
191-17	27374-27382	superior	_
191-18	27382-27383	,	_
191-19	27384-27390	middle	_
191-20	27391-27394	and	_
191-21	27395-27403	inferior	_
191-22	27404-27413	occipital	_
191-23	27414-27418	gyri	_
191-24	27418-27419	.	_

#Text=These results agree with an alcohol study by Camchong et al. where reduced connectivity within insula and within occipital gyrus was reported, but smoking was allowed among the subjects.
192-1	27420-27425	These	_
192-2	27426-27433	results	_
192-3	27434-27439	agree	_
192-4	27440-27444	with	_
192-5	27445-27447	an	_
192-6	27448-27455	alcohol	_
192-7	27456-27461	study	_
192-8	27462-27464	by	_
192-9	27465-27473	Camchong	_
192-10	27474-27476	et	_
192-11	27477-27479	al	_
192-12	27479-27480	.	_
192-13	27481-27486	where	_
192-14	27487-27494	reduced	_
192-15	27495-27507	connectivity	_
192-16	27508-27514	within	_
192-17	27515-27521	insula	_
192-18	27522-27525	and	_
192-19	27526-27532	within	_
192-20	27533-27542	occipital	_
192-21	27543-27548	gyrus	_
192-22	27549-27552	was	_
192-23	27553-27561	reported	_
192-24	27561-27562	,	_
192-25	27563-27566	but	_
192-26	27567-27574	smoking	_
192-27	27575-27578	was	_
192-28	27579-27586	allowed	_
192-29	27587-27592	among	_
192-30	27593-27596	the	_
192-31	27597-27605	subjects	_
192-32	27605-27606	.	_

#Text=Our observations add a reduced connectivity between sensorimotor, precuneus, occipital and insula areas to the picture.
193-1	27607-27610	Our	_
193-2	27611-27623	observations	_
193-3	27624-27627	add	_
193-4	27628-27629	a	_
193-5	27630-27637	reduced	_
193-6	27638-27650	connectivity	_
193-7	27651-27658	between	_
193-8	27659-27671	sensorimotor	_
193-9	27671-27672	,	_
193-10	27673-27682	precuneus	_
193-11	27682-27683	,	_
193-12	27684-27693	occipital	_
193-13	27694-27697	and	_
193-14	27698-27704	insula	_
193-15	27705-27710	areas	_
193-16	27711-27713	to	_
193-17	27714-27717	the	_
193-18	27718-27725	picture	_
193-19	27725-27726	.	_

#Text=Furthermore, the magnitude of connectivity reduction between sensorimotor and visual areas was significantly associated with AUDIT score and the interaction between AUDIT and FTND.
194-1	27727-27738	Furthermore	_
194-2	27738-27739	,	_
194-3	27740-27743	the	_
194-4	27744-27753	magnitude	_
194-5	27754-27756	of	_
194-6	27757-27769	connectivity	_
194-7	27770-27779	reduction	_
194-8	27780-27787	between	_
194-9	27788-27800	sensorimotor	_
194-10	27801-27804	and	_
194-11	27805-27811	visual	_
194-12	27812-27817	areas	_
194-13	27818-27821	was	_
194-14	27822-27835	significantly	_
194-15	27836-27846	associated	_
194-16	27847-27851	with	_
194-17	27852-27857	AUDIT	_
194-18	27858-27863	score	_
194-19	27864-27867	and	_
194-20	27868-27871	the	_
194-21	27872-27883	interaction	_
194-22	27884-27891	between	_
194-23	27892-27897	AUDIT	_
194-24	27898-27901	and	_
194-25	27902-27906	FTND	_
194-26	27906-27907	.	_

#Text=These reduced connectivity results support the idea delineated by Camchong of a link between alcohol and dysfunction in a brain network in charge of sensory awareness and attention that provides important information necessary for decision-making and assessment.
195-1	27908-27913	These	_
195-2	27914-27921	reduced	_
195-3	27922-27934	connectivity	_
195-4	27935-27942	results	_
195-5	27943-27950	support	_
195-6	27951-27954	the	_
195-7	27955-27959	idea	_
195-8	27960-27970	delineated	_
195-9	27971-27973	by	_
195-10	27974-27982	Camchong	_
195-11	27983-27985	of	_
195-12	27986-27987	a	_
195-13	27988-27992	link	_
195-14	27993-28000	between	_
195-15	28001-28008	alcohol	_
195-16	28009-28012	and	_
195-17	28013-28024	dysfunction	_
195-18	28025-28027	in	_
195-19	28028-28029	a	_
195-20	28030-28035	brain	_
195-21	28036-28043	network	_
195-22	28044-28046	in	_
195-23	28047-28053	charge	_
195-24	28054-28056	of	_
195-25	28057-28064	sensory	_
195-26	28065-28074	awareness	_
195-27	28075-28078	and	_
195-28	28079-28088	attention	_
195-29	28089-28093	that	_
195-30	28094-28102	provides	_
195-31	28103-28112	important	_
195-32	28113-28124	information	_
195-33	28125-28134	necessary	_
195-34	28135-28138	for	_
195-35	28139-28154	decision-making	_
195-36	28155-28158	and	_
195-37	28159-28169	assessment	_
195-38	28169-28170	.	_

#Text=Another important observation in our data is the protective effect that smoking exerted in visual memory and visual processing regions.
196-1	28171-28178	Another	_
196-2	28179-28188	important	_
196-3	28189-28200	observation	_
196-4	28201-28203	in	_
196-5	28204-28207	our	_
196-6	28208-28212	data	_
196-7	28213-28215	is	_
196-8	28216-28219	the	_
196-9	28220-28230	protective	_
196-10	28231-28237	effect	_
196-11	28238-28242	that	_
196-12	28243-28250	smoking	_
196-13	28251-28258	exerted	_
196-14	28259-28261	in	_
196-15	28262-28268	visual	_
196-16	28269-28275	memory	_
196-17	28276-28279	and	_
196-18	28280-28286	visual	_
196-19	28287-28297	processing	_
196-20	28298-28305	regions	_
196-21	28305-28306	.	_

#Text=Previous reports indicate that nicotine produce enhanced activation in the fusiform gyrus, but in our resting state results the effect might have prevented observing a difference between SAD and CTR groups.
197-1	28307-28315	Previous	_
197-2	28316-28323	reports	_
197-3	28324-28332	indicate	_
197-4	28333-28337	that	_
197-5	28338-28346	nicotine	_
197-6	28347-28354	produce	_
197-7	28355-28363	enhanced	_
197-8	28364-28374	activation	_
197-9	28375-28377	in	_
197-10	28378-28381	the	_
197-11	28382-28390	fusiform	_
197-12	28391-28396	gyrus	_
197-13	28396-28397	,	_
197-14	28398-28401	but	_
197-15	28402-28404	in	_
197-16	28405-28408	our	_
197-17	28409-28416	resting	_
197-18	28417-28422	state	_
197-19	28423-28430	results	_
197-20	28431-28434	the	_
197-21	28435-28441	effect	_
197-22	28442-28447	might	_
197-23	28448-28452	have	_
197-24	28453-28462	prevented	_
197-25	28463-28472	observing	_
197-26	28473-28474	a	_
197-27	28475-28485	difference	_
197-28	28486-28493	between	_
197-29	28494-28497	SAD	_
197-30	28498-28501	and	_
197-31	28502-28505	CTR	_
197-32	28506-28512	groups	_
197-33	28512-28513	.	_

#Text=This might explain why drinkers span a larger set of visual rsFNC differences including those not present in smokers.
198-1	28514-28518	This	_
198-2	28519-28524	might	_
198-3	28525-28532	explain	_
198-4	28533-28536	why	_
198-5	28537-28545	drinkers	_
198-6	28546-28550	span	_
198-7	28551-28552	a	_
198-8	28553-28559	larger	_
198-9	28560-28563	set	_
198-10	28564-28566	of	_
198-11	28567-28573	visual	_
198-12	28574-28579	rsFNC	_
198-13	28580-28591	differences	_
198-14	28592-28601	including	_
198-15	28602-28607	those	_
198-16	28608-28611	not	_
198-17	28612-28619	present	_
198-18	28620-28622	in	_
198-19	28623-28630	smokers	_
198-20	28630-28631	.	_

#Text=These observations provide an important distinction between nicotine and alcohol effects.
199-1	28632-28637	These	_
199-2	28638-28650	observations	_
199-3	28651-28658	provide	_
199-4	28659-28661	an	_
199-5	28662-28671	important	_
199-6	28672-28683	distinction	_
199-7	28684-28691	between	_
199-8	28692-28700	nicotine	_
199-9	28701-28704	and	_
199-10	28705-28712	alcohol	_
199-11	28713-28720	effects	_
199-12	28720-28721	.	_

#Text=Previous studies on nicotine use have focused in areas such as the insula, known to reduce nicotine withdrawal when injured, the default mode and executive control networks.
200-1	28722-28730	Previous	_
200-2	28731-28738	studies	_
200-3	28739-28741	on	_
200-4	28742-28750	nicotine	_
200-5	28751-28754	use	_
200-6	28755-28759	have	_
200-7	28760-28767	focused	_
200-8	28768-28770	in	_
200-9	28771-28776	areas	_
200-10	28777-28781	such	_
200-11	28782-28784	as	_
200-12	28785-28788	the	_
200-13	28789-28795	insula	_
200-14	28795-28796	,	_
200-15	28797-28802	known	_
200-16	28803-28805	to	_
200-17	28806-28812	reduce	_
200-18	28813-28821	nicotine	_
200-19	28822-28832	withdrawal	_
200-20	28833-28837	when	_
200-21	28838-28845	injured	_
200-22	28845-28846	,	_
200-23	28847-28850	the	_
200-24	28851-28858	default	_
200-25	28859-28863	mode	_
200-26	28864-28867	and	_
200-27	28868-28877	executive	_
200-28	28878-28885	control	_
200-29	28886-28894	networks	_
200-30	28894-28895	.	_

#Text=In our resting state analysis, the insula was involved with decreased connectivity with other regions in all three groups DRN, SAD and SMK, but a link with continuous measures of AUDIT and FTND could not be established.
201-1	28896-28898	In	_
201-2	28899-28902	our	_
201-3	28903-28910	resting	_
201-4	28911-28916	state	_
201-5	28917-28925	analysis	_
201-6	28925-28926	,	_
201-7	28927-28930	the	_
201-8	28931-28937	insula	_
201-9	28938-28941	was	_
201-10	28942-28950	involved	_
201-11	28951-28955	with	_
201-12	28956-28965	decreased	_
201-13	28966-28978	connectivity	_
201-14	28979-28983	with	_
201-15	28984-28989	other	_
201-16	28990-28997	regions	_
201-17	28998-29000	in	_
201-18	29001-29004	all	_
201-19	29005-29010	three	_
201-20	29011-29017	groups	_
201-21	29018-29021	DRN	_
201-22	29021-29022	,	_
201-23	29023-29026	SAD	_
201-24	29027-29030	and	_
201-25	29031-29034	SMK	_
201-26	29034-29035	,	_
201-27	29036-29039	but	_
201-28	29040-29041	a	_
201-29	29042-29046	link	_
201-30	29047-29051	with	_
201-31	29052-29062	continuous	_
201-32	29063-29071	measures	_
201-33	29072-29074	of	_
201-34	29075-29080	AUDIT	_
201-35	29081-29084	and	_
201-36	29085-29089	FTND	_
201-37	29090-29095	could	_
201-38	29096-29099	not	_
201-39	29100-29102	be	_
201-40	29103-29114	established	_
201-41	29114-29115	.	_

#Text=The involvement of the ECN was also very scarce and only comprised one parietal region.
202-1	29116-29119	The	_
202-2	29120-29131	involvement	_
202-3	29132-29134	of	_
202-4	29135-29138	the	_
202-5	29139-29142	ECN	_
202-6	29143-29146	was	_
202-7	29147-29151	also	_
202-8	29152-29156	very	_
202-9	29157-29163	scarce	_
202-10	29164-29167	and	_
202-11	29168-29172	only	_
202-12	29173-29182	comprised	_
202-13	29183-29186	one	_
202-14	29187-29195	parietal	_
202-15	29196-29202	region	_
202-16	29202-29203	.	_

#Text=In contrast, the DMN connectivity (angular gyrus vs. precuneus) was found to be strongly affected by nicotine as group difference and FTND association both indicated a significant connectivity increment.
203-1	29204-29206	In	_
203-2	29207-29215	contrast	_
203-3	29215-29216	,	_
203-4	29217-29220	the	_
203-5	29221-29224	DMN	_
203-6	29225-29237	connectivity	_
203-7	29238-29239	(	_
203-8	29239-29246	angular	_
203-9	29247-29252	gyrus	_
203-10	29253-29255	vs	_
203-11	29255-29256	.	_
203-12	29257-29266	precuneus	_
203-13	29266-29267	)	_
203-14	29268-29271	was	_
203-15	29272-29277	found	_
203-16	29278-29280	to	_
203-17	29281-29283	be	_
203-18	29284-29292	strongly	_
203-19	29293-29301	affected	_
203-20	29302-29304	by	_
203-21	29305-29313	nicotine	_
203-22	29314-29316	as	_
203-23	29317-29322	group	_
203-24	29323-29333	difference	_
203-25	29334-29337	and	_
203-26	29338-29342	FTND	_
203-27	29343-29354	association	_
203-28	29355-29359	both	_
203-29	29360-29369	indicated	_
203-30	29370-29371	a	_
203-31	29372-29383	significant	_
203-32	29384-29396	connectivity	_
203-33	29397-29406	increment	_
203-34	29406-29407	.	_

#Text=The RSN pair PCC and postcentral gyrus also show connectivity increment linked to the DMN as smokers exhibited stronger anti-correlation.
204-1	29408-29411	The	_
204-2	29412-29415	RSN	_
204-3	29416-29420	pair	_
204-4	29421-29424	PCC	_
204-5	29425-29428	and	_
204-6	29429-29440	postcentral	_
204-7	29441-29446	gyrus	_
204-8	29447-29451	also	_
204-9	29452-29456	show	_
204-10	29457-29469	connectivity	_
204-11	29470-29479	increment	_
204-12	29480-29486	linked	_
204-13	29487-29489	to	_
204-14	29490-29493	the	_
204-15	29494-29497	DMN	_
204-16	29498-29500	as	_
204-17	29501-29508	smokers	_
204-18	29509-29518	exhibited	_
204-19	29519-29527	stronger	_
204-20	29528-29544	anti-correlation	_
204-21	29544-29545	.	_

#Text=These results and the fact that smokers were abstinent for at least 3 hours before scanning seem concordant with the hypothesis that nicotine withdrawal might promote an enhancement in DMN functioning and shift network dynamics away from task positive areas in order to maintain homeostasis in a brain suffering from withdrawal effects.
205-1	29546-29551	These	_
205-2	29552-29559	results	_
205-3	29560-29563	and	_
205-4	29564-29567	the	_
205-5	29568-29572	fact	_
205-6	29573-29577	that	_
205-7	29578-29585	smokers	_
205-8	29586-29590	were	_
205-9	29591-29600	abstinent	_
205-10	29601-29604	for	_
205-11	29605-29607	at	_
205-12	29608-29613	least	_
205-13	29614-29615	3	_
205-14	29616-29621	hours	_
205-15	29622-29628	before	_
205-16	29629-29637	scanning	_
205-17	29638-29642	seem	_
205-18	29643-29653	concordant	_
205-19	29654-29658	with	_
205-20	29659-29662	the	_
205-21	29663-29673	hypothesis	_
205-22	29674-29678	that	_
205-23	29679-29687	nicotine	_
205-24	29688-29698	withdrawal	_
205-25	29699-29704	might	_
205-26	29705-29712	promote	_
205-27	29713-29715	an	_
205-28	29716-29727	enhancement	_
205-29	29728-29730	in	_
205-30	29731-29734	DMN	_
205-31	29735-29746	functioning	_
205-32	29747-29750	and	_
205-33	29751-29756	shift	_
205-34	29757-29764	network	_
205-35	29765-29773	dynamics	_
205-36	29774-29778	away	_
205-37	29779-29783	from	_
205-38	29784-29788	task	_
205-39	29789-29797	positive	_
205-40	29798-29803	areas	_
205-41	29804-29806	in	_
205-42	29807-29812	order	_
205-43	29813-29815	to	_
205-44	29816-29824	maintain	_
205-45	29825-29836	homeostasis	_
205-46	29837-29839	in	_
205-47	29840-29841	a	_
205-48	29842-29847	brain	_
205-49	29848-29857	suffering	_
205-50	29858-29862	from	_
205-51	29863-29873	withdrawal	_
205-52	29874-29881	effects	_
205-53	29881-29882	.	_

#Text=In contrast, hypo-connectivity in smokers was found within the reward system including the brain areas of thalamus and putamen.
206-1	29883-29885	In	_
206-2	29886-29894	contrast	_
206-3	29894-29895	,	_
206-4	29896-29913	hypo-connectivity	_
206-5	29914-29916	in	_
206-6	29917-29924	smokers	_
206-7	29925-29928	was	_
206-8	29929-29934	found	_
206-9	29935-29941	within	_
206-10	29942-29945	the	_
206-11	29946-29952	reward	_
206-12	29953-29959	system	_
206-13	29960-29969	including	_
206-14	29970-29973	the	_
206-15	29974-29979	brain	_
206-16	29980-29985	areas	_
206-17	29986-29988	of	_
206-18	29989-29997	thalamus	_
206-19	29998-30001	and	_
206-20	30002-30009	putamen	_
206-21	30009-30010	.	_

#Text=The thalamus is a main hub of information in the brain important in the study of nicotine addiction.
207-1	30011-30014	The	_
207-2	30015-30023	thalamus	_
207-3	30024-30026	is	_
207-4	30027-30028	a	_
207-5	30029-30033	main	_
207-6	30034-30037	hub	_
207-7	30038-30040	of	_
207-8	30041-30052	information	_
207-9	30053-30055	in	_
207-10	30056-30059	the	_
207-11	30060-30065	brain	_
207-12	30066-30075	important	_
207-13	30076-30078	in	_
207-14	30079-30082	the	_
207-15	30083-30088	study	_
207-16	30089-30091	of	_
207-17	30092-30100	nicotine	_
207-18	30101-30110	addiction	_
207-19	30110-30111	.	_

#Text=It has been found that smoking reduces glutamate (one of the major neurotransmitters in the mammalian brain) in the thalamus, thus affecting its information relay function.
208-1	30112-30114	It	_
208-2	30115-30118	has	_
208-3	30119-30123	been	_
208-4	30124-30129	found	_
208-5	30130-30134	that	_
208-6	30135-30142	smoking	_
208-7	30143-30150	reduces	_
208-8	30151-30160	glutamate	_
208-9	30161-30162	(	_
208-10	30162-30165	one	_
208-11	30166-30168	of	_
208-12	30169-30172	the	_
208-13	30173-30178	major	_
208-14	30179-30196	neurotransmitters	_
208-15	30197-30199	in	_
208-16	30200-30203	the	_
208-17	30204-30213	mammalian	_
208-18	30214-30219	brain	_
208-19	30219-30220	)	_
208-20	30221-30223	in	_
208-21	30224-30227	the	_
208-22	30228-30236	thalamus	_
208-23	30236-30237	,	_
208-24	30238-30242	thus	_
208-25	30243-30252	affecting	_
208-26	30253-30256	its	_
208-27	30257-30268	information	_
208-28	30269-30274	relay	_
208-29	30275-30283	function	_
208-30	30283-30284	.	_

#Text=Thalamic activity has been previously found to be correlated with FTND scores and has been mentioned in many studies as part of affected brain networks.
209-1	30285-30293	Thalamic	_
209-2	30294-30302	activity	_
209-3	30303-30306	has	_
209-4	30307-30311	been	_
209-5	30312-30322	previously	_
209-6	30323-30328	found	_
209-7	30329-30331	to	_
209-8	30332-30334	be	_
209-9	30335-30345	correlated	_
209-10	30346-30350	with	_
209-11	30351-30355	FTND	_
209-12	30356-30362	scores	_
209-13	30363-30366	and	_
209-14	30367-30370	has	_
209-15	30371-30375	been	_
209-16	30376-30385	mentioned	_
209-17	30386-30388	in	_
209-18	30389-30393	many	_
209-19	30394-30401	studies	_
209-20	30402-30404	as	_
209-21	30405-30409	part	_
209-22	30410-30412	of	_
209-23	30413-30421	affected	_
209-24	30422-30427	brain	_
209-25	30428-30436	networks	_
209-26	30436-30437	.	_

#Text=Both putamen and thalamus have been found to be abnormally active during smoking cues presentation to abstinent smokers.
210-1	30438-30442	Both	_
210-2	30443-30450	putamen	_
210-3	30451-30454	and	_
210-4	30455-30463	thalamus	_
210-5	30464-30468	have	_
210-6	30469-30473	been	_
210-7	30474-30479	found	_
210-8	30480-30482	to	_
210-9	30483-30485	be	_
210-10	30486-30496	abnormally	_
210-11	30497-30503	active	_
210-12	30504-30510	during	_
210-13	30511-30518	smoking	_
210-14	30519-30523	cues	_
210-15	30524-30536	presentation	_
210-16	30537-30539	to	_
210-17	30540-30549	abstinent	_
210-18	30550-30557	smokers	_
210-19	30557-30558	.	_

#Text=Lack of connectivity between putamen and thalamus can be an indication of reward dysregulation that enhances nicotine-seeking behavior in smokers.
211-1	30559-30563	Lack	_
211-2	30564-30566	of	_
211-3	30567-30579	connectivity	_
211-4	30580-30587	between	_
211-5	30588-30595	putamen	_
211-6	30596-30599	and	_
211-7	30600-30608	thalamus	_
211-8	30609-30612	can	_
211-9	30613-30615	be	_
211-10	30616-30618	an	_
211-11	30619-30629	indication	_
211-12	30630-30632	of	_
211-13	30633-30639	reward	_
211-14	30640-30653	dysregulation	_
211-15	30654-30658	that	_
211-16	30659-30667	enhances	_
211-17	30668-30684	nicotine-seeking	_
211-18	30685-30693	behavior	_
211-19	30694-30696	in	_
211-20	30697-30704	smokers	_
211-21	30704-30705	.	_

#Text=One of the limitations of our data is the unequal behavioral scores collected to measure alcohol use.
212-1	30706-30709	One	_
212-2	30710-30712	of	_
212-3	30713-30716	the	_
212-4	30717-30728	limitations	_
212-5	30729-30731	of	_
212-6	30732-30735	our	_
212-7	30736-30740	data	_
212-8	30741-30743	is	_
212-9	30744-30747	the	_
212-10	30748-30755	unequal	_
212-11	30756-30766	behavioral	_
212-12	30767-30773	scores	_
212-13	30774-30783	collected	_
212-14	30784-30786	to	_
212-15	30787-30794	measure	_
212-16	30795-30802	alcohol	_
212-17	30803-30806	use	_
212-18	30806-30807	.	_

#Text=Subjects in the CTR group were excluded after screening for alcohol dependence or alcohol abuse, but no information regarding number of drinks or AUDIT score was collected.
213-1	30808-30816	Subjects	_
213-2	30817-30819	in	_
213-3	30820-30823	the	_
213-4	30824-30827	CTR	_
213-5	30828-30833	group	_
213-6	30834-30838	were	_
213-7	30839-30847	excluded	_
213-8	30848-30853	after	_
213-9	30854-30863	screening	_
213-10	30864-30867	for	_
213-11	30868-30875	alcohol	_
213-12	30876-30886	dependence	_
213-13	30887-30889	or	_
213-14	30890-30897	alcohol	_
213-15	30898-30903	abuse	_
213-16	30903-30904	,	_
213-17	30905-30908	but	_
213-18	30909-30911	no	_
213-19	30912-30923	information	_
213-20	30924-30933	regarding	_
213-21	30934-30940	number	_
213-22	30941-30943	of	_
213-23	30944-30950	drinks	_
213-24	30951-30953	or	_
213-25	30954-30959	AUDIT	_
213-26	30960-30965	score	_
213-27	30966-30969	was	_
213-28	30970-30979	collected	_
213-29	30979-30980	.	_

#Text=However, several studies indicate that AUDIT and DSM-IV have similar specificity providing evidence that subjects in the CTR group were likely assigned to the correct group.
214-1	30981-30988	However	_
214-2	30988-30989	,	_
214-3	30990-30997	several	_
214-4	30998-31005	studies	_
214-5	31006-31014	indicate	_
214-6	31015-31019	that	_
214-7	31020-31025	AUDIT	_
214-8	31026-31029	and	_
214-9	31030-31036	DSM-IV	_
214-10	31037-31041	have	_
214-11	31042-31049	similar	_
214-12	31050-31061	specificity	_
214-13	31062-31071	providing	_
214-14	31072-31080	evidence	_
214-15	31081-31085	that	_
214-16	31086-31094	subjects	_
214-17	31095-31097	in	_
214-18	31098-31101	the	_
214-19	31102-31105	CTR	_
214-20	31106-31111	group	_
214-21	31112-31116	were	_
214-22	31117-31123	likely	_
214-23	31124-31132	assigned	_
214-24	31133-31135	to	_
214-25	31136-31139	the	_
214-26	31140-31147	correct	_
214-27	31148-31153	group	_
214-28	31153-31154	.	_

#Text=A second limitation of the current study is the lack of inclusion of other measures that could have been useful to distinguish among the four sample groups.
215-1	31155-31156	A	_
215-2	31157-31163	second	_
215-3	31164-31174	limitation	_
215-4	31175-31177	of	_
215-5	31178-31181	the	_
215-6	31182-31189	current	_
215-7	31190-31195	study	_
215-8	31196-31198	is	_
215-9	31199-31202	the	_
215-10	31203-31207	lack	_
215-11	31208-31210	of	_
215-12	31211-31220	inclusion	_
215-13	31221-31223	of	_
215-14	31224-31229	other	_
215-15	31230-31238	measures	_
215-16	31239-31243	that	_
215-17	31244-31249	could	_
215-18	31250-31254	have	_
215-19	31255-31259	been	_
215-20	31260-31266	useful	_
215-21	31267-31269	to	_
215-22	31270-31281	distinguish	_
215-23	31282-31287	among	_
215-24	31288-31291	the	_
215-25	31292-31296	four	_
215-26	31297-31303	sample	_
215-27	31304-31310	groups	_
215-28	31310-31311	.	_

#Text=For example, prior studies have used machine learning algorithms to distinguish controls from various substance dependent samples using features from neurocognitive, personality, and psychiatric measures, whereas the current study only used neuroimaging features.
216-1	31312-31315	For	_
216-2	31316-31323	example	_
216-3	31323-31324	,	_
216-4	31325-31330	prior	_
216-5	31331-31338	studies	_
216-6	31339-31343	have	_
216-7	31344-31348	used	_
216-8	31349-31356	machine	_
216-9	31357-31365	learning	_
216-10	31366-31376	algorithms	_
216-11	31377-31379	to	_
216-12	31380-31391	distinguish	_
216-13	31392-31400	controls	_
216-14	31401-31405	from	_
216-15	31406-31413	various	_
216-16	31414-31423	substance	_
216-17	31424-31433	dependent	_
216-18	31434-31441	samples	_
216-19	31442-31447	using	_
216-20	31448-31456	features	_
216-21	31457-31461	from	_
216-22	31462-31476	neurocognitive	_
216-23	31476-31477	,	_
216-24	31478-31489	personality	_
216-25	31489-31490	,	_
216-26	31491-31494	and	_
216-27	31495-31506	psychiatric	_
216-28	31507-31515	measures	_
216-29	31515-31516	,	_
216-30	31517-31524	whereas	_
216-31	31525-31528	the	_
216-32	31529-31536	current	_
216-33	31537-31542	study	_
216-34	31543-31547	only	_
216-35	31548-31552	used	_
216-36	31553-31565	neuroimaging	_
216-37	31566-31574	features	_
216-38	31574-31575	.	_

#Text=Because we relied on a convenience sample combined from existing studies, few measures overlapped, thus preventing us from conducting our analyses with behavioral assessments.
217-1	31576-31583	Because	_
217-2	31584-31586	we	_
217-3	31587-31593	relied	_
217-4	31594-31596	on	_
217-5	31597-31598	a	_
217-6	31599-31610	convenience	_
217-7	31611-31617	sample	_
217-8	31618-31626	combined	_
217-9	31627-31631	from	_
217-10	31632-31640	existing	_
217-11	31641-31648	studies	_
217-12	31648-31649	,	_
217-13	31650-31653	few	_
217-14	31654-31662	measures	_
217-15	31663-31673	overlapped	_
217-16	31673-31674	,	_
217-17	31675-31679	thus	_
217-18	31680-31690	preventing	_
217-19	31691-31693	us	_
217-20	31694-31698	from	_
217-21	31699-31709	conducting	_
217-22	31710-31713	our	_
217-23	31714-31722	analyses	_
217-24	31723-31727	with	_
217-25	31728-31738	behavioral	_
217-26	31739-31750	assessments	_
217-27	31750-31751	.	_

#Text=Future studies that combine neuroimaging and behavioral assessments will be valuable for determining the utility of neuroimaging measures in predicting group membership.
218-1	31752-31758	Future	_
218-2	31759-31766	studies	_
218-3	31767-31771	that	_
218-4	31772-31779	combine	_
218-5	31780-31792	neuroimaging	_
218-6	31793-31796	and	_
218-7	31797-31807	behavioral	_
218-8	31808-31819	assessments	_
218-9	31820-31824	will	_
218-10	31825-31827	be	_
218-11	31828-31836	valuable	_
218-12	31837-31840	for	_
218-13	31841-31852	determining	_
218-14	31853-31856	the	_
218-15	31857-31864	utility	_
218-16	31865-31867	of	_
218-17	31868-31880	neuroimaging	_
218-18	31881-31889	measures	_
218-19	31890-31892	in	_
218-20	31893-31903	predicting	_
218-21	31904-31909	group	_
218-22	31910-31920	membership	_
218-23	31920-31921	.	_

#Text=Another limitation originates from the strict multiple comparison correction utilized to reduce the number of false positives.
219-1	31922-31929	Another	_
219-2	31930-31940	limitation	_
219-3	31941-31951	originates	_
219-4	31952-31956	from	_
219-5	31957-31960	the	_
219-6	31961-31967	strict	_
219-7	31968-31976	multiple	_
219-8	31977-31987	comparison	_
219-9	31988-31998	correction	_
219-10	31999-32007	utilized	_
219-11	32008-32010	to	_
219-12	32011-32017	reduce	_
219-13	32018-32021	the	_
219-14	32022-32028	number	_
219-15	32029-32031	of	_
219-16	32032-32037	false	_
219-17	32038-32047	positives	_
219-18	32047-32048	.	_

#Text=Reported findings likely reflect only the strongest effects of drinking or smoking, while other possible effects like the ones observed by hypotheses-driven region-of-interest may be missed.
220-1	32049-32057	Reported	_
220-2	32058-32066	findings	_
220-3	32067-32073	likely	_
220-4	32074-32081	reflect	_
220-5	32082-32086	only	_
220-6	32087-32090	the	_
220-7	32091-32100	strongest	_
220-8	32101-32108	effects	_
220-9	32109-32111	of	_
220-10	32112-32120	drinking	_
220-11	32121-32123	or	_
220-12	32124-32131	smoking	_
220-13	32131-32132	,	_
220-14	32133-32138	while	_
220-15	32139-32144	other	_
220-16	32145-32153	possible	_
220-17	32154-32161	effects	_
220-18	32162-32166	like	_
220-19	32167-32170	the	_
220-20	32171-32175	ones	_
220-21	32176-32184	observed	_
220-22	32185-32187	by	_
220-23	32188-32205	hypotheses-driven	_
220-24	32206-32224	region-of-interest	_
220-25	32225-32228	may	_
220-26	32229-32231	be	_
220-27	32232-32238	missed	_
220-28	32238-32239	.	_

#Text=This could explain the relatively small number of ECN effects observed in this work compared to previous studies.
221-1	32240-32244	This	_
221-2	32245-32250	could	_
221-3	32251-32258	explain	_
221-4	32259-32262	the	_
221-5	32263-32273	relatively	_
221-6	32274-32279	small	_
221-7	32280-32286	number	_
221-8	32287-32289	of	_
221-9	32290-32293	ECN	_
221-10	32294-32301	effects	_
221-11	32302-32310	observed	_
221-12	32311-32313	in	_
221-13	32314-32318	this	_
221-14	32319-32323	work	_
221-15	32324-32332	compared	_
221-16	32333-32335	to	_
221-17	32336-32344	previous	_
221-18	32345-32352	studies	_
221-19	32352-32353	.	_

#Text=In this study, participants were not actively using other drugs (including methamphetamine, cocaine, ecstasy, prescription pain medication, prescription sedatives and stimulants).
222-1	32354-32356	In	_
222-2	32357-32361	this	_
222-3	32362-32367	study	_
222-4	32367-32368	,	_
222-5	32369-32381	participants	_
222-6	32382-32386	were	_
222-7	32387-32390	not	_
222-8	32391-32399	actively	_
222-9	32400-32405	using	_
222-10	32406-32411	other	_
222-11	32412-32417	drugs	_
222-12	32418-32419	(	_
222-13	32419-32428	including	_
222-14	32429-32444	methamphetamine	_
222-15	32444-32445	,	_
222-16	32446-32453	cocaine	_
222-17	32453-32454	,	_
222-18	32455-32462	ecstasy	_
222-19	32462-32463	,	_
222-20	32464-32476	prescription	_
222-21	32477-32481	pain	_
222-22	32482-32492	medication	_
222-23	32492-32493	,	_
222-24	32494-32506	prescription	_
222-25	32507-32516	sedatives	_
222-26	32517-32520	and	_
222-27	32521-32531	stimulants	_
222-28	32531-32532	)	_
222-29	32532-32533	.	_

#Text=As has been done here between alcohol and nicotine, future studies should be conducted to evaluate the potential cross effect with other common substances such as marijuana.
223-1	32534-32536	As	_
223-2	32537-32540	has	_
223-3	32541-32545	been	_
223-4	32546-32550	done	_
223-5	32551-32555	here	_
223-6	32556-32563	between	_
223-7	32564-32571	alcohol	_
223-8	32572-32575	and	_
223-9	32576-32584	nicotine	_
223-10	32584-32585	,	_
223-11	32586-32592	future	_
223-12	32593-32600	studies	_
223-13	32601-32607	should	_
223-14	32608-32610	be	_
223-15	32611-32620	conducted	_
223-16	32621-32623	to	_
223-17	32624-32632	evaluate	_
223-18	32633-32636	the	_
223-19	32637-32646	potential	_
223-20	32647-32652	cross	_
223-21	32653-32659	effect	_
223-22	32660-32664	with	_
223-23	32665-32670	other	_
223-24	32671-32677	common	_
223-25	32678-32688	substances	_
223-26	32689-32693	such	_
223-27	32694-32696	as	_
223-28	32697-32706	marijuana	_
223-29	32706-32707	.	_

#Text=In spite of the multiple group differences observed, the results show few relationships with AUDIT and FTND, which could be indication of pre-existing brain states unrelated to drug use.
224-1	32708-32710	In	_
224-2	32711-32716	spite	_
224-3	32717-32719	of	_
224-4	32720-32723	the	_
224-5	32724-32732	multiple	_
224-6	32733-32738	group	_
224-7	32739-32750	differences	_
224-8	32751-32759	observed	_
224-9	32759-32760	,	_
224-10	32761-32764	the	_
224-11	32765-32772	results	_
224-12	32773-32777	show	_
224-13	32778-32781	few	_
224-14	32782-32795	relationships	_
224-15	32796-32800	with	_
224-16	32801-32806	AUDIT	_
224-17	32807-32810	and	_
224-18	32811-32815	FTND	_
224-19	32815-32816	,	_
224-20	32817-32822	which	_
224-21	32823-32828	could	_
224-22	32829-32831	be	_
224-23	32832-32842	indication	_
224-24	32843-32845	of	_
224-25	32846-32858	pre-existing	_
224-26	32859-32864	brain	_
224-27	32865-32871	states	_
224-28	32872-32881	unrelated	_
224-29	32882-32884	to	_
224-30	32885-32889	drug	_
224-31	32890-32893	use	_
224-32	32893-32894	.	_

#Text=It could also indicate that observed differences might be better captured by other covariates not considered in this study.
225-1	32895-32897	It	_
225-2	32898-32903	could	_
225-3	32904-32908	also	_
225-4	32909-32917	indicate	_
225-5	32918-32922	that	_
225-6	32923-32931	observed	_
225-7	32932-32943	differences	_
225-8	32944-32949	might	_
225-9	32950-32952	be	_
225-10	32953-32959	better	_
225-11	32960-32968	captured	_
225-12	32969-32971	by	_
225-13	32972-32977	other	_
225-14	32978-32988	covariates	_
225-15	32989-32992	not	_
225-16	32993-33003	considered	_
225-17	33004-33006	in	_
225-18	33007-33011	this	_
225-19	33012-33017	study	_
225-20	33017-33018	.	_

#Text=Another possible explanation is the stationary behavior assumed for the time courses in the applied method.
226-1	33019-33026	Another	_
226-2	33027-33035	possible	_
226-3	33036-33047	explanation	_
226-4	33048-33050	is	_
226-5	33051-33054	the	_
226-6	33055-33065	stationary	_
226-7	33066-33074	behavior	_
226-8	33075-33082	assumed	_
226-9	33083-33086	for	_
226-10	33087-33090	the	_
226-11	33091-33095	time	_
226-12	33096-33103	courses	_
226-13	33104-33106	in	_
226-14	33107-33110	the	_
226-15	33111-33118	applied	_
226-16	33119-33125	method	_
226-17	33125-33126	.	_

#Text=Methods that analyze dynamic connectivity, e.g., can identify and separate brain states which may exhibit closer relationship with behavioral measures.
227-1	33127-33134	Methods	_
227-2	33135-33139	that	_
227-3	33140-33147	analyze	_
227-4	33148-33155	dynamic	_
227-5	33156-33168	connectivity	_
227-6	33168-33169	,	_
227-7	33170-33173	e.g	_
227-8	33173-33174	.	_
227-9	33174-33175	,	_
227-10	33176-33179	can	_
227-11	33180-33188	identify	_
227-12	33189-33192	and	_
227-13	33193-33201	separate	_
227-14	33202-33207	brain	_
227-15	33208-33214	states	_
227-16	33215-33220	which	_
227-17	33221-33224	may	_
227-18	33225-33232	exhibit	_
227-19	33233-33239	closer	_
227-20	33240-33252	relationship	_
227-21	33253-33257	with	_
227-22	33258-33268	behavioral	_
227-23	33269-33277	measures	_
227-24	33277-33278	.	_

#Text=Finally, this study was designed as a resting state analysis free of important cognitive measures that can be obtained using different task paradigms.
228-1	33279-33286	Finally	_
228-2	33286-33287	,	_
228-3	33288-33292	this	_
228-4	33293-33298	study	_
228-5	33299-33302	was	_
228-6	33303-33311	designed	_
228-7	33312-33314	as	_
228-8	33315-33316	a	_
228-9	33317-33324	resting	_
228-10	33325-33330	state	_
228-11	33331-33339	analysis	_
228-12	33340-33344	free	_
228-13	33345-33347	of	_
228-14	33348-33357	important	_
228-15	33358-33367	cognitive	_
228-16	33368-33376	measures	_
228-17	33377-33381	that	_
228-18	33382-33385	can	_
228-19	33386-33388	be	_
228-20	33389-33397	obtained	_
228-21	33398-33403	using	_
228-22	33404-33413	different	_
228-23	33414-33418	task	_
228-24	33419-33428	paradigms	_
228-25	33428-33429	.	_

#Text=Our observations are then limited to task-free outcomes and leave a cognitive evaluation for future work and experimentation.
#Text=5 Conclusion
#Text=Our data provide evidence for interoceptive and sensorial dysfunctions as reduced connectivity in insula, precentral and visual areas might be associated to reduced awareness of input signals observed in alcohol.
229-1	33430-33433	Our	_
229-2	33434-33446	observations	_
229-3	33447-33450	are	_
229-4	33451-33455	then	_
229-5	33456-33463	limited	_
229-6	33464-33466	to	_
229-7	33467-33476	task-free	_
229-8	33477-33485	outcomes	_
229-9	33486-33489	and	_
229-10	33490-33495	leave	_
229-11	33496-33497	a	_
229-12	33498-33507	cognitive	_
229-13	33508-33518	evaluation	_
229-14	33519-33522	for	_
229-15	33523-33529	future	_
229-16	33530-33534	work	_
229-17	33535-33538	and	_
229-18	33539-33554	experimentation	_
229-19	33554-33555	.	_
229-20	33556-33557	5	_
229-21	33558-33568	Conclusion	_
229-22	33569-33572	Our	_
229-23	33573-33577	data	_
229-24	33578-33585	provide	_
229-25	33586-33594	evidence	_
229-26	33595-33598	for	_
229-27	33599-33612	interoceptive	_
229-28	33613-33616	and	_
229-29	33617-33626	sensorial	_
229-30	33627-33639	dysfunctions	_
229-31	33640-33642	as	_
229-32	33643-33650	reduced	_
229-33	33651-33663	connectivity	_
229-34	33664-33666	in	_
229-35	33667-33673	insula	_
229-36	33673-33674	,	_
229-37	33675-33685	precentral	_
229-38	33686-33689	and	_
229-39	33690-33696	visual	_
229-40	33697-33702	areas	_
229-41	33703-33708	might	_
229-42	33709-33711	be	_
229-43	33712-33722	associated	_
229-44	33723-33725	to	_
229-45	33726-33733	reduced	_
229-46	33734-33743	awareness	_
229-47	33744-33746	of	_
229-48	33747-33752	input	_
229-49	33753-33760	signals	_
229-50	33761-33769	observed	_
229-51	33770-33772	in	_
229-52	33773-33780	alcohol	_
229-53	33780-33781	.	_

#Text=Affected brain areas also span motor (SMA) and cognitive (precuneus) functions suggesting that top-down body control pathways might also be impaired.
230-1	33782-33790	Affected	_
230-2	33791-33796	brain	_
230-3	33797-33802	areas	_
230-4	33803-33807	also	_
230-5	33808-33812	span	_
230-6	33813-33818	motor	_
230-7	33819-33820	(	_
230-8	33820-33823	SMA	_
230-9	33823-33824	)	_
230-10	33825-33828	and	_
230-11	33829-33838	cognitive	_
230-12	33839-33840	(	_
230-13	33840-33849	precuneus	_
230-14	33849-33850	)	_
230-15	33851-33860	functions	_
230-16	33861-33871	suggesting	_
230-17	33872-33876	that	_
230-18	33877-33885	top-down	_
230-19	33886-33890	body	_
230-20	33891-33898	control	_
230-21	33899-33907	pathways	_
230-22	33908-33913	might	_
230-23	33914-33918	also	_
230-24	33919-33921	be	_
230-25	33922-33930	impaired	_
230-26	33930-33931	.	_

#Text=Nicotine induced a protective effect in drinkers who also smoked for particular brain areas in the default network (PCC) and higher visual processing network (lingual gyrus and fusiform girus), but did not improve the reduced connectivity of the primary visual region.
231-1	33932-33940	Nicotine	_
231-2	33941-33948	induced	_
231-3	33949-33950	a	_
231-4	33951-33961	protective	_
231-5	33962-33968	effect	_
231-6	33969-33971	in	_
231-7	33972-33980	drinkers	_
231-8	33981-33984	who	_
231-9	33985-33989	also	_
231-10	33990-33996	smoked	_
231-11	33997-34000	for	_
231-12	34001-34011	particular	_
231-13	34012-34017	brain	_
231-14	34018-34023	areas	_
231-15	34024-34026	in	_
231-16	34027-34030	the	_
231-17	34031-34038	default	_
231-18	34039-34046	network	_
231-19	34047-34048	(	_
231-20	34048-34051	PCC	_
231-21	34051-34052	)	_
231-22	34053-34056	and	_
231-23	34057-34063	higher	_
231-24	34064-34070	visual	_
231-25	34071-34081	processing	_
231-26	34082-34089	network	_
231-27	34090-34091	(	_
231-28	34091-34098	lingual	_
231-29	34099-34104	gyrus	_
231-30	34105-34108	and	_
231-31	34109-34117	fusiform	_
231-32	34118-34123	girus	_
231-33	34123-34124	)	_
231-34	34124-34125	,	_
231-35	34126-34129	but	_
231-36	34130-34133	did	_
231-37	34134-34137	not	_
231-38	34138-34145	improve	_
231-39	34146-34149	the	_
231-40	34150-34157	reduced	_
231-41	34158-34170	connectivity	_
231-42	34171-34173	of	_
231-43	34174-34177	the	_
231-44	34178-34185	primary	_
231-45	34186-34192	visual	_
231-46	34193-34199	region	_
231-47	34199-34200	.	_

#Text=These different effects in visual areas may be useful in separating drinkers and drinkers that smoke.
232-1	34201-34206	These	_
232-2	34207-34216	different	_
232-3	34217-34224	effects	_
232-4	34225-34227	in	_
232-5	34228-34234	visual	_
232-6	34235-34240	areas	_
232-7	34241-34244	may	_
232-8	34245-34247	be	_
232-9	34248-34254	useful	_
232-10	34255-34257	in	_
232-11	34258-34268	separating	_
232-12	34269-34277	drinkers	_
232-13	34278-34281	and	_
232-14	34282-34290	drinkers	_
232-15	34291-34295	that	_
232-16	34296-34301	smoke	_
232-17	34301-34302	.	_

#Text=In addition to PCC, nicotine also increased connectivity in the angular gyrus, which is another important part of the DMN.
233-1	34303-34305	In	_
233-2	34306-34314	addition	_
233-3	34315-34317	to	_
233-4	34318-34321	PCC	_
233-5	34321-34322	,	_
233-6	34323-34331	nicotine	_
233-7	34332-34336	also	_
233-8	34337-34346	increased	_
233-9	34347-34359	connectivity	_
233-10	34360-34362	in	_
233-11	34363-34366	the	_
233-12	34367-34374	angular	_
233-13	34375-34380	gyrus	_
233-14	34380-34381	,	_
233-15	34382-34387	which	_
233-16	34388-34390	is	_
233-17	34391-34398	another	_
233-18	34399-34408	important	_
233-19	34409-34413	part	_
233-20	34414-34416	of	_
233-21	34417-34420	the	_
233-22	34421-34424	DMN	_
233-23	34424-34425	.	_

#Text=This DMN hyper-connectivity supports the idea of a salience disruption that shifts network dynamic towards the DMN in order to resolve withdrawal effects in the brain.
234-1	34426-34430	This	_
234-2	34431-34434	DMN	_
234-3	34435-34453	hyper-connectivity	_
234-4	34454-34462	supports	_
234-5	34463-34466	the	_
234-6	34467-34471	idea	_
234-7	34472-34474	of	_
234-8	34475-34476	a	_
234-9	34477-34485	salience	_
234-10	34486-34496	disruption	_
234-11	34497-34501	that	_
234-12	34502-34508	shifts	_
234-13	34509-34516	network	_
234-14	34517-34524	dynamic	_
234-15	34525-34532	towards	_
234-16	34533-34536	the	_
234-17	34537-34540	DMN	_
234-18	34541-34543	in	_
234-19	34544-34549	order	_
234-20	34550-34552	to	_
234-21	34553-34560	resolve	_
234-22	34561-34571	withdrawal	_
234-23	34572-34579	effects	_
234-24	34580-34582	in	_
234-25	34583-34586	the	_
234-26	34587-34592	brain	_
234-27	34592-34593	.	_

#Text=Our observations seem to lack the ECN emphasis previously found by alcohol studies.
235-1	34594-34597	Our	_
235-2	34598-34610	observations	_
235-3	34611-34615	seem	_
235-4	34616-34618	to	_
235-5	34619-34623	lack	_
235-6	34624-34627	the	_
235-7	34628-34631	ECN	_
235-8	34632-34640	emphasis	_
235-9	34641-34651	previously	_
235-10	34652-34657	found	_
235-11	34658-34660	by	_
235-12	34661-34668	alcohol	_
235-13	34669-34676	studies	_
235-14	34676-34677	.	_

#Text=Only one ECN RSN embracing the left IPL showed significant hypo-connectivity with the left IOG.
236-1	34678-34682	Only	_
236-2	34683-34686	one	_
236-3	34687-34690	ECN	_
236-4	34691-34694	RSN	_
236-5	34695-34704	embracing	_
236-6	34705-34708	the	_
236-7	34709-34713	left	_
236-8	34714-34717	IPL	_
236-9	34718-34724	showed	_
236-10	34725-34736	significant	_
236-11	34737-34754	hypo-connectivity	_
236-12	34755-34759	with	_
236-13	34760-34763	the	_
236-14	34764-34768	left	_
236-15	34769-34772	IOG	_
236-16	34772-34773	.	_

#Text=In our data, reduced ECN-visual connectivity resembles the sensorimotor-visual hypo-connectivity pattern in smoking and drinking subjects.
237-1	34774-34776	In	_
237-2	34777-34780	our	_
237-3	34781-34785	data	_
237-4	34785-34786	,	_
237-5	34787-34794	reduced	_
237-6	34795-34805	ECN-visual	_
237-7	34806-34818	connectivity	_
237-8	34819-34828	resembles	_
237-9	34829-34832	the	_
237-10	34833-34852	sensorimotor-visual	_
237-11	34853-34870	hypo-connectivity	_
237-12	34871-34878	pattern	_
237-13	34879-34881	in	_
237-14	34882-34889	smoking	_
237-15	34890-34893	and	_
237-16	34894-34902	drinking	_
237-17	34903-34911	subjects	_
237-18	34911-34912	.	_

#Text=The similar hypo-connectivity effect in ECN and sensorimotor areas may be related to the hypothesis of a network dynamic that shifts away from exogenous information processing.
238-1	34913-34916	The	_
238-2	34917-34924	similar	_
238-3	34925-34942	hypo-connectivity	_
238-4	34943-34949	effect	_
238-5	34950-34952	in	_
238-6	34953-34956	ECN	_
238-7	34957-34960	and	_
238-8	34961-34973	sensorimotor	_
238-9	34974-34979	areas	_
238-10	34980-34983	may	_
238-11	34984-34986	be	_
238-12	34987-34994	related	_
238-13	34995-34997	to	_
238-14	34998-35001	the	_
238-15	35002-35012	hypothesis	_
238-16	35013-35015	of	_
238-17	35016-35017	a	_
238-18	35018-35025	network	_
238-19	35026-35033	dynamic	_
238-20	35034-35038	that	_
238-21	35039-35045	shifts	_
238-22	35046-35050	away	_
238-23	35051-35055	from	_
238-24	35056-35065	exogenous	_
238-25	35066-35077	information	_
238-26	35078-35088	processing	_
238-27	35088-35089	.	_

#Text=In addition, results support the existence of a putamen-thalamus dysfunction that might be involved in nicotine craving behavior as previously observed in.
239-1	35090-35092	In	_
239-2	35093-35101	addition	_
239-3	35101-35102	,	_
239-4	35103-35110	results	_
239-5	35111-35118	support	_
239-6	35119-35122	the	_
239-7	35123-35132	existence	_
239-8	35133-35135	of	_
239-9	35136-35137	a	_
239-10	35138-35154	putamen-thalamus	_
239-11	35155-35166	dysfunction	_
239-12	35167-35171	that	_
239-13	35172-35177	might	_
239-14	35178-35180	be	_
239-15	35181-35189	involved	_
239-16	35190-35192	in	_
239-17	35193-35201	nicotine	_
239-18	35202-35209	craving	_
239-19	35210-35218	behavior	_
239-20	35219-35221	as	_
239-21	35222-35232	previously	_
239-22	35233-35241	observed	_
239-23	35242-35244	in	_
239-24	35244-35245	.	_

#Text=The different effects observed in our study indicate that alcohol, nicotine and their interaction affect the brain in particular ways that may help understand the specific or interactive mechanisms of substance use on brain function.
240-1	35246-35249	The	_
240-2	35250-35259	different	_
240-3	35260-35267	effects	_
240-4	35268-35276	observed	_
240-5	35277-35279	in	_
240-6	35280-35283	our	_
240-7	35284-35289	study	_
240-8	35290-35298	indicate	_
240-9	35299-35303	that	_
240-10	35304-35311	alcohol	_
240-11	35311-35312	,	_
240-12	35313-35321	nicotine	_
240-13	35322-35325	and	_
240-14	35326-35331	their	_
240-15	35332-35343	interaction	_
240-16	35344-35350	affect	_
240-17	35351-35354	the	_
240-18	35355-35360	brain	_
240-19	35361-35363	in	_
240-20	35364-35374	particular	_
240-21	35375-35379	ways	_
240-22	35380-35384	that	_
240-23	35385-35388	may	_
240-24	35389-35393	help	_
240-25	35394-35404	understand	_
240-26	35405-35408	the	_
240-27	35409-35417	specific	_
240-28	35418-35420	or	_
240-29	35421-35432	interactive	_
240-30	35433-35443	mechanisms	_
240-31	35444-35446	of	_
240-32	35447-35456	substance	_
240-33	35457-35460	use	_
240-34	35461-35463	on	_
240-35	35464-35469	brain	_
240-36	35470-35478	function	_
240-37	35478-35479	.	_

#Text=These results also show that concurrent use of substances must be carefully controlled when studying substance specific effects on the brain.
241-1	35480-35485	These	_
241-2	35486-35493	results	_
241-3	35494-35498	also	_
241-4	35499-35503	show	_
241-5	35504-35508	that	_
241-6	35509-35519	concurrent	_
241-7	35520-35523	use	_
241-8	35524-35526	of	_
241-9	35527-35537	substances	_
241-10	35538-35542	must	_
241-11	35543-35545	be	_
241-12	35546-35555	carefully	_
241-13	35556-35566	controlled	_
241-14	35567-35571	when	_
241-15	35572-35580	studying	_
241-16	35581-35590	substance	_
241-17	35591-35599	specific	_
241-18	35600-35607	effects	_
241-19	35608-35610	on	_
241-20	35611-35614	the	_
241-21	35615-35620	brain	_
241-22	35620-35621	.	_

#Text=Supplementary Material
#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
242-1	35622-35635	Supplementary	_
242-2	35636-35644	Material	_
242-3	35645-35649	This	_
242-4	35650-35652	is	_
242-5	35653-35654	a	_
242-6	35655-35658	PDF	_
242-7	35659-35663	file	_
242-8	35664-35666	of	_
242-9	35667-35669	an	_
242-10	35670-35678	unedited	_
242-11	35679-35689	manuscript	_
242-12	35690-35694	that	_
242-13	35695-35698	has	_
242-14	35699-35703	been	_
242-15	35704-35712	accepted	_
242-16	35713-35716	for	_
242-17	35717-35728	publication	_
242-18	35728-35729	.	_

#Text=As a service to our customers we are providing this early version of the manuscript.
243-1	35730-35732	As	_
243-2	35733-35734	a	_
243-3	35735-35742	service	_
243-4	35743-35745	to	_
243-5	35746-35749	our	_
243-6	35750-35759	customers	_
243-7	35760-35762	we	_
243-8	35763-35766	are	_
243-9	35767-35776	providing	_
243-10	35777-35781	this	_
243-11	35782-35787	early	_
243-12	35788-35795	version	_
243-13	35796-35798	of	_
243-14	35799-35802	the	_
243-15	35803-35813	manuscript	_
243-16	35813-35814	.	_

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
244-1	35815-35818	The	_
244-2	35819-35829	manuscript	_
244-3	35830-35834	will	_
244-4	35835-35842	undergo	_
244-5	35843-35854	copyediting	_
244-6	35854-35855	,	_
244-7	35856-35867	typesetting	_
244-8	35867-35868	,	_
244-9	35869-35872	and	_
244-10	35873-35879	review	_
244-11	35880-35882	of	_
244-12	35883-35886	the	_
244-13	35887-35896	resulting	_
244-14	35897-35902	proof	_
244-15	35903-35909	before	_
244-16	35910-35912	it	_
244-17	35913-35915	is	_
244-18	35916-35925	published	_
244-19	35926-35928	in	_
244-20	35929-35932	its	_
244-21	35933-35938	final	_
244-22	35939-35946	citable	_
244-23	35947-35951	form	_
244-24	35951-35952	.	_

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
245-1	35953-35959	Please	_
245-2	35960-35964	note	_
245-3	35965-35969	that	_
245-4	35970-35976	during	_
245-5	35977-35980	the	_
245-6	35981-35991	production	_
245-7	35992-35999	process	_
245-8	36000-36006	errors	_
245-9	36007-36010	may	_
245-10	36011-36013	be	_
245-11	36014-36024	discovered	_
245-12	36025-36030	which	_
245-13	36031-36036	could	_
245-14	36037-36043	affect	_
245-15	36044-36047	the	_
245-16	36048-36055	content	_
245-17	36055-36056	,	_
245-18	36057-36060	and	_
245-19	36061-36064	all	_
245-20	36065-36070	legal	_
245-21	36071-36082	disclaimers	_
245-22	36083-36087	that	_
245-23	36088-36093	apply	_
245-24	36094-36096	to	_
245-25	36097-36100	the	_
245-26	36101-36108	journal	_
245-27	36109-36116	pertain	_
245-28	36116-36117	.	_

#Text=The author(s) declare that there was no other financial support or compensation that could be perceived as constituting a potential conflict of interest.
246-1	36118-36121	The	_
246-2	36122-36128	author	_
246-3	36128-36129	(	_
246-4	36129-36130	s	_
246-5	36130-36131	)	_
246-6	36132-36139	declare	_
246-7	36140-36144	that	_
246-8	36145-36150	there	_
246-9	36151-36154	was	_
246-10	36155-36157	no	_
246-11	36158-36163	other	_
246-12	36164-36173	financial	_
246-13	36174-36181	support	_
246-14	36182-36184	or	_
246-15	36185-36197	compensation	_
246-16	36198-36202	that	_
246-17	36203-36208	could	_
246-18	36209-36211	be	_
246-19	36212-36221	perceived	_
246-20	36222-36224	as	_
246-21	36225-36237	constituting	_
246-22	36238-36239	a	_
246-23	36240-36249	potential	_
246-24	36250-36258	conflict	_
246-25	36259-36261	of	_
246-26	36262-36270	interest	_
246-27	36270-36271	.	_

#Text=References
#Text=Damage to the insula leads to decreased nicotine withdrawal during abstinence
#Text=Machine-learning identifies substance-specific behavioral markers for opiate and stimulant dependence
#Text=Tracking whole-brain connectivity dynamics in the resting state
#Text=A baseline for the multivariate comparison of resting-state networks
#Text=Audit.
247-1	36272-36282	References	_
247-2	36283-36289	Damage	_
247-3	36290-36292	to	_
247-4	36293-36296	the	_
247-5	36297-36303	insula	_
247-6	36304-36309	leads	_
247-7	36310-36312	to	_
247-8	36313-36322	decreased	_
247-9	36323-36331	nicotine	_
247-10	36332-36342	withdrawal	_
247-11	36343-36349	during	_
247-12	36350-36360	abstinence	_
247-13	36361-36377	Machine-learning	_
247-14	36378-36388	identifies	_
247-15	36389-36407	substance-specific	_
247-16	36408-36418	behavioral	_
247-17	36419-36426	markers	_
247-18	36427-36430	for	_
247-19	36431-36437	opiate	_
247-20	36438-36441	and	_
247-21	36442-36451	stimulant	_
247-22	36452-36462	dependence	_
247-23	36463-36471	Tracking	_
247-24	36472-36483	whole-brain	_
247-25	36484-36496	connectivity	_
247-26	36497-36505	dynamics	_
247-27	36506-36508	in	_
247-28	36509-36512	the	_
247-29	36513-36520	resting	_
247-30	36521-36526	state	_
247-31	36527-36528	A	_
247-32	36529-36537	baseline	_
247-33	36538-36541	for	_
247-34	36542-36545	the	_
247-35	36546-36558	multivariate	_
247-36	36559-36569	comparison	_
247-37	36570-36572	of	_
247-38	36573-36586	resting-state	_
247-39	36587-36595	networks	_
247-40	36596-36601	Audit	_
247-41	36601-36602	.	_

#Text=The Alcohol Use Disorders Identification Test (AUDIT): Guidelines for use in primary care
#Text=Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
#Text=A method for making group inferences from functional MRI data using independent component analysis
#Text=Multisubject independent component analysis of fMRI: a decade of intrinsic networks, default mode, and neurodiagnostic discovery
#Text=Resting-state synchrony during early alcohol abstinence can predict subsequent relapse
#Text=Resting-state synchrony in long-term abstinent alcoholics
#Text=Synaptic and morphological neuroadaptations in the putamen associated with long-term, relapsing alcohol drinking in primates
#Text=Disruption of functional connectivity of the default-mode network in alcoholism
#Text=Identifying neurobiological phenotypes associated with alcohol use disorder severity
#Text=Evaluation of Interoceptive Awareness in Alcohol-Addicted Patients
#Text=Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics
#Text=Interoception: the sense of the physiological condition of the body
#Text=Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders
#Text=Alcohol and dopamine
#Text=Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system
#Text=Revisiting the role of the insula in addiction
#Text=Imaging the Addicted Brain: Alcohol
#Text=Chronic cigarette smoking in healthy middle-aged individuals is associated with decreased regional brain N-acetylaspartate and glutamate levels
#Text=On network derivation, classification, and visualization: a response to Habeck and Moeller
#Text=Comparison of multi-subject ICA methods for analysis of fMRI data
#Text=Nicotine addiction and its assessment
#Text=Resting-state functional connectivity and nicotine addiction: prospects for biomarker development
#Text=Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition
#Text=Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population
#Text=Accuracy of Alcohol Use Disorders Identification Test (AUDIT) for detecting problem drinking in 18–35 year-olds in England
#Text=Statistical parametric mapping
#Text=Cerebral effects of nicotine during cognition in smokers and non-smokers
#Text=The corticocortical structural connectivity of the human insula
#Text=Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network
#Text=The maximum familywise error rate of Fisher's least significant difference test
#Text=Validating the independent components of neuroimaging time series via clustering and visualization
#Text=Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits
#Text=Tobacco, alcohol, and caffeine use: a review of their interrelationships
#Text=A method for functional network connectivity among spatially independent resting-state components in schizophrenia
#Text=Prefrontal and limbic resting state brain network functional connectivity differs between nicotine-dependent smokers and non-smoking controls
#Text=Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans
#Text=On the relationship between seed-based and ICA-based measures of functional connectivity
#Text=Loss in connectivity among regions of the brain reward system in alcohol dependence
#Text=Cognitive mechanisms of nicotine on visual attention
#Text=Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization
#Text=Review of methods for functional brain connectivity detection using fMRI
#Text=Altered brain functional networks in heavy smokers
#Text=Right anterior insula connectivity is important for cue-induced craving in nicotine-dependent smokers
#Text=24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum
#Text=The resting brain of alcoholics
#Text=Is there a common molecular pathway for addiction?
248-1	36603-36606	The	_
248-2	36607-36614	Alcohol	_
248-3	36615-36618	Use	_
248-4	36619-36628	Disorders	_
248-5	36629-36643	Identification	_
248-6	36644-36648	Test	_
248-7	36649-36650	(	_
248-8	36650-36655	AUDIT	_
248-9	36655-36656	)	_
248-10	36656-36657	:	_
248-11	36658-36668	Guidelines	_
248-12	36669-36672	for	_
248-13	36673-36676	use	_
248-14	36677-36679	in	_
248-15	36680-36687	primary	_
248-16	36688-36692	care	_
248-17	36693-36705	Psychometric	_
248-18	36706-36716	properties	_
248-19	36717-36719	of	_
248-20	36720-36723	the	_
248-21	36724-36728	Beck	_
248-22	36729-36739	Depression	_
248-23	36740-36749	Inventory	_
248-24	36749-36750	:	_
248-25	36751-36762	Twenty-five	_
248-26	36763-36768	years	_
248-27	36769-36771	of	_
248-28	36772-36782	evaluation	_
248-29	36783-36784	A	_
248-30	36785-36791	method	_
248-31	36792-36795	for	_
248-32	36796-36802	making	_
248-33	36803-36808	group	_
248-34	36809-36819	inferences	_
248-35	36820-36824	from	_
248-36	36825-36835	functional	_
248-37	36836-36839	MRI	_
248-38	36840-36844	data	_
248-39	36845-36850	using	_
248-40	36851-36862	independent	_
248-41	36863-36872	component	_
248-42	36873-36881	analysis	_
248-43	36882-36894	Multisubject	_
248-44	36895-36906	independent	_
248-45	36907-36916	component	_
248-46	36917-36925	analysis	_
248-47	36926-36928	of	_
248-48	36929-36933	fMRI	_
248-49	36933-36934	:	_
248-50	36935-36936	a	_
248-51	36937-36943	decade	_
248-52	36944-36946	of	_
248-53	36947-36956	intrinsic	_
248-54	36957-36965	networks	_
248-55	36965-36966	,	_
248-56	36967-36974	default	_
248-57	36975-36979	mode	_
248-58	36979-36980	,	_
248-59	36981-36984	and	_
248-60	36985-37000	neurodiagnostic	_
248-61	37001-37010	discovery	_
248-62	37011-37024	Resting-state	_
248-63	37025-37034	synchrony	_
248-64	37035-37041	during	_
248-65	37042-37047	early	_
248-66	37048-37055	alcohol	_
248-67	37056-37066	abstinence	_
248-68	37067-37070	can	_
248-69	37071-37078	predict	_
248-70	37079-37089	subsequent	_
248-71	37090-37097	relapse	_
248-72	37098-37111	Resting-state	_
248-73	37112-37121	synchrony	_
248-74	37122-37124	in	_
248-75	37125-37134	long-term	_
248-76	37135-37144	abstinent	_
248-77	37145-37155	alcoholics	_
248-78	37156-37164	Synaptic	_
248-79	37165-37168	and	_
248-80	37169-37182	morphological	_
248-81	37183-37199	neuroadaptations	_
248-82	37200-37202	in	_
248-83	37203-37206	the	_
248-84	37207-37214	putamen	_
248-85	37215-37225	associated	_
248-86	37226-37230	with	_
248-87	37231-37240	long-term	_
248-88	37240-37241	,	_
248-89	37242-37251	relapsing	_
248-90	37252-37259	alcohol	_
248-91	37260-37268	drinking	_
248-92	37269-37271	in	_
248-93	37272-37280	primates	_
248-94	37281-37291	Disruption	_
248-95	37292-37294	of	_
248-96	37295-37305	functional	_
248-97	37306-37318	connectivity	_
248-98	37319-37321	of	_
248-99	37322-37325	the	_
248-100	37326-37338	default-mode	_
248-101	37339-37346	network	_
248-102	37347-37349	in	_
248-103	37350-37360	alcoholism	_
248-104	37361-37372	Identifying	_
248-105	37373-37388	neurobiological	_
248-106	37389-37399	phenotypes	_
248-107	37400-37410	associated	_
248-108	37411-37415	with	_
248-109	37416-37423	alcohol	_
248-110	37424-37427	use	_
248-111	37428-37436	disorder	_
248-112	37437-37445	severity	_
248-113	37446-37456	Evaluation	_
248-114	37457-37459	of	_
248-115	37460-37473	Interoceptive	_
248-116	37474-37483	Awareness	_
248-117	37484-37486	in	_
248-118	37487-37503	Alcohol-Addicted	_
248-119	37504-37512	Patients	_
248-120	37513-37521	Nicotine	_
248-121	37522-37533	replacement	_
248-122	37534-37536	in	_
248-123	37537-37546	abstinent	_
248-124	37547-37554	smokers	_
248-125	37555-37563	improves	_
248-126	37564-37573	cognitive	_
248-127	37574-37584	withdrawal	_
248-128	37585-37593	symptoms	_
248-129	37594-37598	with	_
248-130	37599-37609	modulation	_
248-131	37610-37612	of	_
248-132	37613-37620	resting	_
248-133	37621-37626	brain	_
248-134	37627-37634	network	_
248-135	37635-37643	dynamics	_
248-136	37644-37657	Interoception	_
248-137	37657-37658	:	_
248-138	37659-37662	the	_
248-139	37663-37668	sense	_
248-140	37669-37671	of	_
248-141	37672-37675	the	_
248-142	37676-37689	physiological	_
248-143	37690-37699	condition	_
248-144	37700-37702	of	_
248-145	37703-37706	the	_
248-146	37707-37711	body	_
248-147	37712-37723	Comparative	_
248-148	37724-37735	performance	_
248-149	37736-37738	of	_
248-150	37739-37742	the	_
248-151	37743-37750	AUDIT-C	_
248-152	37751-37753	in	_
248-153	37754-37763	screening	_
248-154	37764-37767	for	_
248-155	37768-37774	DSM-IV	_
248-156	37775-37778	and	_
248-157	37779-37782	DSM	_
248-158	37782-37783	-	_
248-159	37783-37784	5	_
248-160	37785-37792	alcohol	_
248-161	37793-37796	use	_
248-162	37797-37806	disorders	_
248-163	37807-37814	Alcohol	_
248-164	37815-37818	and	_
248-165	37819-37827	dopamine	_
248-166	37828-37837	Potential	_
248-167	37838-37848	substrates	_
248-168	37849-37852	for	_
248-169	37853-37861	nicotine	_
248-170	37862-37865	and	_
248-171	37866-37873	alcohol	_
248-172	37874-37886	interactions	_
248-173	37886-37887	:	_
248-174	37888-37889	a	_
248-175	37890-37895	focus	_
248-176	37896-37898	on	_
248-177	37899-37902	the	_
248-178	37903-37920	mesocorticolimbic	_
248-179	37921-37929	dopamine	_
248-180	37930-37936	system	_
248-181	37937-37947	Revisiting	_
248-182	37948-37951	the	_
248-183	37952-37956	role	_
248-184	37957-37959	of	_
248-185	37960-37963	the	_
248-186	37964-37970	insula	_
248-187	37971-37973	in	_
248-188	37974-37983	addiction	_
248-189	37984-37991	Imaging	_
248-190	37992-37995	the	_
248-191	37996-38004	Addicted	_
248-192	38005-38010	Brain	_
248-193	38010-38011	:	_
248-194	38012-38019	Alcohol	_
248-195	38020-38027	Chronic	_
248-196	38028-38037	cigarette	_
248-197	38038-38045	smoking	_
248-198	38046-38048	in	_
248-199	38049-38056	healthy	_
248-200	38057-38068	middle-aged	_
248-201	38069-38080	individuals	_
248-202	38081-38083	is	_
248-203	38084-38094	associated	_
248-204	38095-38099	with	_
248-205	38100-38109	decreased	_
248-206	38110-38118	regional	_
248-207	38119-38124	brain	_
248-208	38125-38142	N-acetylaspartate	_
248-209	38143-38146	and	_
248-210	38147-38156	glutamate	_
248-211	38157-38163	levels	_
248-212	38164-38166	On	_
248-213	38167-38174	network	_
248-214	38175-38185	derivation	_
248-215	38185-38186	,	_
248-216	38187-38201	classification	_
248-217	38201-38202	,	_
248-218	38203-38206	and	_
248-219	38207-38220	visualization	_
248-220	38220-38221	:	_
248-221	38222-38223	a	_
248-222	38224-38232	response	_
248-223	38233-38235	to	_
248-224	38236-38242	Habeck	_
248-225	38243-38246	and	_
248-226	38247-38254	Moeller	_
248-227	38255-38265	Comparison	_
248-228	38266-38268	of	_
248-229	38269-38282	multi-subject	_
248-230	38283-38286	ICA	_
248-231	38287-38294	methods	_
248-232	38295-38298	for	_
248-233	38299-38307	analysis	_
248-234	38308-38310	of	_
248-235	38311-38315	fMRI	_
248-236	38316-38320	data	_
248-237	38321-38329	Nicotine	_
248-238	38330-38339	addiction	_
248-239	38340-38343	and	_
248-240	38344-38347	its	_
248-241	38348-38358	assessment	_
248-242	38359-38372	Resting-state	_
248-243	38373-38383	functional	_
248-244	38384-38396	connectivity	_
248-245	38397-38400	and	_
248-246	38401-38409	nicotine	_
248-247	38410-38419	addiction	_
248-248	38419-38420	:	_
248-249	38421-38430	prospects	_
248-250	38431-38434	for	_
248-251	38435-38444	biomarker	_
248-252	38445-38456	development	_
248-253	38457-38467	Structured	_
248-254	38468-38476	Clinical	_
248-255	38477-38486	Interview	_
248-256	38487-38490	for	_
248-257	38491-38500	DSM-IV-TR	_
248-258	38501-38505	Axis	_
248-259	38506-38507	I	_
248-260	38508-38517	Disorders	_
248-261	38517-38518	,	_
248-262	38519-38527	Research	_
248-263	38528-38535	Version	_
248-264	38535-38536	,	_
248-265	38537-38544	Patient	_
248-266	38545-38552	Edition	_
248-267	38553-38562	Frequency	_
248-268	38563-38575	distribution	_
248-269	38576-38578	of	_
248-270	38579-38582	the	_
248-271	38583-38589	values	_
248-272	38590-38592	of	_
248-273	38593-38596	the	_
248-274	38597-38608	correlation	_
248-275	38609-38620	coefficient	_
248-276	38621-38623	in	_
248-277	38624-38631	samples	_
248-278	38632-38636	from	_
248-279	38637-38639	an	_
248-280	38640-38652	indefinitely	_
248-281	38653-38658	large	_
248-282	38659-38669	population	_
248-283	38670-38678	Accuracy	_
248-284	38679-38681	of	_
248-285	38682-38689	Alcohol	_
248-286	38690-38693	Use	_
248-287	38694-38703	Disorders	_
248-288	38704-38718	Identification	_
248-289	38719-38723	Test	_
248-290	38724-38725	(	_
248-291	38725-38730	AUDIT	_
248-292	38730-38731	)	_
248-293	38732-38735	for	_
248-294	38736-38745	detecting	_
248-295	38746-38753	problem	_
248-296	38754-38762	drinking	_
248-297	38763-38765	in	_
248-298	38766-38768	18	_
248-299	38768-38769	–	_
248-300	38769-38771	35	_
248-301	38772-38781	year-olds	_
248-302	38782-38784	in	_
248-303	38785-38792	England	_
248-304	38793-38804	Statistical	_
248-305	38805-38815	parametric	_
248-306	38816-38823	mapping	_
248-307	38824-38832	Cerebral	_
248-308	38833-38840	effects	_
248-309	38841-38843	of	_
248-310	38844-38852	nicotine	_
248-311	38853-38859	during	_
248-312	38860-38869	cognition	_
248-313	38870-38872	in	_
248-314	38873-38880	smokers	_
248-315	38881-38884	and	_
248-316	38885-38896	non-smokers	_
248-317	38897-38900	The	_
248-318	38901-38916	corticocortical	_
248-319	38917-38927	structural	_
248-320	38928-38940	connectivity	_
248-321	38941-38943	of	_
248-322	38944-38947	the	_
248-323	38948-38953	human	_
248-324	38954-38960	insula	_
248-325	38961-38969	Nicotine	_
248-326	38970-38978	enhances	_
248-327	38979-38991	visuospatial	_
248-328	38992-39001	attention	_
248-329	39002-39004	by	_
248-330	39005-39017	deactivating	_
248-331	39018-39023	areas	_
248-332	39024-39026	of	_
248-333	39027-39030	the	_
248-334	39031-39038	resting	_
248-335	39039-39044	brain	_
248-336	39045-39052	default	_
248-337	39053-39060	network	_
248-338	39061-39064	The	_
248-339	39065-39072	maximum	_
248-340	39073-39083	familywise	_
248-341	39084-39089	error	_
248-342	39090-39094	rate	_
248-343	39095-39097	of	_
248-344	39098-39106	Fisher's	_
248-345	39107-39112	least	_
248-346	39113-39124	significant	_
248-347	39125-39135	difference	_
248-348	39136-39140	test	_
248-349	39141-39151	Validating	_
248-350	39152-39155	the	_
248-351	39156-39167	independent	_
248-352	39168-39178	components	_
248-353	39179-39181	of	_
248-354	39182-39194	neuroimaging	_
248-355	39195-39199	time	_
248-356	39200-39206	series	_
248-357	39207-39210	via	_
248-358	39211-39221	clustering	_
248-359	39222-39225	and	_
248-360	39226-39239	visualization	_
248-361	39240-39251	Association	_
248-362	39252-39254	of	_
248-363	39255-39263	nicotine	_
248-364	39264-39273	addiction	_
248-365	39274-39277	and	_
248-366	39278-39288	nicotine's	_
248-367	39289-39296	actions	_
248-368	39297-39301	with	_
248-369	39302-39310	separate	_
248-370	39311-39320	cingulate	_
248-371	39321-39327	cortex	_
248-372	39328-39338	functional	_
248-373	39339-39347	circuits	_
248-374	39348-39355	Tobacco	_
248-375	39355-39356	,	_
248-376	39357-39364	alcohol	_
248-377	39364-39365	,	_
248-378	39366-39369	and	_
248-379	39370-39378	caffeine	_
248-380	39379-39382	use	_
248-381	39382-39383	:	_
248-382	39384-39385	a	_
248-383	39386-39392	review	_
248-384	39393-39395	of	_
248-385	39396-39401	their	_
248-386	39402-39420	interrelationships	_
248-387	39421-39422	A	_
248-388	39423-39429	method	_
248-389	39430-39433	for	_
248-390	39434-39444	functional	_
248-391	39445-39452	network	_
248-392	39453-39465	connectivity	_
248-393	39466-39471	among	_
248-394	39472-39481	spatially	_
248-395	39482-39493	independent	_
248-396	39494-39507	resting-state	_
248-397	39508-39518	components	_
248-398	39519-39521	in	_
248-399	39522-39535	schizophrenia	_
248-400	39536-39546	Prefrontal	_
248-401	39547-39550	and	_
248-402	39551-39557	limbic	_
248-403	39558-39565	resting	_
248-404	39566-39571	state	_
248-405	39572-39577	brain	_
248-406	39578-39585	network	_
248-407	39586-39596	functional	_
248-408	39597-39609	connectivity	_
248-409	39610-39617	differs	_
248-410	39618-39625	between	_
248-411	39626-39644	nicotine-dependent	_
248-412	39645-39652	smokers	_
248-413	39653-39656	and	_
248-414	39657-39668	non-smoking	_
248-415	39669-39677	controls	_
248-416	39678-39682	Dual	_
248-417	39683-39687	role	_
248-418	39688-39690	of	_
248-419	39691-39699	nicotine	_
248-420	39700-39702	in	_
248-421	39703-39712	addiction	_
248-422	39713-39716	and	_
248-423	39717-39726	cognition	_
248-424	39726-39727	:	_
248-425	39728-39729	a	_
248-426	39730-39736	review	_
248-427	39737-39739	of	_
248-428	39740-39752	neuroimaging	_
248-429	39753-39760	studies	_
248-430	39761-39763	in	_
248-431	39764-39770	humans	_
248-432	39771-39773	On	_
248-433	39774-39777	the	_
248-434	39778-39790	relationship	_
248-435	39791-39798	between	_
248-436	39799-39809	seed-based	_
248-437	39810-39813	and	_
248-438	39814-39823	ICA-based	_
248-439	39824-39832	measures	_
248-440	39833-39835	of	_
248-441	39836-39846	functional	_
248-442	39847-39859	connectivity	_
248-443	39860-39864	Loss	_
248-444	39865-39867	in	_
248-445	39868-39880	connectivity	_
248-446	39881-39886	among	_
248-447	39887-39894	regions	_
248-448	39895-39897	of	_
248-449	39898-39901	the	_
248-450	39902-39907	brain	_
248-451	39908-39914	reward	_
248-452	39915-39921	system	_
248-453	39922-39924	in	_
248-454	39925-39932	alcohol	_
248-455	39933-39943	dependence	_
248-456	39944-39953	Cognitive	_
248-457	39954-39964	mechanisms	_
248-458	39965-39967	of	_
248-459	39968-39976	nicotine	_
248-460	39977-39979	on	_
248-461	39980-39986	visual	_
248-462	39987-39996	attention	_
248-463	39997-40006	Nicotinic	_
248-464	40007-40014	effects	_
248-465	40015-40017	on	_
248-466	40018-40027	cognitive	_
248-467	40028-40036	function	_
248-468	40036-40037	:	_
248-469	40038-40048	behavioral	_
248-470	40049-40065	characterization	_
248-471	40065-40066	,	_
248-472	40067-40082	pharmacological	_
248-473	40083-40096	specification	_
248-474	40096-40097	,	_
248-475	40098-40101	and	_
248-476	40102-40110	anatomic	_
248-477	40111-40123	localization	_
248-478	40124-40130	Review	_
248-479	40131-40133	of	_
248-480	40134-40141	methods	_
248-481	40142-40145	for	_
248-482	40146-40156	functional	_
248-483	40157-40162	brain	_
248-484	40163-40175	connectivity	_
248-485	40176-40185	detection	_
248-486	40186-40191	using	_
248-487	40192-40196	fMRI	_
248-488	40197-40204	Altered	_
248-489	40205-40210	brain	_
248-490	40211-40221	functional	_
248-491	40222-40230	networks	_
248-492	40231-40233	in	_
248-493	40234-40239	heavy	_
248-494	40240-40247	smokers	_
248-495	40248-40253	Right	_
248-496	40254-40262	anterior	_
248-497	40263-40269	insula	_
248-498	40270-40282	connectivity	_
248-499	40283-40285	is	_
248-500	40286-40295	important	_
248-501	40296-40299	for	_
248-502	40300-40311	cue-induced	_
248-503	40312-40319	craving	_
248-504	40320-40322	in	_
248-505	40323-40341	nicotine-dependent	_
248-506	40342-40349	smokers	_
248-507	40350-40352	24	_
248-508	40352-40353	-	_
248-509	40353-40354	h	_
248-510	40355-40362	smoking	_
248-511	40363-40373	abstinence	_
248-512	40374-40385	potentiates	_
248-513	40386-40395	fMRI-BOLD	_
248-514	40396-40406	activation	_
248-515	40407-40409	to	_
248-516	40410-40417	smoking	_
248-517	40418-40422	cues	_
248-518	40423-40425	in	_
248-519	40426-40434	cerebral	_
248-520	40435-40441	cortex	_
248-521	40442-40445	and	_
248-522	40446-40452	dorsal	_
248-523	40453-40461	striatum	_
248-524	40462-40465	The	_
248-525	40466-40473	resting	_
248-526	40474-40479	brain	_
248-527	40480-40482	of	_
248-528	40483-40493	alcoholics	_
248-529	40494-40496	Is	_
248-530	40497-40502	there	_
248-531	40503-40504	a	_
248-532	40505-40511	common	_
248-533	40512-40521	molecular	_
248-534	40522-40529	pathway	_
248-535	40530-40533	for	_
248-536	40534-40543	addiction	_
248-537	40543-40544	?	_

#Text=Thalamic glutamate decreases with cigarette smoking
#Text=Alcohol attenuates activation in the bilateral anterior insula during an emotional processing task: a pilot study
#Text=Machine learning classification of resting state functional connectivity predicts smoking status
#Text=Brain substrates of craving to alcohol cues in subjects with alcohol use disorder
#Text=Recruitment of additional brain regions to accomplish simple motor tasks in chronic alcohol-dependent patients
#Text=Neurocognitive deficits in alcoholics and social drinkers: a continuum?
249-1	40545-40553	Thalamic	_
249-2	40554-40563	glutamate	_
249-3	40564-40573	decreases	_
249-4	40574-40578	with	_
249-5	40579-40588	cigarette	_
249-6	40589-40596	smoking	_
249-7	40597-40604	Alcohol	_
249-8	40605-40615	attenuates	_
249-9	40616-40626	activation	_
249-10	40627-40629	in	_
249-11	40630-40633	the	_
249-12	40634-40643	bilateral	_
249-13	40644-40652	anterior	_
249-14	40653-40659	insula	_
249-15	40660-40666	during	_
249-16	40667-40669	an	_
249-17	40670-40679	emotional	_
249-18	40680-40690	processing	_
249-19	40691-40695	task	_
249-20	40695-40696	:	_
249-21	40697-40698	a	_
249-22	40699-40704	pilot	_
249-23	40705-40710	study	_
249-24	40711-40718	Machine	_
249-25	40719-40727	learning	_
249-26	40728-40742	classification	_
249-27	40743-40745	of	_
249-28	40746-40753	resting	_
249-29	40754-40759	state	_
249-30	40760-40770	functional	_
249-31	40771-40783	connectivity	_
249-32	40784-40792	predicts	_
249-33	40793-40800	smoking	_
249-34	40801-40807	status	_
249-35	40808-40813	Brain	_
249-36	40814-40824	substrates	_
249-37	40825-40827	of	_
249-38	40828-40835	craving	_
249-39	40836-40838	to	_
249-40	40839-40846	alcohol	_
249-41	40847-40851	cues	_
249-42	40852-40854	in	_
249-43	40855-40863	subjects	_
249-44	40864-40868	with	_
249-45	40869-40876	alcohol	_
249-46	40877-40880	use	_
249-47	40881-40889	disorder	_
249-48	40890-40901	Recruitment	_
249-49	40902-40904	of	_
249-50	40905-40915	additional	_
249-51	40916-40921	brain	_
249-52	40922-40929	regions	_
249-53	40930-40932	to	_
249-54	40933-40943	accomplish	_
249-55	40944-40950	simple	_
249-56	40951-40956	motor	_
249-57	40957-40962	tasks	_
249-58	40963-40965	in	_
249-59	40966-40973	chronic	_
249-60	40974-40991	alcohol-dependent	_
249-61	40992-41000	patients	_
249-62	41001-41015	Neurocognitive	_
249-63	41016-41024	deficits	_
249-64	41025-41027	in	_
249-65	41028-41038	alcoholics	_
249-66	41039-41042	and	_
249-67	41043-41049	social	_
249-68	41050-41058	drinkers	_
249-69	41058-41059	:	_
249-70	41060-41061	a	_
249-71	41062-41071	continuum	_
249-72	41071-41072	?	_

#Text=In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism
#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Regional brain activity correlates of nicotine dependence
#Text=Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II
#Text=Decoding subject-driven cognitive states with whole-brain connectivity patterns
#Text=Loss of brain graph network efficiency in alcohol dependence
#Text=Resting state functional connectivity in addiction: lessons learned and a road ahead
#Text=Nicotine effects on default mode network during resting state
#Text=The effect of preprocessing pipelines in subject classification and detection of abnormal resting state functional network connectivity using group ICA
#Text=A hyper-connected but less efficient small-world network in the substance-dependent brain
#Text=Reduced left executive control network functional connectivity is associated with alcohol use disorders
#Text=Effects of smoking on rapid information processing performance
#Text=Model-free functional connectivity and impulsivity correlates of alcohol dependence: a resting-state study
#Text=Item revisions in the sensation seeking scale form V (SSS-V)
#Text=Set of 39 RSNs considered in this work.
250-1	41073-41075	In	_
250-2	41076-41080	vivo	_
250-3	41081-41090	detection	_
250-4	41091-41094	and	_
250-5	41095-41105	functional	_
250-6	41106-41116	correlates	_
250-7	41117-41119	of	_
250-8	41120-41125	white	_
250-9	41126-41132	matter	_
250-10	41133-41148	microstructural	_
250-11	41149-41159	disruption	_
250-12	41160-41162	in	_
250-13	41163-41170	chronic	_
250-14	41171-41181	alcoholism	_
250-15	41182-41190	Spurious	_
250-16	41191-41194	but	_
250-17	41195-41205	systematic	_
250-18	41206-41218	correlations	_
250-19	41219-41221	in	_
250-20	41222-41232	functional	_
250-21	41233-41245	connectivity	_
250-22	41246-41249	MRI	_
250-23	41250-41258	networks	_
250-24	41259-41264	arise	_
250-25	41265-41269	from	_
250-26	41270-41277	subject	_
250-27	41278-41284	motion	_
250-28	41285-41293	Regional	_
250-29	41294-41299	brain	_
250-30	41300-41308	activity	_
250-31	41309-41319	correlates	_
250-32	41320-41322	of	_
250-33	41323-41331	nicotine	_
250-34	41332-41342	dependence	_
250-35	41343-41354	Development	_
250-36	41355-41357	of	_
250-37	41358-41361	the	_
250-38	41362-41369	alcohol	_
250-39	41370-41373	use	_
250-40	41374-41383	disorders	_
250-41	41384-41398	identification	_
250-42	41399-41403	test	_
250-43	41404-41405	(	_
250-44	41405-41410	AUDIT	_
250-45	41410-41411	)	_
250-46	41411-41412	:	_
250-47	41413-41416	WHO	_
250-48	41417-41430	collaborative	_
250-49	41431-41438	project	_
250-50	41439-41441	on	_
250-51	41442-41447	early	_
250-52	41448-41457	detection	_
250-53	41458-41460	of	_
250-54	41461-41468	persons	_
250-55	41469-41473	with	_
250-56	41474-41481	harmful	_
250-57	41482-41489	alcohol	_
250-58	41490-41504	consumption-II	_
250-59	41505-41513	Decoding	_
250-60	41514-41528	subject-driven	_
250-61	41529-41538	cognitive	_
250-62	41539-41545	states	_
250-63	41546-41550	with	_
250-64	41551-41562	whole-brain	_
250-65	41563-41575	connectivity	_
250-66	41576-41584	patterns	_
250-67	41585-41589	Loss	_
250-68	41590-41592	of	_
250-69	41593-41598	brain	_
250-70	41599-41604	graph	_
250-71	41605-41612	network	_
250-72	41613-41623	efficiency	_
250-73	41624-41626	in	_
250-74	41627-41634	alcohol	_
250-75	41635-41645	dependence	_
250-76	41646-41653	Resting	_
250-77	41654-41659	state	_
250-78	41660-41670	functional	_
250-79	41671-41683	connectivity	_
250-80	41684-41686	in	_
250-81	41687-41696	addiction	_
250-82	41696-41697	:	_
250-83	41698-41705	lessons	_
250-84	41706-41713	learned	_
250-85	41714-41717	and	_
250-86	41718-41719	a	_
250-87	41720-41724	road	_
250-88	41725-41730	ahead	_
250-89	41731-41739	Nicotine	_
250-90	41740-41747	effects	_
250-91	41748-41750	on	_
250-92	41751-41758	default	_
250-93	41759-41763	mode	_
250-94	41764-41771	network	_
250-95	41772-41778	during	_
250-96	41779-41786	resting	_
250-97	41787-41792	state	_
250-98	41793-41796	The	_
250-99	41797-41803	effect	_
250-100	41804-41806	of	_
250-101	41807-41820	preprocessing	_
250-102	41821-41830	pipelines	_
250-103	41831-41833	in	_
250-104	41834-41841	subject	_
250-105	41842-41856	classification	_
250-106	41857-41860	and	_
250-107	41861-41870	detection	_
250-108	41871-41873	of	_
250-109	41874-41882	abnormal	_
250-110	41883-41890	resting	_
250-111	41891-41896	state	_
250-112	41897-41907	functional	_
250-113	41908-41915	network	_
250-114	41916-41928	connectivity	_
250-115	41929-41934	using	_
250-116	41935-41940	group	_
250-117	41941-41944	ICA	_
250-118	41945-41946	A	_
250-119	41947-41962	hyper-connected	_
250-120	41963-41966	but	_
250-121	41967-41971	less	_
250-122	41972-41981	efficient	_
250-123	41982-41993	small-world	_
250-124	41994-42001	network	_
250-125	42002-42004	in	_
250-126	42005-42008	the	_
250-127	42009-42028	substance-dependent	_
250-128	42029-42034	brain	_
250-129	42035-42042	Reduced	_
250-130	42043-42047	left	_
250-131	42048-42057	executive	_
250-132	42058-42065	control	_
250-133	42066-42073	network	_
250-134	42074-42084	functional	_
250-135	42085-42097	connectivity	_
250-136	42098-42100	is	_
250-137	42101-42111	associated	_
250-138	42112-42116	with	_
250-139	42117-42124	alcohol	_
250-140	42125-42128	use	_
250-141	42129-42138	disorders	_
250-142	42139-42146	Effects	_
250-143	42147-42149	of	_
250-144	42150-42157	smoking	_
250-145	42158-42160	on	_
250-146	42161-42166	rapid	_
250-147	42167-42178	information	_
250-148	42179-42189	processing	_
250-149	42190-42201	performance	_
250-150	42202-42212	Model-free	_
250-151	42213-42223	functional	_
250-152	42224-42236	connectivity	_
250-153	42237-42240	and	_
250-154	42241-42252	impulsivity	_
250-155	42253-42263	correlates	_
250-156	42264-42266	of	_
250-157	42267-42274	alcohol	_
250-158	42275-42285	dependence	_
250-159	42285-42286	:	_
250-160	42287-42288	a	_
250-161	42289-42302	resting-state	_
250-162	42303-42308	study	_
250-163	42309-42313	Item	_
250-164	42314-42323	revisions	_
250-165	42324-42326	in	_
250-166	42327-42330	the	_
250-167	42331-42340	sensation	_
250-168	42341-42348	seeking	_
250-169	42349-42354	scale	_
250-170	42355-42359	form	_
250-171	42360-42361	V	_
250-172	42362-42363	(	_
250-173	42363-42368	SSS-V	_
250-174	42368-42369	)	_
250-175	42370-42373	Set	_
250-176	42374-42376	of	_
250-177	42377-42379	39	_
250-178	42380-42384	RSNs	_
250-179	42385-42395	considered	_
250-180	42396-42398	in	_
250-181	42399-42403	this	_
250-182	42404-42408	work	_
250-183	42408-42409	.	_

#Text=The figure was obtained using the spatial t-maps of each RSN.
251-1	42410-42413	The	_
251-2	42414-42420	figure	_
251-3	42421-42424	was	_
251-4	42425-42433	obtained	_
251-5	42434-42439	using	_
251-6	42440-42443	the	_
251-7	42444-42451	spatial	_
251-8	42452-42458	t-maps	_
251-9	42459-42461	of	_
251-10	42462-42466	each	_
251-11	42467-42470	RSN	_
251-12	42470-42471	.	_

#Text=This set has been selected from a gICA decomposition with 100 components.
252-1	42472-42476	This	_
252-2	42477-42480	set	_
252-3	42481-42484	has	_
252-4	42485-42489	been	_
252-5	42490-42498	selected	_
252-6	42499-42503	from	_
252-7	42504-42505	a	_
252-8	42506-42510	gICA	_
252-9	42511-42524	decomposition	_
252-10	42525-42529	with	_
252-11	42530-42533	100	_
252-12	42534-42544	components	_
252-13	42544-42545	.	_

#Text=A total of 61 gICA components were discarded based on frequency spectrum, peak activation located outside grey matter areas and visual inspection.
253-1	42546-42547	A	_
253-2	42548-42553	total	_
253-3	42554-42556	of	_
253-4	42557-42559	61	_
253-5	42560-42564	gICA	_
253-6	42565-42575	components	_
253-7	42576-42580	were	_
253-8	42581-42590	discarded	_
253-9	42591-42596	based	_
253-10	42597-42599	on	_
253-11	42600-42609	frequency	_
253-12	42610-42618	spectrum	_
253-13	42618-42619	,	_
253-14	42620-42624	peak	_
253-15	42625-42635	activation	_
253-16	42636-42643	located	_
253-17	42644-42651	outside	_
253-18	42652-42656	grey	_
253-19	42657-42663	matter	_
253-20	42664-42669	areas	_
253-21	42670-42673	and	_
253-22	42674-42680	visual	_
253-23	42681-42691	inspection	_
253-24	42691-42692	.	_

#Text=Peak activation coordinates can be found in Table.
254-1	42693-42697	Peak	_
254-2	42698-42708	activation	_
254-3	42709-42720	coordinates	_
254-4	42721-42724	can	_
254-5	42725-42727	be	_
254-6	42728-42733	found	_
254-7	42734-42736	in	_
254-8	42737-42742	Table	_
254-9	42742-42743	.	_

#Text=Mean rsFNC matrices for each sample group.
255-1	42744-42748	Mean	_
255-2	42749-42754	rsFNC	_
255-3	42755-42763	matrices	_
255-4	42764-42767	for	_
255-5	42768-42772	each	_
255-6	42773-42779	sample	_
255-7	42780-42785	group	_
255-8	42785-42786	.	_

#Text=CTR and SMK matrices are very similar with very few differences difficult to identify.
256-1	42787-42790	CTR	_
256-2	42791-42794	and	_
256-3	42795-42798	SMK	_
256-4	42799-42807	matrices	_
256-5	42808-42811	are	_
256-6	42812-42816	very	_
256-7	42817-42824	similar	_
256-8	42825-42829	with	_
256-9	42830-42834	very	_
256-10	42835-42838	few	_
256-11	42839-42850	differences	_
256-12	42851-42860	difficult	_
256-13	42861-42863	to	_
256-14	42864-42872	identify	_
256-15	42872-42873	.	_

#Text=The DRN and SAD matrices exhibit stronger differences compared to CTR between VIS-SEN, VISSAL and SEN-PRE groups.
257-1	42874-42877	The	_
257-2	42878-42881	DRN	_
257-3	42882-42885	and	_
257-4	42886-42889	SAD	_
257-5	42890-42898	matrices	_
257-6	42899-42906	exhibit	_
257-7	42907-42915	stronger	_
257-8	42916-42927	differences	_
257-9	42928-42936	compared	_
257-10	42937-42939	to	_
257-11	42940-42943	CTR	_
257-12	42944-42951	between	_
257-13	42952-42959	VIS-SEN	_
257-14	42959-42960	,	_
257-15	42961-42967	VISSAL	_
257-16	42968-42971	and	_
257-17	42972-42979	SEN-PRE	_
257-18	42980-42986	groups	_
257-19	42986-42987	.	_

#Text=Histogram summarizing significant rsFNC differences.
258-1	42988-42997	Histogram	_
258-2	42998-43009	summarizing	_
258-3	43010-43021	significant	_
258-4	43022-43027	rsFNC	_
258-5	43028-43039	differences	_
258-6	43039-43040	.	_

#Text=The Fisher r-to-z transformation was applied to all correlation values and the color scale was restricted to the range [−1 1].
259-1	43041-43044	The	_
259-2	43045-43051	Fisher	_
259-3	43052-43058	r-to-z	_
259-4	43059-43073	transformation	_
259-5	43074-43077	was	_
259-6	43078-43085	applied	_
259-7	43086-43088	to	_
259-8	43089-43092	all	_
259-9	43093-43104	correlation	_
259-10	43105-43111	values	_
259-11	43112-43115	and	_
259-12	43116-43119	the	_
259-13	43120-43125	color	_
259-14	43126-43131	scale	_
259-15	43132-43135	was	_
259-16	43136-43146	restricted	_
259-17	43147-43149	to	_
259-18	43150-43153	the	_
259-19	43154-43159	range	_
259-20	43160-43161	[	_
259-21	43161-43162	−	_
259-22	43162-43163	1	_
259-23	43164-43165	1	_
259-24	43165-43166	]	_
259-25	43166-43167	.	_

#Text=Results were classified according to the significance found on the sample groups.
260-1	43168-43175	Results	_
260-2	43176-43180	were	_
260-3	43181-43191	classified	_
260-4	43192-43201	according	_
260-5	43202-43204	to	_
260-6	43205-43208	the	_
260-7	43209-43221	significance	_
260-8	43222-43227	found	_
260-9	43228-43230	on	_
260-10	43231-43234	the	_
260-11	43235-43241	sample	_
260-12	43242-43248	groups	_
260-13	43248-43249	.	_

#Text=In those driven by “Smoking and Drinking” either the SAD group was different from CTR or both DRN and SMK groups were different.
261-1	43250-43252	In	_
261-2	43253-43258	those	_
261-3	43259-43265	driven	_
261-4	43266-43268	by	_
261-5	43269-43270	“	_
261-6	43270-43277	Smoking	_
261-7	43278-43281	and	_
261-8	43282-43290	Drinking	_
261-9	43290-43291	”	_
261-10	43292-43298	either	_
261-11	43299-43302	the	_
261-12	43303-43306	SAD	_
261-13	43307-43312	group	_
261-14	43313-43316	was	_
261-15	43317-43326	different	_
261-16	43327-43331	from	_
261-17	43332-43335	CTR	_
261-18	43336-43338	or	_
261-19	43339-43343	both	_
261-20	43344-43347	DRN	_
261-21	43348-43351	and	_
261-22	43352-43355	SMK	_
261-23	43356-43362	groups	_
261-24	43363-43367	were	_
261-25	43368-43377	different	_
261-26	43377-43378	.	_

#Text=Driven by Drinking: only DRN was different from CTR.
262-1	43379-43385	Driven	_
262-2	43386-43388	by	_
262-3	43389-43397	Drinking	_
262-4	43397-43398	:	_
262-5	43399-43403	only	_
262-6	43404-43407	DRN	_
262-7	43408-43411	was	_
262-8	43412-43421	different	_
262-9	43422-43426	from	_
262-10	43427-43430	CTR	_
262-11	43430-43431	.	_

#Text=Driven by Smoking: only SMK was different from CTR.
263-1	43432-43438	Driven	_
263-2	43439-43441	by	_
263-3	43442-43449	Smoking	_
263-4	43449-43450	:	_
263-5	43451-43455	only	_
263-6	43456-43459	SMK	_
263-7	43460-43463	was	_
263-8	43464-43473	different	_
263-9	43474-43478	from	_
263-10	43479-43482	CTR	_
263-11	43482-43483	.	_

#Text=Significance is presented in the black and white histograms on the right.
264-1	43484-43496	Significance	_
264-2	43497-43499	is	_
264-3	43500-43509	presented	_
264-4	43510-43512	in	_
264-5	43513-43516	the	_
264-6	43517-43522	black	_
264-7	43523-43526	and	_
264-8	43527-43532	white	_
264-9	43533-43543	histograms	_
264-10	43544-43546	on	_
264-11	43547-43550	the	_
264-12	43551-43556	right	_
264-13	43556-43557	.	_

#Text=In those, one of the groups is set as baseline or reference and labeled as (REF).
265-1	43558-43560	In	_
265-2	43561-43566	those	_
265-3	43566-43567	,	_
265-4	43568-43571	one	_
265-5	43572-43574	of	_
265-6	43575-43578	the	_
265-7	43579-43585	groups	_
265-8	43586-43588	is	_
265-9	43589-43592	set	_
265-10	43593-43595	as	_
265-11	43596-43604	baseline	_
265-12	43605-43607	or	_
265-13	43608-43617	reference	_
265-14	43618-43621	and	_
265-15	43622-43629	labeled	_
265-16	43630-43632	as	_
265-17	43633-43634	(	_
265-18	43634-43637	REF	_
265-19	43637-43638	)	_
265-20	43638-43639	.	_

#Text=Significant relationship with AUDIT is labeled as “A”, with FTND as “F”, and the interaction AUDIT-FTND as “AF”.
266-1	43640-43651	Significant	_
266-2	43652-43664	relationship	_
266-3	43665-43669	with	_
266-4	43670-43675	AUDIT	_
266-5	43676-43678	is	_
266-6	43679-43686	labeled	_
266-7	43687-43689	as	_
266-8	43690-43691	“	_
266-9	43691-43692	A	_
266-10	43692-43693	”	_
266-11	43693-43694	,	_
266-12	43695-43699	with	_
266-13	43700-43704	FTND	_
266-14	43705-43707	as	_
266-15	43708-43709	“	_
266-16	43709-43710	F	_
266-17	43710-43711	”	_
266-18	43711-43712	,	_
266-19	43713-43716	and	_
266-20	43717-43720	the	_
266-21	43721-43732	interaction	_
266-22	43733-43743	AUDIT-FTND	_
266-23	43744-43746	as	_
266-24	43747-43748	“	_
266-25	43748-43750	AF	_
266-26	43750-43751	”	_
266-27	43751-43752	.	_

#Text=Networks with significant rsFNC differences.
267-1	43753-43761	Networks	_
267-2	43762-43766	with	_
267-3	43767-43778	significant	_
267-4	43779-43784	rsFNC	_
267-5	43785-43796	differences	_
267-6	43796-43797	.	_

#Text=In this figure, changes in rsFNC are compared with respect to controls.
268-1	43798-43800	In	_
268-2	43801-43805	this	_
268-3	43806-43812	figure	_
268-4	43812-43813	,	_
268-5	43814-43821	changes	_
268-6	43822-43824	in	_
268-7	43825-43830	rsFNC	_
268-8	43831-43834	are	_
268-9	43835-43843	compared	_
268-10	43844-43848	with	_
268-11	43849-43856	respect	_
268-12	43857-43859	to	_
268-13	43860-43868	controls	_
268-14	43868-43869	.	_

#Text=Blue dots indicate the position of RSNs where hypo-connectivity was observed.
269-1	43870-43874	Blue	_
269-2	43875-43879	dots	_
269-3	43880-43888	indicate	_
269-4	43889-43892	the	_
269-5	43893-43901	position	_
269-6	43902-43904	of	_
269-7	43905-43909	RSNs	_
269-8	43910-43915	where	_
269-9	43916-43933	hypo-connectivity	_
269-10	43934-43937	was	_
269-11	43938-43946	observed	_
269-12	43946-43947	.	_

#Text=Hypo-connectivity is the most common observation among rsFNCs driven by “Smoking and Drinking”.
270-1	43948-43965	Hypo-connectivity	_
270-2	43966-43968	is	_
270-3	43969-43972	the	_
270-4	43973-43977	most	_
270-5	43978-43984	common	_
270-6	43985-43996	observation	_
270-7	43997-44002	among	_
270-8	44003-44009	rsFNCs	_
270-9	44010-44016	driven	_
270-10	44017-44019	by	_
270-11	44020-44021	“	_
270-12	44021-44028	Smoking	_
270-13	44029-44032	and	_
270-14	44033-44041	Drinking	_
270-15	44041-44042	”	_
270-16	44042-44043	.	_

#Text=Red dots designate RSNs with hyper-connectivity.
271-1	44044-44047	Red	_
271-2	44048-44052	dots	_
271-3	44053-44062	designate	_
271-4	44063-44067	RSNs	_
271-5	44068-44072	with	_
271-6	44073-44091	hyper-connectivity	_
271-7	44091-44092	.	_

#Text=Hyper-connected RSNs were found in rsFNC driven by “Drinking” alone and “Smoking” alone.
272-1	44093-44108	Hyper-connected	_
272-2	44109-44113	RSNs	_
272-3	44114-44118	were	_
272-4	44119-44124	found	_
272-5	44125-44127	in	_
272-6	44128-44133	rsFNC	_
272-7	44134-44140	driven	_
272-8	44141-44143	by	_
272-9	44144-44145	“	_
272-10	44145-44153	Drinking	_
272-11	44153-44154	”	_
272-12	44155-44160	alone	_
272-13	44161-44164	and	_
272-14	44165-44166	“	_
272-15	44166-44173	Smoking	_
272-16	44173-44174	”	_
272-17	44175-44180	alone	_
272-18	44180-44181	.	_

#Text=The yellow dots were use for the RSN pair where smokers had increased negative connectivity (anti-correlation), but the drinkers exhibited decreased negative connectivity.
273-1	44182-44185	The	_
273-2	44186-44192	yellow	_
273-3	44193-44197	dots	_
273-4	44198-44202	were	_
273-5	44203-44206	use	_
273-6	44207-44210	for	_
273-7	44211-44214	the	_
273-8	44215-44218	RSN	_
273-9	44219-44223	pair	_
273-10	44224-44229	where	_
273-11	44230-44237	smokers	_
273-12	44238-44241	had	_
273-13	44242-44251	increased	_
273-14	44252-44260	negative	_
273-15	44261-44273	connectivity	_
273-16	44274-44275	(	_
273-17	44275-44291	anti-correlation	_
273-18	44291-44292	)	_
273-19	44292-44293	,	_
273-20	44294-44297	but	_
273-21	44298-44301	the	_
273-22	44302-44310	drinkers	_
273-23	44311-44320	exhibited	_
273-24	44321-44330	decreased	_
273-25	44331-44339	negative	_
273-26	44340-44352	connectivity	_
273-27	44352-44353	.	_

#Text=Subject Demographics by Groups.
274-1	44354-44361	Subject	_
274-2	44362-44374	Demographics	_
274-3	44375-44377	by	_
274-4	44378-44384	Groups	_
274-5	44384-44385	.	_

#Text=CTR\tSMK\tDRN\tSAD\t \tSize\t51\t73\t28\t36\t \tFemales\t18(35.3%)\t29(39.7%)\t12(42.9%)\t12(33.3%)\t \t\tµ\tσ\tµ\tσ\tµ\tσ\tµ\tσ\t \tAge\t34.6\t11.3\t33.9\t9.2\t29.8\t7.6\t33.0\t6.7\t \t*FTND\t0\t0\t9.0\t1.4\t2.96\t0.9\t9.0\t1.5\t \t*AUDIT\tN/A\tN/A\t2.8\t2.15\t15.3\t5.3\t14.8\t6.5\t \t*BDI\tN/A\tN/A\t5.1\t5.7\t8.7\t6.5\t8.0\t7.16\t \t*ImpSS\tN/A\tN/A\t8.0\t4.6\t9.4\t4.3\t11.0\t5.9\t \tIncome\tN/A\tN/A\t2.8\t1.8\t2.4\t1.6\t2.9\t1.8\t \t
#Text=The 188 subjects were grouped according to substance use into controls (CTR) that do not drink or smoke, smoking and drinking subjects (SAD) that use both substances, pure drinkers (DRN) and pure smokers (SMK) comprised of subjects that regularly use one of the two substances.
275-1	44387-44390	CTR	_
275-2	44391-44394	SMK	_
275-3	44395-44398	DRN	_
275-4	44399-44402	SAD	_
275-5	44405-44409	Size	_
275-6	44410-44412	51	_
275-7	44413-44415	73	_
275-8	44416-44418	28	_
275-9	44419-44421	36	_
275-10	44424-44431	Females	_
275-11	44432-44434	18	_
275-12	44434-44435	(	_
275-13	44435-44440	35.3%	_
275-14	44440-44441	)	_
275-15	44442-44444	29	_
275-16	44444-44445	(	_
275-17	44445-44450	39.7%	_
275-18	44450-44451	)	_
275-19	44452-44454	12	_
275-20	44454-44455	(	_
275-21	44455-44460	42.9%	_
275-22	44460-44461	)	_
275-23	44462-44464	12	_
275-24	44464-44465	(	_
275-25	44465-44470	33.3%	_
275-26	44470-44471	)	_
275-27	44475-44476	µ	_
275-28	44477-44478	σ	_
275-29	44479-44480	µ	_
275-30	44481-44482	σ	_
275-31	44483-44484	µ	_
275-32	44485-44486	σ	_
275-33	44487-44488	µ	_
275-34	44489-44490	σ	_
275-35	44493-44496	Age	_
275-36	44497-44501	34.6	_
275-37	44502-44506	11.3	_
275-38	44507-44511	33.9	_
275-39	44512-44515	9.2	_
275-40	44516-44520	29.8	_
275-41	44521-44524	7.6	_
275-42	44525-44529	33.0	_
275-43	44530-44533	6.7	_
275-44	44536-44537	*	_
275-45	44537-44541	FTND	_
275-46	44542-44543	0	_
275-47	44544-44545	0	_
275-48	44546-44549	9.0	_
275-49	44550-44553	1.4	_
275-50	44554-44558	2.96	_
275-51	44559-44562	0.9	_
275-52	44563-44566	9.0	_
275-53	44567-44570	1.5	_
275-54	44573-44574	*	_
275-55	44574-44579	AUDIT	_
275-56	44580-44581	N	_
275-57	44581-44582	/	_
275-58	44582-44583	A	_
275-59	44584-44585	N	_
275-60	44585-44586	/	_
275-61	44586-44587	A	_
275-62	44588-44591	2.8	_
275-63	44592-44596	2.15	_
275-64	44597-44601	15.3	_
275-65	44602-44605	5.3	_
275-66	44606-44610	14.8	_
275-67	44611-44614	6.5	_
275-68	44617-44618	*	_
275-69	44618-44621	BDI	_
275-70	44622-44623	N	_
275-71	44623-44624	/	_
275-72	44624-44625	A	_
275-73	44626-44627	N	_
275-74	44627-44628	/	_
275-75	44628-44629	A	_
275-76	44630-44633	5.1	_
275-77	44634-44637	5.7	_
275-78	44638-44641	8.7	_
275-79	44642-44645	6.5	_
275-80	44646-44649	8.0	_
275-81	44650-44654	7.16	_
275-82	44657-44658	*	_
275-83	44658-44663	ImpSS	_
275-84	44664-44665	N	_
275-85	44665-44666	/	_
275-86	44666-44667	A	_
275-87	44668-44669	N	_
275-88	44669-44670	/	_
275-89	44670-44671	A	_
275-90	44672-44675	8.0	_
275-91	44676-44679	4.6	_
275-92	44680-44683	9.4	_
275-93	44684-44687	4.3	_
275-94	44688-44692	11.0	_
275-95	44693-44696	5.9	_
275-96	44699-44705	Income	_
275-97	44706-44707	N	_
275-98	44707-44708	/	_
275-99	44708-44709	A	_
275-100	44710-44711	N	_
275-101	44711-44712	/	_
275-102	44712-44713	A	_
275-103	44714-44717	2.8	_
275-104	44718-44721	1.8	_
275-105	44722-44725	2.4	_
275-106	44726-44729	1.6	_
275-107	44730-44733	2.9	_
275-108	44734-44737	1.8	_
275-109	44741-44744	The	_
275-110	44745-44748	188	_
275-111	44749-44757	subjects	_
275-112	44758-44762	were	_
275-113	44763-44770	grouped	_
275-114	44771-44780	according	_
275-115	44781-44783	to	_
275-116	44784-44793	substance	_
275-117	44794-44797	use	_
275-118	44798-44802	into	_
275-119	44803-44811	controls	_
275-120	44812-44813	(	_
275-121	44813-44816	CTR	_
275-122	44816-44817	)	_
275-123	44818-44822	that	_
275-124	44823-44825	do	_
275-125	44826-44829	not	_
275-126	44830-44835	drink	_
275-127	44836-44838	or	_
275-128	44839-44844	smoke	_
275-129	44844-44845	,	_
275-130	44846-44853	smoking	_
275-131	44854-44857	and	_
275-132	44858-44866	drinking	_
275-133	44867-44875	subjects	_
275-134	44876-44877	(	_
275-135	44877-44880	SAD	_
275-136	44880-44881	)	_
275-137	44882-44886	that	_
275-138	44887-44890	use	_
275-139	44891-44895	both	_
275-140	44896-44906	substances	_
275-141	44906-44907	,	_
275-142	44908-44912	pure	_
275-143	44913-44921	drinkers	_
275-144	44922-44923	(	_
275-145	44923-44926	DRN	_
275-146	44926-44927	)	_
275-147	44928-44931	and	_
275-148	44932-44936	pure	_
275-149	44937-44944	smokers	_
275-150	44945-44946	(	_
275-151	44946-44949	SMK	_
275-152	44949-44950	)	_
275-153	44951-44960	comprised	_
275-154	44961-44963	of	_
275-155	44964-44972	subjects	_
275-156	44973-44977	that	_
275-157	44978-44987	regularly	_
275-158	44988-44991	use	_
275-159	44992-44995	one	_
275-160	44996-44998	of	_
275-161	44999-45002	the	_
275-162	45003-45006	two	_
275-163	45007-45017	substances	_
275-164	45017-45018	.	_

#Text=Group differences were assessed using one way ANOVA.
276-1	45019-45024	Group	_
276-2	45025-45036	differences	_
276-3	45037-45041	were	_
276-4	45042-45050	assessed	_
276-5	45051-45056	using	_
276-6	45057-45060	one	_
276-7	45061-45064	way	_
276-8	45065-45070	ANOVA	_
276-9	45070-45071	.	_

#Text=Significant ANOVA tests (p < 0.05) are indicated with an asterisk *.
277-1	45072-45083	Significant	_
277-2	45084-45089	ANOVA	_
277-3	45090-45095	tests	_
277-4	45096-45097	(	_
277-5	45097-45098	p	_
277-6	45099-45100	<	_
277-7	45101-45105	0.05	_
277-8	45105-45106	)	_
277-9	45107-45110	are	_
277-10	45111-45120	indicated	_
277-11	45121-45125	with	_
277-12	45126-45128	an	_
277-13	45129-45137	asterisk	_
277-14	45138-45139	*	_
277-15	45139-45140	.	_

#Text=Because of missing data for the CTR group, ANOVAs for AUDIT, BDI, ImpSS and Income included SMK, DRN and SAD groups only.
278-1	45141-45148	Because	_
278-2	45149-45151	of	_
278-3	45152-45159	missing	_
278-4	45160-45164	data	_
278-5	45165-45168	for	_
278-6	45169-45172	the	_
278-7	45173-45176	CTR	_
278-8	45177-45182	group	_
278-9	45182-45183	,	_
278-10	45184-45190	ANOVAs	_
278-11	45191-45194	for	_
278-12	45195-45200	AUDIT	_
278-13	45200-45201	,	_
278-14	45202-45205	BDI	_
278-15	45205-45206	,	_
278-16	45207-45212	ImpSS	_
278-17	45213-45216	and	_
278-18	45217-45223	Income	_
278-19	45224-45232	included	_
278-20	45233-45236	SMK	_
278-21	45236-45237	,	_
278-22	45238-45241	DRN	_
278-23	45242-45245	and	_
278-24	45246-45249	SAD	_
278-25	45250-45256	groups	_
278-26	45257-45261	only	_
278-27	45261-45262	.	_

#Text=List of the 39 RSNs and peak activations.
279-1	45263-45267	List	_
279-2	45268-45270	of	_
279-3	45271-45274	the	_
279-4	45275-45277	39	_
279-5	45278-45282	RSNs	_
279-6	45283-45286	and	_
279-7	45287-45291	peak	_
279-8	45292-45303	activations	_
279-9	45303-45304	.	_

#Text=RSN Group\tBrain Region\tMNI-X\tMNI-Y\tMNI-Z\t \tSBC\tThalamus\t0\t−7\t8\t \tSBC\tPutamen\t24\t6\t−4\t \tSBC\tL Putamen/Caudate\t−18\t0\t9\t \tCER\tL Lb.
280-1	45305-45308	RSN	_
280-2	45309-45314	Group	_
280-3	45315-45320	Brain	_
280-4	45321-45327	Region	_
280-5	45328-45333	MNI-X	_
280-6	45334-45339	MNI-Y	_
280-7	45340-45345	MNI-Z	_
280-8	45348-45351	SBC	_
280-9	45352-45360	Thalamus	_
280-10	45361-45362	0	_
280-11	45363-45364	−	_
280-12	45364-45365	7	_
280-13	45366-45367	8	_
280-14	45370-45373	SBC	_
280-15	45374-45381	Putamen	_
280-16	45382-45384	24	_
280-17	45385-45386	6	_
280-18	45387-45388	−	_
280-19	45388-45389	4	_
280-20	45392-45395	SBC	_
280-21	45396-45397	L	_
280-22	45398-45405	Putamen	_
280-23	45405-45406	/	_
280-24	45406-45413	Caudate	_
280-25	45414-45415	−	_
280-26	45415-45417	18	_
280-27	45418-45419	0	_
280-28	45420-45421	9	_
280-29	45424-45427	CER	_
280-30	45428-45429	L	_
280-31	45430-45432	Lb	_
280-32	45432-45433	.	_

#Text=VIIa Crus I\t−32\t−73\t−38\t \tCER\tR Lb.
281-1	45434-45438	VIIa	_
281-2	45439-45443	Crus	_
281-3	45444-45445	I	_
281-4	45446-45447	−	_
281-5	45447-45449	32	_
281-6	45450-45451	−	_
281-7	45451-45453	73	_
281-8	45454-45455	−	_
281-9	45455-45457	38	_
281-10	45460-45463	CER	_
281-11	45464-45465	R	_
281-12	45466-45468	Lb	_
281-13	45468-45469	.	_

#Text=VIIa Crus I\t40\t−64\t−37\t \tAUD\tR Heschl’s Gyrus\t42\t−19\t6\t \tSEN\tPostcentral-3b\t55\t−12\t32\t \tSEN\tSMA-6\t0\t0\t52\t \tSEN\tL Postcentral-1\t−42\t−28\t59\t \tSEN\tSMA\t0\t−1\t74\t \tSEN\tR Postcentral-1\t46\t−27\t57\t \tSEN\tL Postcentral-1-3b\t−24\t−47\t69\t \tSEN\tR Postcentral-1-3b\t28\t−38\t70\t \tVIS\tR Fusiform/Lingual\t22\t−59\t−11\t \tVIS\tL Fusiform/Lingual\t−20\t−59\t−11\t \tVIS\tLingual\t0\t−79\t5\t \tVIS\tL MOG\t−30\t−85\t15\t \tVIS\tLingual/Vermis\t0\t−66\t−11\t \tVIS\tR SOG\t28\t−74\t42\t \tVIS\tR IOG\t48\t−68\t−11\t \tVIS\tL IOG\t−48\t−65\t−16\t \tSAL\tR Insula\t40\t19\t−6\t \tSAL\tR Supramarginal\t61\t−32\t27\t \tSAL\tL Insula\t−44\t−10\t2\t \tSAL\tR STG\t48\t3\t−12\t \tDMN\tACC\t0\t45\t5\t \tDMN\tL Angular\t−44\t−68\t36\t \tDMN\tPCC\t0\t−38\t26\t \tDMN\tPCC/Precuneus\t0\t−63\t31\t \tECN\tL IFG-44\t−44\t13\t33\t \tECN\tL IPL\t−48\t−44\t50\t \tECN\tR IFG-45\t48\t17\t29\t \tECN\tL IFG-45\t−44\t39\t15\t \tECN\tL MFG\t−24\t3\t61\t \tECN\tR IPL\t48\t−52\t45\t \tPRE\tPrecuneus-7m\t0\t−76\t44\t \tPRE\tCuneus\t0\t−86\t28\t \tPRE\tPrecuneus-7a\t0\t−69\t62\t \tPRE\tPrecuneus\t0\t−56\t10\t \t
#Text=RSNs were categorized in the following functional groups: SBC (subcortical), CER (cerebellum), AUD (auditory), SEN (sensorimotor), VIS (visual), SAL (salience), DMN (default mode network), ECN (executive control network) and PRE (precuneus).
282-1	45470-45474	VIIa	_
282-2	45475-45479	Crus	_
282-3	45480-45481	I	_
282-4	45482-45484	40	_
282-5	45485-45486	−	_
282-6	45486-45488	64	_
282-7	45489-45490	−	_
282-8	45490-45492	37	_
282-9	45495-45498	AUD	_
282-10	45499-45500	R	_
282-11	45501-45507	Heschl	_
282-12	45507-45508	’	_
282-13	45508-45509	s	_
282-14	45510-45515	Gyrus	_
282-15	45516-45518	42	_
282-16	45519-45520	−	_
282-17	45520-45522	19	_
282-18	45523-45524	6	_
282-19	45527-45530	SEN	_
282-20	45531-45542	Postcentral	_
282-21	45542-45543	-	_
282-22	45543-45545	3b	_
282-23	45546-45548	55	_
282-24	45549-45550	−	_
282-25	45550-45552	12	_
282-26	45553-45555	32	_
282-27	45558-45561	SEN	_
282-28	45562-45565	SMA	_
282-29	45565-45566	-	_
282-30	45566-45567	6	_
282-31	45568-45569	0	_
282-32	45570-45571	0	_
282-33	45572-45574	52	_
282-34	45577-45580	SEN	_
282-35	45581-45582	L	_
282-36	45583-45594	Postcentral	_
282-37	45594-45595	-	_
282-38	45595-45596	1	_
282-39	45597-45598	−	_
282-40	45598-45600	42	_
282-41	45601-45602	−	_
282-42	45602-45604	28	_
282-43	45605-45607	59	_
282-44	45610-45613	SEN	_
282-45	45614-45617	SMA	_
282-46	45618-45619	0	_
282-47	45620-45621	−	_
282-48	45621-45622	1	_
282-49	45623-45625	74	_
282-50	45628-45631	SEN	_
282-51	45632-45633	R	_
282-52	45634-45645	Postcentral	_
282-53	45645-45646	-	_
282-54	45646-45647	1	_
282-55	45648-45650	46	_
282-56	45651-45652	−	_
282-57	45652-45654	27	_
282-58	45655-45657	57	_
282-59	45660-45663	SEN	_
282-60	45664-45665	L	_
282-61	45666-45677	Postcentral	_
282-62	45677-45678	-	_
282-63	45678-45679	1	_
282-64	45679-45680	-	_
282-65	45680-45682	3b	_
282-66	45683-45684	−	_
282-67	45684-45686	24	_
282-68	45687-45688	−	_
282-69	45688-45690	47	_
282-70	45691-45693	69	_
282-71	45696-45699	SEN	_
282-72	45700-45701	R	_
282-73	45702-45713	Postcentral	_
282-74	45713-45714	-	_
282-75	45714-45715	1	_
282-76	45715-45716	-	_
282-77	45716-45718	3b	_
282-78	45719-45721	28	_
282-79	45722-45723	−	_
282-80	45723-45725	38	_
282-81	45726-45728	70	_
282-82	45731-45734	VIS	_
282-83	45735-45736	R	_
282-84	45737-45745	Fusiform	_
282-85	45745-45746	/	_
282-86	45746-45753	Lingual	_
282-87	45754-45756	22	_
282-88	45757-45758	−	_
282-89	45758-45760	59	_
282-90	45761-45762	−	_
282-91	45762-45764	11	_
282-92	45767-45770	VIS	_
282-93	45771-45772	L	_
282-94	45773-45781	Fusiform	_
282-95	45781-45782	/	_
282-96	45782-45789	Lingual	_
282-97	45790-45791	−	_
282-98	45791-45793	20	_
282-99	45794-45795	−	_
282-100	45795-45797	59	_
282-101	45798-45799	−	_
282-102	45799-45801	11	_
282-103	45804-45807	VIS	_
282-104	45808-45815	Lingual	_
282-105	45816-45817	0	_
282-106	45818-45819	−	_
282-107	45819-45821	79	_
282-108	45822-45823	5	_
282-109	45826-45829	VIS	_
282-110	45830-45831	L	_
282-111	45832-45835	MOG	_
282-112	45836-45837	−	_
282-113	45837-45839	30	_
282-114	45840-45841	−	_
282-115	45841-45843	85	_
282-116	45844-45846	15	_
282-117	45849-45852	VIS	_
282-118	45853-45860	Lingual	_
282-119	45860-45861	/	_
282-120	45861-45867	Vermis	_
282-121	45868-45869	0	_
282-122	45870-45871	−	_
282-123	45871-45873	66	_
282-124	45874-45875	−	_
282-125	45875-45877	11	_
282-126	45880-45883	VIS	_
282-127	45884-45885	R	_
282-128	45886-45889	SOG	_
282-129	45890-45892	28	_
282-130	45893-45894	−	_
282-131	45894-45896	74	_
282-132	45897-45899	42	_
282-133	45902-45905	VIS	_
282-134	45906-45907	R	_
282-135	45908-45911	IOG	_
282-136	45912-45914	48	_
282-137	45915-45916	−	_
282-138	45916-45918	68	_
282-139	45919-45920	−	_
282-140	45920-45922	11	_
282-141	45925-45928	VIS	_
282-142	45929-45930	L	_
282-143	45931-45934	IOG	_
282-144	45935-45936	−	_
282-145	45936-45938	48	_
282-146	45939-45940	−	_
282-147	45940-45942	65	_
282-148	45943-45944	−	_
282-149	45944-45946	16	_
282-150	45949-45952	SAL	_
282-151	45953-45954	R	_
282-152	45955-45961	Insula	_
282-153	45962-45964	40	_
282-154	45965-45967	19	_
282-155	45968-45969	−	_
282-156	45969-45970	6	_
282-157	45973-45976	SAL	_
282-158	45977-45978	R	_
282-159	45979-45992	Supramarginal	_
282-160	45993-45995	61	_
282-161	45996-45997	−	_
282-162	45997-45999	32	_
282-163	46000-46002	27	_
282-164	46005-46008	SAL	_
282-165	46009-46010	L	_
282-166	46011-46017	Insula	_
282-167	46018-46019	−	_
282-168	46019-46021	44	_
282-169	46022-46023	−	_
282-170	46023-46025	10	_
282-171	46026-46027	2	_
282-172	46030-46033	SAL	_
282-173	46034-46035	R	_
282-174	46036-46039	STG	_
282-175	46040-46042	48	_
282-176	46043-46044	3	_
282-177	46045-46046	−	_
282-178	46046-46048	12	_
282-179	46051-46054	DMN	_
282-180	46055-46058	ACC	_
282-181	46059-46060	0	_
282-182	46061-46063	45	_
282-183	46064-46065	5	_
282-184	46068-46071	DMN	_
282-185	46072-46073	L	_
282-186	46074-46081	Angular	_
282-187	46082-46083	−	_
282-188	46083-46085	44	_
282-189	46086-46087	−	_
282-190	46087-46089	68	_
282-191	46090-46092	36	_
282-192	46095-46098	DMN	_
282-193	46099-46102	PCC	_
282-194	46103-46104	0	_
282-195	46105-46106	−	_
282-196	46106-46108	38	_
282-197	46109-46111	26	_
282-198	46114-46117	DMN	_
282-199	46118-46121	PCC	_
282-200	46121-46122	/	_
282-201	46122-46131	Precuneus	_
282-202	46132-46133	0	_
282-203	46134-46135	−	_
282-204	46135-46137	63	_
282-205	46138-46140	31	_
282-206	46143-46146	ECN	_
282-207	46147-46148	L	_
282-208	46149-46152	IFG	_
282-209	46152-46153	-	_
282-210	46153-46155	44	_
282-211	46156-46157	−	_
282-212	46157-46159	44	_
282-213	46160-46162	13	_
282-214	46163-46165	33	_
282-215	46168-46171	ECN	_
282-216	46172-46173	L	_
282-217	46174-46177	IPL	_
282-218	46178-46179	−	_
282-219	46179-46181	48	_
282-220	46182-46183	−	_
282-221	46183-46185	44	_
282-222	46186-46188	50	_
282-223	46191-46194	ECN	_
282-224	46195-46196	R	_
282-225	46197-46200	IFG	_
282-226	46200-46201	-	_
282-227	46201-46203	45	_
282-228	46204-46206	48	_
282-229	46207-46209	17	_
282-230	46210-46212	29	_
282-231	46215-46218	ECN	_
282-232	46219-46220	L	_
282-233	46221-46224	IFG	_
282-234	46224-46225	-	_
282-235	46225-46227	45	_
282-236	46228-46229	−	_
282-237	46229-46231	44	_
282-238	46232-46234	39	_
282-239	46235-46237	15	_
282-240	46240-46243	ECN	_
282-241	46244-46245	L	_
282-242	46246-46249	MFG	_
282-243	46250-46251	−	_
282-244	46251-46253	24	_
282-245	46254-46255	3	_
282-246	46256-46258	61	_
282-247	46261-46264	ECN	_
282-248	46265-46266	R	_
282-249	46267-46270	IPL	_
282-250	46271-46273	48	_
282-251	46274-46275	−	_
282-252	46275-46277	52	_
282-253	46278-46280	45	_
282-254	46283-46286	PRE	_
282-255	46287-46296	Precuneus	_
282-256	46296-46297	-	_
282-257	46297-46299	7m	_
282-258	46300-46301	0	_
282-259	46302-46303	−	_
282-260	46303-46305	76	_
282-261	46306-46308	44	_
282-262	46311-46314	PRE	_
282-263	46315-46321	Cuneus	_
282-264	46322-46323	0	_
282-265	46324-46325	−	_
282-266	46325-46327	86	_
282-267	46328-46330	28	_
282-268	46333-46336	PRE	_
282-269	46337-46346	Precuneus	_
282-270	46346-46347	-	_
282-271	46347-46349	7a	_
282-272	46350-46351	0	_
282-273	46352-46353	−	_
282-274	46353-46355	69	_
282-275	46356-46358	62	_
282-276	46361-46364	PRE	_
282-277	46365-46374	Precuneus	_
282-278	46375-46376	0	_
282-279	46377-46378	−	_
282-280	46378-46380	56	_
282-281	46381-46383	10	_
282-282	46387-46391	RSNs	_
282-283	46392-46396	were	_
282-284	46397-46408	categorized	_
282-285	46409-46411	in	_
282-286	46412-46415	the	_
282-287	46416-46425	following	_
282-288	46426-46436	functional	_
282-289	46437-46443	groups	_
282-290	46443-46444	:	_
282-291	46445-46448	SBC	_
282-292	46449-46450	(	_
282-293	46450-46461	subcortical	_
282-294	46461-46462	)	_
282-295	46462-46463	,	_
282-296	46464-46467	CER	_
282-297	46468-46469	(	_
282-298	46469-46479	cerebellum	_
282-299	46479-46480	)	_
282-300	46480-46481	,	_
282-301	46482-46485	AUD	_
282-302	46486-46487	(	_
282-303	46487-46495	auditory	_
282-304	46495-46496	)	_
282-305	46496-46497	,	_
282-306	46498-46501	SEN	_
282-307	46502-46503	(	_
282-308	46503-46515	sensorimotor	_
282-309	46515-46516	)	_
282-310	46516-46517	,	_
282-311	46518-46521	VIS	_
282-312	46522-46523	(	_
282-313	46523-46529	visual	_
282-314	46529-46530	)	_
282-315	46530-46531	,	_
282-316	46532-46535	SAL	_
282-317	46536-46537	(	_
282-318	46537-46545	salience	_
282-319	46545-46546	)	_
282-320	46546-46547	,	_
282-321	46548-46551	DMN	_
282-322	46552-46553	(	_
282-323	46553-46560	default	_
282-324	46561-46565	mode	_
282-325	46566-46573	network	_
282-326	46573-46574	)	_
282-327	46574-46575	,	_
282-328	46576-46579	ECN	_
282-329	46580-46581	(	_
282-330	46581-46590	executive	_
282-331	46591-46598	control	_
282-332	46599-46606	network	_
282-333	46606-46607	)	_
282-334	46608-46611	and	_
282-335	46612-46615	PRE	_
282-336	46616-46617	(	_
282-337	46617-46626	precuneus	_
282-338	46626-46627	)	_
282-339	46627-46628	.	_

#Text=List of rsFNCs significantly related to FTND and AUDIT.
283-1	46629-46633	List	_
283-2	46634-46636	of	_
283-3	46637-46643	rsFNCs	_
283-4	46644-46657	significantly	_
283-5	46658-46665	related	_
283-6	46666-46668	to	_
283-7	46669-46673	FTND	_
283-8	46674-46677	and	_
283-9	46678-46683	AUDIT	_
283-10	46683-46684	.	_

#Text=RSN Pair\tSamples\tVariable Tested\tbeta\tp-value\t \tSMA-6 vs.
284-1	46685-46688	RSN	_
284-2	46689-46693	Pair	_
284-3	46694-46701	Samples	_
284-4	46702-46710	Variable	_
284-5	46711-46717	Tested	_
284-6	46718-46722	beta	_
284-7	46723-46730	p-value	_
284-8	46733-46736	SMA	_
284-9	46736-46737	-	_
284-10	46737-46738	6	_
284-11	46739-46741	vs	_
284-12	46741-46742	.	_

#Text=R IOG\tSAD\tFTND × AUDIT\t−0.0015\t0.037\t \tL Fusiform/Lingual vs.
285-1	46743-46744	R	_
285-2	46745-46748	IOG	_
285-3	46749-46752	SAD	_
285-4	46753-46757	FTND	_
285-5	46758-46759	×	_
285-6	46760-46765	AUDIT	_
285-7	46766-46767	−	_
285-8	46767-46773	0.0015	_
285-9	46774-46779	0.037	_
285-10	46782-46783	L	_
285-11	46784-46792	Fusiform	_
285-12	46792-46793	/	_
285-13	46793-46800	Lingual	_
285-14	46801-46803	vs	_
285-15	46803-46804	.	_

#Text=Cuneus\tSAD\tFTND × AUDIT\t−0.0019\t0.020\t \tPostcentral-3b vs.
286-1	46805-46811	Cuneus	_
286-2	46812-46815	SAD	_
286-3	46816-46820	FTND	_
286-4	46821-46822	×	_
286-5	46823-46828	AUDIT	_
286-6	46829-46830	−	_
286-7	46830-46836	0.0019	_
286-8	46837-46842	0.020	_
286-9	46845-46856	Postcentral	_
286-10	46856-46857	-	_
286-11	46857-46859	3b	_
286-12	46860-46862	vs	_
286-13	46862-46863	.	_

#Text=R Fusiform/Lingual\tDRN\tAUDIT\t−0.0162\t0.028\t \tL Angular vs.
287-1	46864-46865	R	_
287-2	46866-46874	Fusiform	_
287-3	46874-46875	/	_
287-4	46875-46882	Lingual	_
287-5	46883-46886	DRN	_
287-6	46887-46892	AUDIT	_
287-7	46893-46894	−	_
287-8	46894-46900	0.0162	_
287-9	46901-46906	0.028	_
287-10	46909-46910	L	_
287-11	46911-46918	Angular	_
287-12	46919-46921	vs	_
287-13	46921-46922	.	_

#Text=Precuneus\tSMK\tFTND\t0.0408\t0.015
288-1	46923-46932	Precuneus	_
288-2	46933-46936	SMK	_
288-3	46937-46941	FTND	_
288-4	46942-46948	0.0408	_
288-5	46949-46954	0.015	_
